Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.8107165864665312,-2.274090665375616,0.0,0.0,0.0,11/19,8.00%,GRM7;GRID2;GRIA4;GRM3;GRIK2;GRM5;GRIK4;GRIA1;GRIK1;GRM8;GRIA2
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6865526403978626,-2.1645706578339525,0.0,0.0,0.0,18/29,20.05%,GRID2;GRIA4;GRIK2;GRIK4;GABRA2;GABRB3;GLRA3;GRIK1;GABRA3;GABRA4;GRIA2;GABRB1;GABRG3;GABRB2;GABRA5;GRIK3;GLRA2;GABRA1
prerank,ligand-gated ion channel activity (GO:0015276),-0.6825798572714094,-2.1543856351097204,0.0,0.0,0.0,13/30,9.47%,GRID2;GRIA4;GRIK2;GRIN3A;GRIK4;GRIA1;GRIK1;GRIN2A;GRIA3;GRIN2B;GRIA2;GABRB1;GRIN1
prerank,ligand-gated channel activity (GO:0022834),-0.6867963669919215,-2.1393546742915657,0.0,0.0002532381413190661,0.001,13/29,9.47%,GRID2;GRIA4;GRIK2;GRIN3A;GRIK4;GRIA1;GRIK1;GRIN2A;GRIA3;GRIN2B;GRIA2;GABRB1;GRIN1
prerank,retinoid binding (GO:0005501),0.7844694938681976,2.1008108356854427,0.0,0.0019815664778398945,0.002,5/22,3.59%,ALDH1A2;RBP1;NR2F2;ABCA4;RBP4
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7840321053617584,-2.0804660321347996,0.0,0.002025905130552529,0.008,12/17,9.47%,GRIA4;GRIK2;GRIN3A;GRIK4;PTK2B;GRIA1;GRIK1;GRIN2A;GRIA3;GRIN2B;GRIA2;GRIN1
prerank,cell adhesion mediator activity (GO:0098631),-0.6627649783876424,-1.9739016264628533,0.0,0.01029835108030869,0.054,11/24,10.19%,LRRC4C;BSG;ESAM;CNTN4;CNTN6;BCAM;ROBO4;NPTN;JAM3;CNTN2;EMB
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6686786472599561,-1.9193001812856771,0.0,0.017509608628346857,0.106,10/19,16.02%,GRID2;GRIK2;GRIK4;GABRA2;GRIK1;GABRA3;GABRA4;GABRG3;GABRA5;GRIK3
prerank,acetylation-dependent protein binding (GO:0140033),0.7434950021535717,1.9190251800256948,0.0,0.057135166777716954,0.139,10/20,15.26%,KMT2A;MLLT3;PHIP;BAZ2A;DPF2;TRIM24;PSME4;BRD4;CARM1;SMARCA4
prerank,lysine-acetylated histone binding (GO:0070577),0.7434950021535717,1.9190251800256948,0.0,0.057135166777716954,0.139,10/20,15.26%,KMT2A;MLLT3;PHIP;BAZ2A;DPF2;TRIM24;PSME4;BRD4;CARM1;SMARCA4
prerank,voltage-gated cation channel activity (GO:0022843),-0.4678402058589098,-1.8971754001949621,0.0,0.022031718294758754,0.144,24/97,11.84%,KCNB2;KCND2;CACNA1E;KCNQ5;CACNB2;GRIN3A;KCNMA1;KCNH7;PTK2B;KCNC2;KCNQ3;CACNB4;HCN1;GRIN2A;OPRM1;GRIN2B;HCN2;KCNH1;KCNH5;KCND3;CACNA1D;GRIN1;KCNB1;KCNQ1
prerank,cation:chloride symporter activity (GO:0015377),-0.805400680120303,-1.8787226710012352,0.0,0.025548914701968007,0.185,5/10,10.28%,SLC12A7;SLC12A2;SLC6A1;SLC12A5;SLC12A6
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5954752362167814,-1.8731102543758493,0.002352941176470588,0.024918633105796107,0.199,13/28,20.26%,GRID2;GRIK2;GRIK4;GABRA2;GRIK1;GABRA3;GABRA4;GABRG3;GABRA5;GRIK3;CHRNA4;GABRA1;CHRNA7
prerank,phospholipase activator activity (GO:0016004),0.8298386214307436,1.8632050853891893,0.001968503937007874,0.09883062808226473,0.289,2/10,0.50%,PDPK1;ARHGAP6
prerank,glutamate receptor binding (GO:0035254),-0.6661284879427477,-1.8578077476157215,0.0,0.02974397078038486,0.245,11/17,18.48%,SHANK3;HIP1;NSF;SYNDIG1;HOMER1;GNAS;SHANK2;CAMK2A;SHISA6;SHANK1;AKAP5
prerank,ligand-gated anion channel activity (GO:0099095),-0.6821948231212026,-1.8494631678926245,0.0,0.029966513389422827,0.27,12/17,20.05%,GABRA2;GABRB3;GLRA3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GLRA2;GLRA1;GABRA1
prerank,phospholipase binding (GO:0043274),0.7733790537490188,1.8411913179709292,0.0019193857965451055,0.11017509616789811,0.377,2/13,0.50%,PDPK1;ARHGAP6
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7483492262230097,1.8375326127678746,0.00186219739292365,0.09792241011325478,0.394,4/15,9.55%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH2
prerank,lipase activator activity (GO:0060229),0.8214364695765073,1.8356992461752586,0.001949317738791423,0.08577352039792685,0.398,2/10,0.50%,PDPK1;ARHGAP6
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.708975070975036,-1.8165037223303455,0.006160164271047228,0.04363487973497755,0.375,6/14,13.12%,KCNJ3;KCNJ2;KCND3;KCNJ8;KCNQ1;KCNE4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7589953501563657,1.788898520888656,0.005758157389635317,0.1467597672650172,0.616,4/13,9.55%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH2
prerank,sialyltransferase activity (GO:0008373),-0.6250040770861072,-1.7777156625891277,0.008438818565400843,0.0680848831374975,0.551,9/20,18.59%,ST6GALNAC3;ST8SIA4;ST3GAL6;ST8SIA6;ST6GALNAC4;ST6GALNAC5;ST3GAL4;ST6GAL2;ST8SIA5
prerank,GABA receptor activity (GO:0016917),-0.6206037198479646,-1.7761083684987833,0.004807692307692308,0.06442378315157042,0.553,10/21,15.75%,GABRA2;GABBR2;GABRB3;GABRA3;GABRA4;GABRB1;GPR156;GABRG3;GABRB2;GABRA5
prerank,chloride channel activity (GO:0005254),-0.4903458607011249,-1.7625457694526943,0.0,0.06919732211543482,0.608,27/59,20.05%,SLC26A7;ANO1;GABRA2;ANO3;GABRB3;GLRA3;GABRA3;CLCN3;GABRA4;CLCN7;SLC1A4;ANO4;TTYH2;GABRB1;GABRG3;CLCN1;TTYH3;ANO2;GABRB2;GABRA5;TTYH1;FXYD1;CLCN5;ANO5;GLRA2;GLRA1;GABRA1
prerank,cytokine activity (GO:0005125),0.4747782041438332,1.73397011012163,0.0,0.2592549475173862,0.851,23/131,7.90%,BMP6;WNT4;CXCL10;IL16;WNT6;CXCL16;WNT2B;WNT10B;WNT3A;OSM;IL11;IL34;BMP2;IL17D;IL6;WNT5B;BMP7;FAM3B;CKLF;CCL2;BMP8B;WNT5A;IL18
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.54121322135206,-1.7271154548267165,0.0,0.09807764249674891,0.748,10/31,10.28%,SLC12A7;SLC12A2;KCNK5;ABCC9;HCN1;TMEM38B;KCNK10;TMEM175;SLC12A5;SLC12A6
prerank,AMP binding (GO:0016208),0.7505729641889749,1.711105114435866,0.013133208255159476,0.2974331283237681,0.914,2/11,1.25%,MPPED2;PRKAG2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.7149517956875625,-1.7034620586170226,0.011811023622047244,0.11800897385468481,0.825,5/11,13.12%,KCNJ3;KCND3;KCNJ8;KCNQ1;KCNE4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6943143197096154,1.7013030742407438,0.013307984790874524,0.30056760620689665,0.933,2/14,0.77%,SLC7A11;SLC1A3
prerank,LRR domain binding (GO:0030275),0.7032932107502542,1.700505847034841,0.008976660682226212,0.27849265540641516,0.934,3/14,5.03%,ROBO1;PAWR;LRRFIP2
prerank,frizzled binding (GO:0005109),0.5757864484461637,1.696063256123478,0.013816925734024179,0.2691881846050195,0.941,11/34,15.19%,WNT4;WNT6;WNT2B;WNT10B;WNT3A;WNT5B;WNT5A;DVL3;WNT2;RNF43;RYK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6343206047102242,-1.691203019381976,0.00936768149882904,0.11881933590690581,0.856,8/16,11.10%,PTPRG;PTPRB;PTPRD;PTPRK;PTPRN2;PTPRM;PTPRT;PTPRO
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6343206047102242,-1.691203019381976,0.00936768149882904,0.11881933590690581,0.856,8/16,11.10%,PTPRG;PTPRB;PTPRD;PTPRK;PTPRN2;PTPRM;PTPRT;PTPRO
prerank,wide pore channel activity (GO:0022829),0.6328063631852243,1.6902507932845232,0.0068846815834767644,0.2651052866424373,0.952,7/23,10.17%,GJB2;GJB6;PANX3;GJA1;PRF1;GJA3;PANX1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6979328247207968,-1.6876939680367062,0.009861932938856016,0.1168271958618625,0.863,6/10,16.22%,SHANK3;NSF;GNAS;SHANK2;SHISA6;SHANK1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6654955755327367,-1.6747858920992542,0.008968609865470852,0.12689533045006296,0.905,9/13,20.05%,GABRA2;GLRA3;GABRA3;GABRA4;GABRG3;GABRA5;GLRA2;GLRA1;GABRA1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6913426141959069,-1.6743625127524275,0.0022123893805309734,0.12199472199196752,0.905,9/12,20.05%,GABRA2;GABRB3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GABRA1
prerank,potassium channel activity (GO:0005267),-0.4201619751062416,-1.659772195099152,0.0,0.13354091318892086,0.93,21/89,6.96%,KCNB2;KCND2;KCNQ5;GRIK2;KCNMB2;KCNK5;KCNMA1;ABCC9;KCNH7;GRIK4;KCNC2;KCNQ3;HCN1;GRIK1;KCNT1;TMEM38B;KCNK10;HCN2;TMEM175;KCNH1;KCNH5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6518239243943393,1.6554261538744108,0.02727272727272727,0.3472364991334775,0.986,2/18,0.35%,ALDH1A2;ALDH1A1
prerank,GABA-A receptor activity (GO:0004890),-0.5984019566536629,-1.6505311902403,0.017857142857142856,0.1397064178029024,0.948,9/18,20.05%,GABRA2;GABRB3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GABRA1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6767687215499861,1.6408874052227402,0.023297491039426525,0.3721010301668727,0.992,5/13,7.55%,BMP6;CDH5;BMP2;BMP7;BMP8B
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5099032984510349,1.6331722653035838,0.010606060606060607,0.37579825438563647,0.994,11/55,4.74%,PDPN;SLC7A2;SLC6A13;SLC13A3;SLC16A11;SLC19A1;SLC16A12;SLC16A2;SLC6A12;SLC7A14;SLC16A5
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.5201851790155921,-1.62378460454557,0.019704433497536946,0.17099418496144328,0.973,10/32,14.60%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNH1;KCNB1;KCNQ1;KCNE4;KCNC1;KCNA2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6660264675639257,-1.6215460779261899,0.01511879049676026,0.1678875085041216,0.976,7/11,9.45%,ATP8A1;ATP10A;ABCA3;ATP8A2;ATP11A;ATP8B2;ATP8B1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.4428148411223101,-1.6143486482218043,0.0079155672823219,0.17212958234230236,0.981,31/57,30.23%,COX4I1;NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;UQCRH;UQCR11;NDUFA1;COX8A;CYBRD1;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFB7;NDUFC2;NDUFB10;NDUFA13;NDUFA4L2;CYB5A;UQCR10;NDUFA9;CYB561A3;UQCRQ;NDUFA10;COX4I2;NDUFS6;NDUFS1;COX5B;NDUFV3
prerank,cAMP response element binding (GO:0035497),0.7221795913672606,1.6064472330737347,0.019267822736030827,0.44464150022196297,0.999,4/10,10.05%,CREB5;CREB3L2;ATF7;E4F1
prerank,R-SMAD binding (GO:0070412),0.6019636226493885,1.6043134953278038,0.034358047016274866,0.42833123813097085,0.999,6/18,11.55%,SMAD3;PPM1A;LDLRAD4;PMEPA1;SMAD6;SMAD4
prerank,anion channel activity (GO:0005253),-0.4392225763884031,-1.6040998278150287,0.007936507936507936,0.18082949760121453,0.986,26/61,20.05%,SLC26A7;ANO1;GABRA2;ANO3;GABRB3;GLRA3;GABRA3;CLCN3;GABRA4;CLCN7;SLC1A4;ANO4;GABRB1;LRRC8C;GABRG3;TTYH3;ANO2;GABRB2;VDAC1;GABRA5;FXYD1;CLCN5;ANO5;GLRA2;GLRA1;GABRA1
prerank,amyloid-beta binding (GO:0001540),-0.41355157848240987,-1.6036479603670928,0.005988023952095809,0.1756459748189043,0.986,24/79,13.00%,APBB2;NLGN1;COL25A1;GRIA4;CST3;TGFB2;INSR;GRIA1;ITM2A;GRIN2A;SORL1;GRIA3;GRIN2B;APBA2;PFDN5;BCHE;GRIA2;LDLRAP1;GRIN1;CD74;ADRB2;PFDN2;CLSTN1;FZD4
prerank,tropomyosin binding (GO:0005523),0.6454239579395895,1.603633524415659,0.020560747663551402,0.4084008510828022,0.999,4/16,5.53%,TMOD3;CALD1;S100A6;NEBL
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6534752981779932,1.6034232280088823,0.04081632653061224,0.38942499304977357,0.999,3/14,5.12%,SDR9C7;RDH10;RDH5
prerank,hormone receptor binding (GO:0051427),0.6622816841598401,1.5996851063955615,0.036101083032490974,0.38347814906378863,0.999,5/14,11.74%,GHRH;PTHLH;NCOA6;NPPC;JAK1
prerank,pentosyltransferase activity (GO:0016763),0.5297400738995981,1.596258176795419,0.016233766233766232,0.3777468792212616,0.999,13/36,12.84%,PARP14;ZC3HAV1;PARP9;LACC1;LARGE1;PARP3;PARP10;UPP1;PARP11;SIRT4;TIPARP;UMPS;PARP16
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.5560860599485146,-1.5959374477529,0.023706896551724137,0.18180864752248826,0.99,7/20,13.72%,SLC39A10;SLC39A6;SLC30A1;SLC39A12;SLC39A14;SLC39A13;SLC39A8
prerank,gap junction channel activity (GO:0005243),0.5982146348640593,1.5934385417914132,0.020942408376963352,0.36956214811714033,1.0,6/22,10.17%,GJB2;GJB6;PANX3;GJA1;GJA3;PANX1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5376063656919853,1.589848310649987,0.019448946515397084,0.3658764344683581,1.0,10/38,12.89%,TFPI;SERPING1;ANXA2;SERPINB7;TFPI2;SERPINE1;SPINT2;SERPINE2;SERPINB8;SERPINE3
prerank,BMP receptor binding (GO:0070700),0.6767734466923186,1.5847887167266026,0.040740740740740744,0.3676567957346019,1.0,5/12,7.55%,BMP6;CDH5;BMP2;BMP7;BMP8B
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.4979337760837885,-1.5819034944856685,0.025056947608200455,0.1974940954612067,0.993,10/30,15.83%,SLC39A10;SLC40A1;SLC39A6;SLC31A1;SLC30A1;SLC39A12;SLC39A14;SLC39A13;SLC39A8;TTYH1
prerank,transforming growth factor beta binding (GO:0050431),0.5870483867846643,1.5817890012577958,0.021164021164021163,0.36387431841222945,1.0,7/23,7.03%,TGFBR3;LTBP1;TWSG1;LRRC32;WFIKKN1;TGFBR1;TGFBR2
prerank,alanine transmembrane transporter activity (GO:0022858),-0.6479665416482262,-1.5726035962193994,0.04516129032258064,0.20615119479986038,0.996,5/12,13.49%,SLC6A6;SLC38A5;SLC1A4;SLC36A1;SLC3A2
prerank,poly(U) RNA binding (GO:0008266),0.6046856893679313,1.5715601426196888,0.04212454212454213,0.380673074439314,1.0,7/20,8.15%,RBMS3;RBMS1;ATXN1;RBMS2;PABPC5;HNRNPH1;HNRNPC
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5647464874927459,1.5715286659849494,0.034722222222222224,0.36771724139639284,1.0,13/25,19.96%,PARP14;ZC3HAV1;PARP9;PARP3;PARP10;PARP11;SIRT4;TIPARP;PARP16;TNKS2;PARP4;SIRT3;SIRT2
prerank,SUMO transferase activity (GO:0019789),0.6387692983378722,1.5708372827467505,0.04477611940298507,0.35770577535806497,1.0,7/16,15.88%,RANBP2;HDAC4;PIAS1;NSMCE2;EGR2;CBX4;MUL1
prerank,phospholipid transfer activity (GO:0120014),-0.5488332844469479,-1.5698895260633137,0.02850877192982456,0.20455683274078917,0.996,7/21,8.32%,CERT1;PITPNC1;PITPNA;ABCA3;GLTP;PRELID2;PRELID1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6151362256793071,1.566525354482634,0.03925233644859813,0.3582480427436674,1.0,6/18,5.11%,TMOD3;ANXA2;ANXA1;RAB10;PKP3;BAIAP2L1
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.399617175092908,1.5658916219513725,0.0,0.34875570009982143,1.0,62/232,18.38%,RNF220;PDZRN3;CBLB;RNF152;SMURF2;TRIM56;TRIM10;RNF217;SH3RF1;TRIP12;NEDD4;NHLRC3;DTX4;RC3H1;MYCBP2;TRIM17;RNF19A;SIAH2;BIRC3;RNF216;PELI2;DTX1;ANAPC11;DTX3L;TRIM5;MGRN1;RNF111;TRIM24;RNF145;PIAS1;UBR4;AMFR;WWP2;HUWE1;RFWD3;TRIM21;CUL3;HECTD1;NSMCE2;EGR2;TRIM7;TRIM26;HECW2;CBX4;BRAP;RNF181;RNF39;RNF43;BFAR;PRPF19;RCHY1;KCMF1;MUL1;RNF2;RNF180;RNF185;RING1;RNF135;UBR5;TRIM3;RNF215;SHPRH
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.7019531547727909,1.5609119063148857,0.054878048780487805,0.3498365545422795,1.0,1/10,0.23%,DPYSL3
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5563948247353923,-1.5599387774626605,0.024886877828054297,0.21422499680499743,0.999,4/19,3.70%,NRG3;EFNA5;GRM5;GAS6
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5956658435843882,-1.5502379357451928,0.027896995708154508,0.22515684520390747,1.0,6/15,2.84%,HS3ST1;HS6ST3;HS6ST2;NDST3;HS3ST4;HS3ST5
prerank,endopeptidase inhibitor activity (GO:0004866),0.455239589126573,1.5481445732791281,0.01023391812865497,0.37486575251371174,1.0,19/82,10.90%,TFPI;COL4A3;TIMP3;SERPING1;ANXA2;CSTB;ITIH2;SERPINB7;TFPI2;SERPINE1;BST2;SPINT2;PZP;SERPINE2;PROS1;TIMP2;UBE2Z;CAST;SERPINB8
prerank,RNA polymerase II complex binding (GO:0000993),0.5391412006330325,1.5387425676362636,0.03633217993079585,0.38934950480299874,1.0,12/32,19.70%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;BRD4;PAF1;ERCC5;URI1;UVSSA;RPRD1B
prerank,receptor ligand activity (GO:0048018),0.39348817384049994,1.5376489156895832,0.0012453300124533001,0.38178180806381967,1.0,32/245,7.90%,SEMA3D;BMP6;WNT4;PTN;DPP4;EPHA7;CXCL10;IL16;WNT6;FGF1;WNT2B;WNT10B;WNT3A;OSM;NBL1;IL11;IL34;VEGFD;TGFA;PTHLH;BMP2;IL17D;IL6;WNT5B;BMP7;FAM3B;SEMA4B;EDA;BMP8B;NPPC;WNT5A;IL18
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.5664492658858823,-1.5370628572211427,0.022267206477732792,0.24091844795759806,1.0,6/17,9.45%,ATP10A;PITPNC1;PITPNA;ABCA3;ATP8B2;ATP8B1
prerank,water transmembrane transporter activity (GO:0005372),0.6958646423595877,1.5349244800498623,0.03740157480314961,0.3787737544465582,1.0,2/11,6.14%,PDPN;SLC4A11
prerank,acylglycerol lipase activity (GO:0047372),-0.6317963060719456,-1.5335972042903439,0.043478260869565216,0.24025635449565713,1.0,6/11,25.39%,MGLL;ABHD2;LIPE;ABHD6;FAAH;ABHD15
prerank,Tat protein binding (GO:0030957),-0.6420159994105883,-1.5330511730997913,0.03382663847780127,0.23505694142949218,1.0,5/10,9.28%,ACTB;CTDP1;GABARAPL1;NPM1;SMARCB1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5629553480520814,1.5323793164917479,0.05326460481099656,0.37600223917011993,1.0,7/23,8.15%,RBMS3;RBMS1;ATXN1;RBMS2;PABPC5;HNRNPH1;HNRNPC
prerank,peptidase inhibitor activity (GO:0030414),0.5308221603362648,1.5302437587483706,0.023890784982935155,0.3713404770075094,1.0,8/33,9.76%,TFPI;CSTB;ITIH2;SPINT2;PZP;PROS1;TIMP2;CAST
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.39926062473188584,1.5287635625940474,0.0038860103626943004,0.36592101971410945,1.0,36/181,12.21%,TCF7L2;SMAD3;RBPJ;ARNT2;NCOA3;PARP9;LDB2;DACT1;CRY1;TACC2;ARNT;MIER3;PRRX1;MTDH;TACC1;BAZ2A;MIER1;CPNE1;ANXA4;FOXP3;DTX3L;CREBBP;PPARA;HDAC4;STAT1;POU1F1;GSK3B;PIAS1;MEF2A;RERE;MAPK14;WWP2;RBBP8;IFI27;ATN1;EGR2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3898264983971178,1.5253894812859077,0.004956629491945477,0.36562318060631227,1.0,59/228,18.38%,RNF220;PDZRN3;CBLB;RNF152;SMURF2;TRIM56;TRIM10;RNF217;SH3RF1;TRIP12;NEDD4;NHLRC3;DTX4;RC3H1;MYCBP2;TRIM17;RNF19A;SIAH2;BIRC3;RNF216;PELI2;DTX1;ANAPC11;DTX3L;TRIM5;MGRN1;RNF111;TRIM24;RNF145;UBR4;AMFR;WWP2;HUWE1;RFWD3;TRIM21;CUL3;HECTD1;TRIM7;TRIM26;HECW2;BRAP;RNF181;RNF39;RNF43;BFAR;PRPF19;RCHY1;KCMF1;MUL1;RNF2;RNF180;RNF185;RING1;RNF135;UBE4B;UBR5;TRIM3;RNF215;SHPRH
prerank,filamin binding (GO:0031005),0.6779799726359499,1.5246609719794952,0.055865921787709494,0.35859276225766945,1.0,5/11,10.06%,DPYSL3;SYNPO2;NEBL;FBLIM1;RFLNA
prerank,protein kinase C activity (GO:0004697),-0.591606685492421,-1.5200355674368429,0.03991596638655462,0.25333943657559377,1.0,4/14,5.74%,PRKCH;PRKCB;PRKCQ;PKN1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6094884643630273,-1.5162487520032806,0.049783549783549784,0.2535840275608678,1.0,5/11,21.84%,PPP1R1A;PPP1R11;PPP1R14B;PPP1R14C;PPP1R8
prerank,microtubule motor activity (GO:0003777),-0.4224068383607135,-1.5071168003335236,0.018469656992084433,0.2650559212472893,1.0,20/51,24.43%,KIF1B;KIF21A;KIF26B;KIF1C;STARD9;DNAH8;KIF26A;KIF18A;KIF5C;DYNC1I2;KIF15;KIF3B;KIF16B;KIF5A;KIF27;KIF23;KIF4A;KIF22;KIF14;KIFC3
prerank,sterol binding (GO:0032934),0.4675813699223599,1.5056038843932913,0.028985507246376812,0.4013363361745963,1.0,14/56,12.55%,RORA;SIDT1;GRAMD1C;APOA2;APOF;OSBPL8;VDAC2;NR1H3;NPC1;INSIG2;SCP2;SOAT1;ABCA1;OSBPL5
prerank,poly-purine tract binding (GO:0070717),0.5403451285586783,1.5031905743267246,0.047285464098073555,0.3989478782714706,1.0,5/27,5.65%,RBMS3;RBMS1;ATXN1;RBMS2;PABPC5
prerank,ligand-gated cation channel activity (GO:0099094),-0.39354696327745226,-1.4953814336862545,0.01764705882352941,0.2804700753995164,1.0,17/75,12.33%,GRIA4;GRIK2;GRIN3A;KCNJ3;GRIK4;KCNJ2;PTK2B;GRIA1;GRIK1;GRIN2A;GRIA3;GRIN2B;GRIA2;GRIN1;KCNJ6;KCNJ8;KCNJ15
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6304005096264259,-1.4925995586879026,0.05042016806722689,0.27975908120993564,1.0,6/10,20.05%,GABRA2;GABRA3;GABRA4;GABRG3;GABRA5;GABRA1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6174434425516562,1.489183572997745,0.06111111111111111,0.4270716107851159,1.0,4/15,11.59%,KMT2A;KMT2C;SETD4;SETD1B
prerank,neurexin family protein binding (GO:0042043),-0.6436555877829895,-1.4845198631393344,0.05496828752642706,0.2892542325288889,1.0,4/10,8.78%,NLGN1;CPE;SYTL2;NLGN3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5830263738965732,-1.4844747328008567,0.0611353711790393,0.28303215916295277,1.0,5/13,12.79%,CCDC88A;ARHGDIB;GDI2;ARHGDIA;RANBP1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.36493506393954095,1.4827761586481336,0.001182033096926714,0.43622462908360193,1.0,83/346,17.01%,RNF220;PDZRN3;CBLB;RNF152;RNF213;SMURF2;TRIM56;TRIM10;RNF217;TRAF5;FBXO11;SH3RF1;TRIP12;NEDD4;TTC3;NHLRC3;DTX4;RC3H1;MYCBP2;BCOR;TRIM17;RNF19A;KLHL21;SIAH2;UBE2U;DZIP3;BIRC3;RNF216;PELI2;CUL4A;DTX1;ANAPC11;DTX3L;TRIM5;FBXO9;MGRN1;RNF20;RNF111;FBXL3;TRIM24;RNF145;UBR4;UBE2Z;PJA2;AMFR;UBE2C;FBXO4;FBXO24;WWP2;KLHL13;HUWE1;RFWD3;TRIM21;CUL3;HECTD1;FBXW11;TRIM7;TRIM26;BTRC;HECW2;UBE2Q2;BRAP;UBE2E3;RNF103-CHMP3;RNF181;RNF39;RNF43;BFAR;PRPF19;FBXO3;UBE2R2;BIRC6;RCHY1;PML;KCMF1;MUL1;RNF146;RNF2;RNF180;RNF185;RING1;RNF135;TRIM23
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5093973858191334,1.4787722827392125,0.05414551607445008,0.4375256622081597,1.0,11/33,19.70%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;PAF1;ERCC5;URI1;UVSSA;RPRD1B
prerank,telomerase RNA binding (GO:0070034),0.5638415366831134,1.4755576514633535,0.04912280701754386,0.43782298501522915,1.0,12/22,21.63%,TERT;DCP2;HNRNPC;XRN1;SMG5;SMG6;SMG7;EXOSC10;DHX36;PARN;TENT4B;TEP1
prerank,MAP-kinase scaffold activity (GO:0005078),0.6530484689177976,1.4686674314702561,0.07184466019417475,0.4472678621410047,1.0,3/11,3.21%,AKAP13;KSR1;SH3RF1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.47127640395593945,1.4667742530629515,0.0448,0.4439105223656931,1.0,6/47,4.45%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC16A2;SLC7A14
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6339279301513522,1.4666986681752125,0.05849056603773585,0.43542009282181915,1.0,5/12,7.03%,TGFBR3;LTBP1;BMPR1A;TGFBR1;TGFBR2
prerank,NAD+ binding (GO:0070403),0.6280818772776602,1.4661284874820497,0.08317929759704251,0.42826605502314713,1.0,3/12,4.65%,ZC3HAV1;PARP9;CRYL1
prerank,growth factor receptor binding (GO:0070851),0.41862657362018646,1.4597292566556435,0.01791044776119403,0.4382252959766302,1.0,15/95,6.06%,EFEMP1;PDGFRA;FGF1;IL6ST;IL11;FRS2;IL23R;FER;ITGA5;KL;VEGFD;TGFA;IL6;PDGFRB;ARF4
prerank,channel activity (GO:0015267),0.48106231397544447,1.4588541413106904,0.04377104377104377,0.43231175324873694,1.0,7/41,10.17%,PDPN;PANX3;PRF1;BCL2;MPV17;BAX;PANX1
prerank,cholesterol transfer activity (GO:0120020),0.5847275347677214,1.4526491130620554,0.08806262230919765,0.44129485461494444,1.0,2/16,2.13%,GRAMD1C;APOA2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.33975412118607284,1.4483407866278097,0.001076426264800861,0.44477321148586696,1.0,146/731,15.88%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;ZEB2;RBPJ;MXI1;NR2F2;KCNIP3;ELF1;CREB3L2;TEAD1;ARNT2;GATA6;FOXC1;STAT2;NFIA;NFAT5;NFYC;ZNF697;MAF;SPIB;POU5F1;HIF3A;ZNF395;ZBTB4;NR6A1;ZIC2;GLI3;FOXC2;ZIC4;NFATC4;MYB;HIVEP2;PRRX2;IKZF2;HIVEP1;LITAF;HOXC6;HOXC4;ZIC1;STAT5B;RFX3;CREB3L3;CREB3L4;ARNT;GLI1;ZFP30;PRRX1;GLIS3;HLF;TOP1;EN2;SALL1;GZF1;TCF12;MGA;KLF5;SP9;NR1H3;RARB;FOXP3;PPARA;TCF7L1;ZKSCAN4;HDAC4;NSD1;STAT1;ZBTB37;GLIS2;KLF9;POU1F1;ZBTB7C;ZEB1;HOXA2;ZSCAN21;TRIM24;SKI;MEF2A;ZNF182;ATF7;ELF4;SP8;TEAD2;SOX21;ZNF394;MAFB;ZBTB3;CREM;E4F1;EBF4;PBX1;EGR3;HEYL;MSC;TCF7;ZNF235;SMAD4;FOXO3;HIVEP3;STAT4;EGR2;NR4A1;ZNF219;ZFAT;POU2F1;ZKSCAN7;MZF1;HOXA10;BPTF;THAP1;NFIC;NR3C1;PRDM5;GMEB1;NRF1;NFE2L1;BHLHE41;ZNF205;PKNOX1;ZBTB12;HIC1;DMTF1;SALL2;SNAPC3;ZNF18;RFX2;ZNF569;RARA;SP3;ZNF260;SMAD2;CCAR1;IRF9;ZNF383;ELK4;HOXB4;SOX4;ZBTB5;TEF
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4963464881921532,-1.4476473057812393,0.06787330316742081,0.3552877242250898,1.0,11/22,21.18%,ATP6V0A1;ATP6V1B2;ATP2C1;ATP2A3;ATP6V0C;ATP6V1D;ATP5F1B;ATP2A2;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.3766615057474163,1.445227001930946,0.011780104712041885,0.44580031102771733,1.0,36/188,13.92%,TCF7L2;ZBTB20;SOX5;SMAD3;ARID4A;CREB3L2;TBL1XR1;GATA6;FOXC1;NFYC;POU5F1;FOXC2;CRY2;RFX3;GABPB1;GABPB2;CREB3L3;GLI1;BCOR;TCF12;NR1H3;HDAC4;GLIS2;YAP1;TAF7;SMAD6;PBX1;PSPC1;TCF7;SMAD4;FOXO3;EGR2;ARID5B;MZF1;PRDM5;CARM1
prerank,protein phosphatase 1 binding (GO:0008157),-0.4920985853561403,-1.4403831823275655,0.06981981981981981,0.3643463758228064,1.0,9/21,23.60%,PPP1R16B;PHACTR4;PPP1R3B;PPP1R11;KCNQ1;PPP1R3C;SH3RF2;PPP1R15A;SMTNL2
prerank,outward rectifier potassium channel activity (GO:0015271),0.6352743315938033,1.4378668101999184,0.09541984732824428,0.45881805196811837,1.0,2/11,0.48%,KCNK2;KCNT2
prerank,platelet-derived growth factor binding (GO:0048407),0.6164733005023063,1.4356150950347437,0.08555133079847908,0.45775864931726856,1.0,4/11,5.76%,COL3A1;PDGFRA;COL5A1;PDGFRB
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3363627488714189,1.4338559315592123,0.0010626992561105207,0.45447227169257975,1.0,173/831,16.87%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;ZEB2;RBPJ;MXI1;NR2F2;KCNIP3;ELF1;TEAD1;ARNT2;OSR1;GATA6;FOXC1;STAT2;NFIA;NFAT5;NFYC;ZNF697;MAF;SPIB;TCF24;POU5F1;HIF3A;ZNF395;ZBTB4;NR6A1;ZIC2;GLI3;FOXC2;ZIC4;NFATC4;MYB;HIVEP2;PRRX2;IKZF2;HIVEP1;ZBTB8A;LITAF;HOXC6;HOXC4;ZIC1;STAT5B;RFX3;CREB3L3;CREB3L4;ARNT;GLI1;ZFP30;PRRX1;GLIS3;EPAS1;HLF;TOP1;EN2;SIM2;AEBP1;SALL1;GZF1;STOX1;TCF12;OTP;ZNF3;MGA;ZNF35;KLF5;SP9;NR1H3;RARB;FOXP3;PPARA;TCF7L1;ZKSCAN4;HDAC4;NSD1;STAT1;ZBTB37;GLIS2;KLF9;POU1F1;ZBTB7C;ZEB1;HOXA2;ZSCAN21;ZNF25;CREBRF;NFXL1;SKI;MEF2A;ZNF182;ATF7;ELF4;ZFP37;SP8;TEAD2;CUX1;SOX21;ZNF394;MAFB;ZBTB3;CREM;E4F1;EBF4;PBX1;EGR3;RFXANK;HEYL;MSC;TCF7;CUX2;ZNF235;SMAD4;FOXO3;HIVEP3;STAT4;RFXAP;EGR2;LHX9;NR4A1;ZNF219;ZFAT;POU2F1;ZKSCAN7;MZF1;HOXA10;BPTF;THAP1;NFIC;NR3C1;PRDM5;GMEB1;NRF1;NFE2L1;BHLHE41;ZNF205;PKNOX1;ZBTB12;HIC1;DMTF1;SALL2;SNAPC3;ZNF18;RFX2;ZNF569;RARA;SP3;ZNF260;SMAD2;CCAR1;IRF9;ZNF383;ELK4;HOXB4;SOX4;ZBTB5;TEF;VEZF1;BCL11B;POU6F1;NRIP1;MUC1;DRGX;JDP2;DNMT3A;ZNF483;STAT5A
prerank,calcium channel regulator activity (GO:0005246),-0.43281255148366965,-1.4338091819460652,0.037783375314861464,0.3721463689817002,1.0,7/37,7.63%,NRXN1;PRKG1;FKBP1A;CALM1;MCUB;CALM2;SLC30A1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.33606674339935644,1.4324386481893556,0.001075268817204301,0.450822616056755,1.0,145/732,15.88%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;ZEB2;RBPJ;MXI1;NR2F2;KCNIP3;ELF1;TEAD1;ARNT2;GATA6;FOXC1;STAT2;NFIA;NFAT5;NFYC;ZNF697;MAF;SPIB;POU5F1;HIF3A;ZNF395;ZBTB4;NR6A1;ZIC2;GLI3;FOXC2;ZIC4;NFATC4;MYB;HIVEP2;PRRX2;IKZF2;HIVEP1;LITAF;HOXC6;HOXC4;ZIC1;STAT5B;RFX3;CREB3L3;CREB3L4;ARNT;GLI1;ZFP30;PRRX1;GLIS3;HLF;TOP1;EN2;SALL1;GZF1;TCF12;MGA;KLF5;SP9;NR1H3;RARB;FOXP3;PPARA;TCF7L1;ZKSCAN4;HDAC4;NSD1;STAT1;ZBTB37;GLIS2;KLF9;POU1F1;ZBTB7C;ZEB1;HOXA2;ZSCAN21;SKI;MEF2A;ZNF182;ATF7;ELF4;SP8;TEAD2;SOX21;ZNF394;MAFB;ZBTB3;CREM;E4F1;EBF4;PBX1;TIPARP;EGR3;HEYL;MSC;TCF7;ZNF235;SMAD4;FOXO3;HIVEP3;STAT4;EGR2;NR4A1;ZNF219;ZFAT;POU2F1;ZKSCAN7;MZF1;HOXA10;BPTF;THAP1;NFIC;NR3C1;PRDM5;GMEB1;NRF1;NFE2L1;BHLHE41;ZNF205;PKNOX1;ZBTB12;HIC1;DMTF1;SALL2;SNAPC3;ZNF18;RFX2;ZNF569;RARA;SP3;ZNF260;SMAD2;CCAR1;IRF9;ZNF383;ELK4;HOXB4;SOX4;ZBTB5;TEF
prerank,C-C chemokine receptor activity (GO:0016493),0.534850886050071,1.4313956159328045,0.08630393996247655,0.44665147625504076,1.0,6/21,17.69%,ACKR2;CCR9;ACKR3;CXCR4;CCRL2;GPR75
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.48558907511967875,-1.4308586305431394,0.058823529411764705,0.3718346276616112,1.0,5/23,1.59%,PLCB1;EDNRA;PLCB4;CHRM3;PLCG2
prerank,motor activity (GO:0003774),-0.3890743247747117,-1.427842763915381,0.01907356948228883,0.3712371842662483,1.0,22/60,24.43%,KIF1B;KIF21A;KIF26B;MYL6;KIF1C;STARD9;DNAH8;KIF26A;KIF18A;KIF5C;DYNC1I2;KIF15;KIF3B;KIF16B;KIF5A;GPR88;KIF27;KIF23;KIF4A;KIF22;KIF14;KIFC3
prerank,phospholipase C activity (GO:0004629),-0.4685947583703243,-1.4270236603523403,0.05555555555555555,0.366123912776296,1.0,5/25,1.59%,PLCB1;EDNRA;PLCB4;CHRM3;PLCG2
prerank,bHLH transcription factor binding (GO:0043425),0.5483300915601023,1.4268138397492127,0.06846846846846846,0.451482622585934,1.0,4/19,6.42%,FHL2;SMAD3;TCF12;CREBBP
prerank,sequence-specific DNA binding (GO:0043565),0.33905337878913366,1.4257895542859078,0.0,0.4471993034793831,1.0,133/590,19.53%,TCF7L2;TCF4;CREB5;KMT2A;RORA;ZBTB20;FOXD1;SMAD3;ZEB2;RBPJ;NR2F2;ELF1;TEAD1;ARNT2;OSR1;GATA6;FOXC1;NFAT5;LBX1;MAF;SPIB;POU5F1;ZBTB4;NR6A1;GLI3;FOXC2;ZIC4;NFATC4;MBD2;PRRX2;HIVEP1;HOXC4;ZIC1;TERT;RFX3;CREB3L4;ARNT;BCL2;ZNF276;EPAS1;HLF;EN2;GZF1;TCF12;ZNF35;KLF5;SP9;RARB;FOXP3;PPARA;TCF7L1;HDAC4;ZBTB37;GLIS2;POU1F1;HOXA2;MEF2A;ATF7;ELF4;SP8;TEAD2;CUX1;MAFB;CREM;PBX1;EGR3;MSC;TCF7;CUX2;SMG5;SMG6;ELF2;SMAD4;FOXO3;EGR2;LHX9;NR4A1;KDM5B;KDM2A;POU2F1;HOXA10;BPTF;THAP1;NFIC;NR3C1;PRDM5;SMG7;GMEB1;BHLHE41;PKNOX1;ZBTB12;HIC1;ERH;RFX2;ZBTB21;RARA;SP3;HDAC2;IRF9;ELK4;KDM2B;HOXB4;SOX4;TEF;MBNL2;BCL11B;POU6F1;DRGX;JDP2;LRWD1;SMG1;UPF3A;ZFP1;ATF2;NFATC2;GLIS1;MAFG;RFX7;KLF15;CLOCK;TEN1;KDM1A;SIRT3;HMBOX1;BCL6;KLF6;ESRRA;BHLHE40;ARID5A;CEBPB;E2F2;NFATC3;SOX30
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.4419268147606453,-1.425196161524652,0.051643192488262914,0.35640923593053747,1.0,21/34,35.28%,NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFB7;NDUFC2;NDUFB10;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFS1;NDUFV3;NDUFA2;NDUFA6;NDUFS2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.4419268147606453,-1.425196161524652,0.051643192488262914,0.35640923593053747,1.0,21/34,35.28%,NDUFV1;NDUFA8;NDUFC1;NDUFB4;NDUFS7;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFB7;NDUFC2;NDUFB10;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFS1;NDUFV3;NDUFA2;NDUFA6;NDUFS2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5067846943205776,1.4222718384759678,0.0800711743772242,0.44952597690751017,1.0,10/27,16.48%,POLR2D;TERT;POLR1D;POLR1C;POLR3F;POLR2C;MED20;POLR2F;TENT2;POLR3H
prerank,alkali metal ion binding (GO:0031420),0.5915009787327686,1.4213771449792767,0.0989399293286219,0.4450117929476199,1.0,4/13,11.05%,ATP1A2;HDAC4;PDXK;ACAT1
prerank,sterol transfer activity (GO:0120015),0.5702436347732617,1.4210240475520954,0.09430255402750491,0.43949369941344524,1.0,2/17,2.13%,GRAMD1C;APOA2
prerank,translation elongation factor activity (GO:0003746),-0.5568516685889373,-1.4163178280869406,0.08438818565400844,0.36980135560331123,1.0,8/14,22.41%,EEF1A1;GTPBP1;EEF2;GFM1;EIF5A;EIF5AL1;EIF5A2;TUFM
prerank,NAD binding (GO:0051287),0.513847990317415,1.4128433188595655,0.07432432432432433,0.45519204657497153,1.0,11/26,20.45%,ALDH1A1;ZC3HAV1;PARP9;CRYL1;NNT;ALDH2;NUDT6;GRHPR;SIRT3;SIRT2;SORD
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5251287635322273,-1.4093003104699375,0.09662921348314607,0.37944117788928927,1.0,5/16,8.66%,SLC26A7;SLC26A2;SLC1A1;CLCN7;SLC12A5
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5924362034754783,-1.408152203214341,0.10105263157894737,0.3755566063505842,1.0,2/10,3.39%,MECOM;PRDM16
prerank,peptide hormone receptor binding (GO:0051428),0.6144493942988225,1.4079265838813568,0.10150375939849623,0.46078600198465375,1.0,2/11,3.74%,GHRH;PTHLH
prerank,histone methyltransferase binding (GO:1990226),-0.5846535564618724,-1.4053633654108366,0.08669354838709678,0.3752639960360533,1.0,8/11,29.56%,LCORL;CTNNB1;HSP90AB1;CBX3;NOP56;WIZ;CBX1;PRDM4
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5709296622605781,-1.397486226614319,0.08842105263157894,0.3882011941264681,1.0,7/12,13.55%,PDE4D;PDE4B;PDE8A;PDE3B;PDE2A;PDE3A;PDE4C
prerank,diacylglycerol kinase activity (GO:0004143),-0.5817050234608372,-1.3961051694505167,0.08731808731808732,0.38495573989048976,1.0,4/11,6.75%,DGKB;DGKI;DGKH;DGKZ
prerank,voltage-gated potassium channel activity (GO:0005249),-0.36721406346176455,-1.3929952005586221,0.03470031545741325,0.38581868691194643,1.0,23/80,14.60%,KCNB2;KCND2;KCNQ5;KCNMA1;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;KCNT1;HCN2;KCNH1;KCNH5;KCND3;KCNB1;KCNJ6;KCNJ8;KCNQ1;KCNJ15;KCNE4;KCNC1;KCNA2
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5718480022229273,-1.3869516962603514,0.1168032786885246,0.3935320716098288,1.0,4/10,18.29%,CACNB2;CACNB4;CACNA1D;CACNA1A
prerank,leak channel activity (GO:0022840),0.5404474731320122,1.3866516757134943,0.09357798165137615,0.5123764749843156,1.0,2/18,2.04%,KCNK2;NALCN
prerank,MHC class II protein complex binding (GO:0023026),-0.5847244593564103,-1.3854167106318447,0.10450819672131148,0.3906781179536933,1.0,6/11,12.77%,HSPA8;ATP1B1;PKM;HSP90AB1;CD74;HSP90AA1
prerank,poly(A) binding (GO:0008143),0.5186807636793758,1.3842454410656522,0.08807339449541285,0.5119279312644825,1.0,4/21,5.65%,RBMS3;RBMS1;RBMS2;PABPC5
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6257426973357484,1.380411783632356,0.1311787072243346,0.5149183057936876,1.0,3/10,9.79%,CXADR;CD47;DSC2
prerank,carboxylic acid binding (GO:0031406),-0.41574650939753627,-1.379257174370321,0.05811138014527845,0.39796373908291244,1.0,15/38,22.73%,GRM7;NOS3;GRIN3A;GLRA3;GRIN2B;SESN3;GRIN1;NOS1;GCLC;EPDR1;UBR1;GLRA2;GLRA1;HIF1AN;SHMT2
prerank,transcription cis-regulatory region binding (GO:0000976),0.33756302416069517,1.378123501421915,0.009291521486643438,0.5141757838800449,1.0,81/406,16.26%,TCF7L2;RORA;ZBTB20;SOX5;SMAD3;MXI1;ARID4A;CREB3L2;TEAD1;OSR1;TBL1XR1;GATA6;FOXC1;NFYC;TCF24;POU5F1;HIF3A;ZNF395;ZBTB4;GLI3;FOXC2;ZBTB8A;CRY2;RFX3;GABPB1;GABPB2;CREB3L3;ARNT;GLI1;BCOR;EPAS1;SIM2;AEBP1;STOX1;TCF12;OTP;ZNF3;ZNF35;NR1H3;HDAC4;GLIS2;YAP1;ZNF25;CREBRF;NFXL1;MEF2A;ZFP37;CUX1;TAF7;CREM;SMAD6;E4F1;PBX1;TIPARP;RFXANK;MSC;PSPC1;TCF7;CUX2;SMAD4;FOXO3;RFXAP;EGR2;LHX9;ARID5B;MZF1;NR3C1;PRDM5;CARM1;DMTF1;SALL2;SNAPC3;RARA;SP3;SMAD2;SOX4;PER3;ZBTB5;VEZF1;TBL1X;TAF9
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.444613653743962,-1.376717430773998,0.08089887640449438,0.39721766055887237,1.0,9/27,13.72%,SLC26A7;SLC26A2;ANO1;XPR1;SLC5A5;SLC22A6;SLC39A14;SLC25A30;SLC39A8
prerank,serotonin receptor activity (GO:0099589),-0.47565116204336955,-1.376015296359362,0.08695652173913043,0.38098933543390795,1.0,8/22,19.21%,CHRM3;HTR2C;CHRM2;HRH1;HTR4;HTR2B;HTR2A;HRH2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.47565116204336955,-1.376015296359362,0.08695652173913043,0.38098933543390795,1.0,8/22,19.21%,CHRM3;HTR2C;CHRM2;HRH1;HTR4;HTR2B;HTR2A;HRH2
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.47565116204336955,-1.376015296359362,0.08695652173913043,0.38098933543390795,1.0,8/22,19.21%,CHRM3;HTR2C;CHRM2;HRH1;HTR4;HTR2B;HTR2A;HRH2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4252332016613712,1.3751470414640234,0.0637329286798179,0.5154215076413823,1.0,14/60,5.76%,EFEMP1;EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;NRP1;EPHA8;ROR1;KIT;EPHA1;PDGFRB
prerank,pyridoxal phosphate binding (GO:0030170),0.5285249540915863,1.3739664562836933,0.10114503816793893,0.5113498348281775,1.0,5/20,10.50%,SHMT1;PYGB;PDXK;PYGM;ABAT
prerank,retinoic acid binding (GO:0001972),0.5943441495992176,1.3699832751849033,0.14041745730550284,0.5155723096421851,1.0,1/12,0.92%,NR2F2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5452768969588146,1.3688365054644807,0.10299625468164794,0.512029057484954,1.0,5/18,7.03%,TGFBR3;LTBP1;BMPR1A;TGFBR1;TGFBR2
prerank,cholesterol binding (GO:0015485),0.437239040812771,1.3668439839500401,0.0915032679738562,0.510545522075762,1.0,12/47,12.55%,SIDT1;GRAMD1C;APOA2;APOF;OSBPL8;VDAC2;NR1H3;NPC1;SCP2;SOAT1;ABCA1;OSBPL5
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6098909058025607,1.3648244385643111,0.12859884836852206,0.509576123804511,1.0,6/10,27.61%,NSD3;NSD1;SETD5;SETD2;ASH1L;SMYD2
prerank,ribosomal large subunit binding (GO:0043023),-0.5560512945685003,-1.360462011184667,0.10887096774193548,0.4079996767269267,1.0,7/11,30.50%,CPEB2;NPM1;RBM3;MALSU1;LTN1;EIF6;CPSF6
prerank,phospholipase inhibitor activity (GO:0004859),0.626194683977857,1.3576571004914584,0.13539651837524178,0.5227124672731911,1.0,7/10,21.78%,ANXA2;ANXA1;ANXA4;ANXA5;ANXA9;ANGPTL3;SNCB
prerank,intracellular chloride channel activity (GO:0061778),-0.497885521558064,-1.350015227117693,0.1278825995807128,0.42073198802812733,1.0,9/16,22.51%,ANO1;ANO3;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5;NMUR2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.497885521558064,-1.350015227117693,0.1278825995807128,0.42073198802812733,1.0,9/16,22.51%,ANO1;ANO3;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5;NMUR2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.500202561735069,-1.3429202726897491,0.11392405063291139,0.42534294497826486,1.0,8/16,21.18%,ATP6V0A1;ATP6V1B2;ATP6V0C;ATP6V1D;ATP5F1B;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.500202561735069,-1.3429202726897491,0.11392405063291139,0.42534294497826486,1.0,8/16,21.18%,ATP6V0A1;ATP6V1B2;ATP6V0C;ATP6V1D;ATP5F1B;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,thyroid hormone receptor binding (GO:0046966),0.4808181619211813,1.3422684613045752,0.12020033388981637,0.5598659213408012,1.0,10/28,13.49%,NCOA3;TRIP12;NCOA6;TACC1;NSD1;OASL;TAF7;ZNHIT3;MED12;BRD8
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.318834867759675,1.3411811813631949,0.005488474204171241,0.5563006232086987,1.0,135/597,19.53%,TCF7L2;TCF4;CREB5;ZBTB20;SOX5;SMAD3;ARID4A;ELF1;CREB3L2;TEAD1;ARNT2;OSR1;TBL1XR1;GATA6;FOXC1;NFAT5;LBX1;NFYC;MAF;SPIB;POU5F1;NR6A1;GLI3;FOXC2;ORC5;ZIC4;NFATC4;MBD2;PRRX2;HIVEP1;CRY2;HOXC4;ZIC1;RFX3;GABPB1;GABPB2;CREB3L3;CREB3L4;ARNT;GLI1;ZNF276;BCOR;HLF;EN2;TCF12;KLF5;SP9;NR1H3;RARB;FOXP3;TCF7L1;HDAC4;ZBTB37;GLIS2;POU1F1;HOXA2;YAP1;ATF7;ELF4;SP8;TEAD2;CUX1;TAF7;CREM;SMAD6;PBX1;EGR3;MCM4;MSC;PSPC1;TCF7;CUX2;ELF2;SMAD4;FOXO3;TSPYL2;EGR2;LHX9;NR4A1;KDM5B;ARID5B;MZF1;HOXA10;NFIC;NR3C1;PRDM5;GMEB1;BHLHE41;MCM6;PKNOX1;CARM1;ZBTB12;HIC1;DMTF1;RFX2;RARA;SP3;ORC3;IRF9;ELK4;ORC4;HOXB4;SOX4;PER3;TEF;MBNL2;TBL1X;BCL11B;POU6F1;TAF9;DRGX;JDP2;ZFP1;CENPC;ATF2;NFATC2;GLIS1;MAFG;RFX7;KLF15;CLOCK;HMBOX1;DHX36;BCL6;KLF6;NKX2-1;ESRRA;BHLHE40;BRD7;NFYA;ARID5A;CEBPB;E2F2;NFATC3;SOX30
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5361798226045349,-1.3401039374421508,0.1468682505399568,0.4260013078913869,1.0,4/12,6.82%,INSR;PIK3R1;GNAS;YWHAH
prerank,ion channel activity (GO:0005216),-0.3496589194174676,-1.3388051550984972,0.030303030303030304,0.4233196300460529,1.0,18/80,9.47%,GRID2;PIEZO2;GRIA4;GRIK2;GRIN3A;ABCC9;GRIK4;GRIA1;UNC80;MCUB;GRIK1;GRIN2A;GRIA3;GRIN2B;TRPC6;GRIA2;GABRB1;GRIN1
prerank,chemokine binding (GO:0019956),0.47040950023368044,1.3368655839680386,0.0985663082437276,0.5622515823658848,1.0,3/30,2.30%,PDPN;ACKR2;CCR9
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.4042023183488313,1.3364739605525906,0.08150470219435736,0.5566786398103075,1.0,19/69,15.86%,PLA2G4A;CERS5;CERS6;LIPT1;ZDHHC3;MOGAT3;CREBBP;PLA2G4C;SCP2;KAT6B;NAA16;SOAT1;NAA15;ESCO1;DGAT2;PORCN;KAT6A;ZDHHC17;KAT2B
prerank,titin binding (GO:0031432),-0.515858982673618,-1.3333638572659998,0.13725490196078433,0.4301316471920475,1.0,4/13,8.04%,CALM1;CALM2;CALM3;CAMK2D
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.41120141432463964,1.330589797857113,0.10593900481540931,0.5666114499282192,1.0,4/53,3.04%,SLC7A11;SLC7A2;SLC1A3;SLC6A9
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5379469765136267,1.3289102627998137,0.1553784860557769,0.5647464461843699,1.0,2/15,2.30%,ACKR2;CCR9
prerank,lysine N-methyltransferase activity (GO:0016278),0.5024727163449813,1.3245398584537897,0.12777777777777777,0.5709758534451654,1.0,11/20,27.79%,ETFBKMT;METTL21C;SETD4;SETD7;ATPSCKMT;SETD2;EHMT2;EEF1AKMT4;SETD6;SMYD2;EHMT1
prerank,GTPase inhibitor activity (GO:0005095),-0.517177311390843,-1.3230808682548925,0.13548387096774195,0.4468962544805193,1.0,7/13,21.21%,SLIT2;CPEB2;TNK2;RHOH;GPS1;PDE6D;ARL2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5114697693033061,1.3225327351144232,0.15625,0.5700831649940069,1.0,6/18,11.07%,TGFBR3;SMAD3;TGFBR1;TGFBR2;SMAD6;TGFBRAP1
prerank,DNA-binding transcription factor binding (GO:0140297),0.34133915102747264,1.3218543549510466,0.045103092783505154,0.5655813758800889,1.0,36/189,13.65%,TCF7L2;FHL2;SMAD3;RBPJ;TLE1;LDB2;DACT1;TLE3;BCL2;MIER3;PRRX1;MTDH;TCF12;MIER1;CREBBP;PPARA;HDAC4;STAT1;POU1F1;GSK3B;YAP1;SKI;PIAS1;MEF2A;CRTC1;CREM;RERE;WWP2;CRTC3;RBBP8;IFI27;ATN1;EGR2;PRDM5;BHLHE41;RUNX1T1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.46294703991811087,1.3214990220913163,0.10350877192982456,0.5603099390145395,1.0,12/33,19.73%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;PAF1;ERCC5;URI1;UVSSA;RPRD1B;ERBB2
prerank,cadherin binding (GO:0045296),-0.2775880137332981,-1.3185846791607334,0.0,0.45124439468787647,1.0,83/315,15.39%,PTPRB;DOCK9;COBLL1;CTNND2;CTNNA2;BSG;ITGA6;PTPRJ;CDH2;PROM1;FNBP1L;CDH11;HSPA8;LRRFIP1;CTNNA3;CDH12;MRTFB;KDR;BMPR2;RPL24;FXYD5;NOTCH3;CDH1;EPN2;CSNK1D;ANK3;PTPRM;MACF1;DIAPH3;TRPC4;EEF1G;CDH10;DAB2IP;RPL6;CTNNB1;MRE11;CDH8;PUF60;CLINT1;PKM;HSP90AB1;CDH22;CDH4;TES;EEF2;EFHD2;RPS2;STXBP6;SHTN1;CDH7;CDH20;HNRNPK;PCBP1;RPL14;PTPRT;BZW2;RPS26;VASP;RACK1;CD46;CDC42EP1;PTPRO;ARHGAP1;DBNL;PPP1CA;CBL;ANLN;RPL29;GPRC5A;RANBP1;TJP2;EHD4;EGFR;F11R;SLC3A2;ACVR1;MPP7;GLOD4;NOP56;PAK4;PARK7;TWF1;ADD1
prerank,sodium:proton antiporter activity (GO:0015385),-0.5518413134933885,-1.3181272144962255,0.13052631578947368,0.4466992591024621,1.0,4/11,14.26%,SLC9A2;SLC9B2;SLC9A8;SLC9A5
prerank,FAD binding (GO:0071949),0.4832447217412632,1.3170200652257547,0.14629948364888123,0.5663360544578019,1.0,7/24,12.01%,MICAL3;DDO;CRY2;CRY1;SQOR;CYB5R2;NQO2
prerank,chemokine activity (GO:0008009),0.4650081214439247,1.3143669664121236,0.13756613756613756,0.567298789962892,1.0,4/31,7.35%,CXCL10;CXCL16;CKLF;CCL2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3986597689948451,-1.314311375402936,0.10025706940874037,0.44896590074457227,1.0,17/37,33.60%,LARS2;KARS1;CARS1;EARS2;IARS1;TARS3;RARS2;VARS2;HARS1;YARS2;FARSB;WARS2;QARS1;NARS1;PARS2;YARS1;TARS1
prerank,rRNA binding (GO:0019843),-0.3841412551371997,-1.3140738218109178,0.10789473684210527,0.443873312986614,1.0,17/42,24.52%,RPS9;RPL5;RPS3;RPLP0;RPL11;RPS13;MRPS18A;RPL23;RPS5;FASTKD2;RPS14;PPAN;RPL12;ERI1;MRPL11;EMG1;RCC1L
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.5431785838081409,-1.3137509236231244,0.148,0.43923846784790416,1.0,2/11,6.66%,HCN1;HCN2
prerank,potassium ion leak channel activity (GO:0022841),0.5339732528629179,1.3134090021756373,0.15327102803738318,0.5639687346097338,1.0,1/15,0.05%,KCNK2
prerank,nuclear import signal receptor activity (GO:0061608),0.5333593150635602,1.3116294117145368,0.15732368896925858,0.5631548688537645,1.0,4/15,7.26%,TNPO1;KPNA7;KPNA6;KPNA4
prerank,nuclear localization sequence binding (GO:0008139),0.5194329481855076,1.3114348943048268,0.12880143112701253,0.5578839685926928,1.0,6/18,14.67%,TNPO1;KPNA7;KPNA6;KPNA4;BRAP;POM121
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5534738837366657,-1.31096818209645,0.13765182186234817,0.4404146894352357,1.0,4/11,15.68%,SGMS1;SGMS2;PTDSS1;PIGO
prerank,retinoid X receptor binding (GO:0046965),0.5619638931830261,1.3101121522614025,0.16472868217054262,0.555561059906883,1.0,5/11,19.37%,NCOA6;TACC1;NSD1;NRIP1;ARID5A
prerank,glycine binding (GO:0016594),-0.5440516029081343,-1.3080164487757677,0.1646586345381526,0.4420090872337643,1.0,8/11,28.70%,GRIN3A;GLRA3;GRIN2B;GRIN1;GLRA2;GLRA1;GLDC;GNMT
prerank,leucine zipper domain binding (GO:0043522),0.5947235019618236,1.307767146603285,0.17590822179732313,0.55576811147292,1.0,1/10,0.55%,PAWR
prerank,endopeptidase regulator activity (GO:0061135),0.43251794882338246,1.3075566321875711,0.13810316139767054,0.5506429500793361,1.0,7/40,9.76%,TFPI;CSTB;ITIH2;SPINT2;PZP;PROS1;CAST
prerank,calcium channel inhibitor activity (GO:0019855),-0.5409497174547566,-1.3068500653027517,0.15644820295983086,0.43950224243986624,1.0,5/11,7.63%,FKBP1A;CALM1;MCUB;CALM2;SLC30A1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4075483854275664,1.3053269892639254,0.11802232854864433,0.551596050467796,1.0,13/53,12.01%,MICAL3;DDO;AOX1;POR;CRY2;CRY1;SQOR;ACOXL;DPYD;NOS2;CYB5R2;ETFA;NQO2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.537523036113219,1.3047578718570974,0.16506717850287908,0.5476455274806116,1.0,2/15,6.62%,PLA2G4A;PLA2G4C
prerank,store-operated calcium channel activity (GO:0015279),-0.5565860366241915,-1.3040708029735784,0.16962524654832348,0.44050480219496535,1.0,4/10,7.06%,TRPC3;TRPC5;TRPC4;TRPC6
prerank,protease binding (GO:0002020),0.3726013602842667,1.302493107052287,0.07747489239598278,0.5482268523790116,1.0,25/99,13.96%,DPP4;COL3A1;FN1;ECM1;TIMP3;ANXA2;CSTB;ADAMTSL4;CFLAR;BCL2;SERPINE1;BDKRB2;GSK3B;POLG;PZP;TIMP2;RIPK2;INSL3;AMFR;SUMO1;CCBE1;COL1A2;DVL3;CHMP3;BFAR
prerank,regulatory RNA binding (GO:0061980),0.4329244110489076,1.3012124365399,0.1256198347107438,0.5466986495381614,1.0,15/38,24.63%,POU5F1;TUT4;PIWIL4;RC3H1;TARBP2;ZC3H7B;DDX21;HNRNPA2B1;PUM2;TUT7;ELAVL1;ZC3H12A;PNPT1;DHX9;ZC3H10
prerank,DNA binding (GO:0003677),0.306323549196682,1.2989874069704752,0.005434782608695652,0.547422168385391,1.0,167/694,19.67%,TCF7L2;TCF4;RORA;TSHZ2;FOXD1;SMAD3;ZEB2;RBPJ;RBMS1;ARID4A;NR2F2;TEAD1;NUPR1;FOXC1;DDX60;NFYC;POU5F1;PDS5B;SSBP2;ZNF395;ZBTB4;DENND4A;NR6A1;ZIC2;FOXC2;ZIC4;NHEJ1;HIVEP2;POLR2D;ZBP1;NUCKS1;CRY2;TERT;RFX3;CRY1;WRN;ARNT;BCL2;GLI1;EPAS1;HLF;TOP1;SIM2;GZF1;OTP;ZNF3;RAD50;APLP2;ZNF35;HDGFL3;NR1H3;RARB;TSHZ3;FOXP3;CREBBP;PPARA;TCF7L1;HDAC4;OASL;STAT1;RFC1;FBH1;POLG;NTHL1;QRICH1;ZMYND11;MEF2A;CRLF3;SYCP2;GLYR1;RLF;CUX1;SOX21;ACR;FUBP1;MAFB;XRCC4;CREM;NABP1;RAD51B;HDGFL2;ZNF292;RPA3;PBX1;MCM4;XRN1;DCLRE1A;CUX2;CENPX;POLR3F;HUWE1;SMAD4;RBBP8;FOXO3;RTF1;ILF3;ZMYM6;EGR2;MTERF2;SPO11;NR4A1;ZNF219;KDM5B;TRIM26;ARID5B;POU2F1;OGG1;BPTF;THAP1;SUPV3L1;PRDM5;RBM6;MCM6;RBM5;HIC1;MND1;KAT6A;GTF2H4;ERCC6;SNAPC3;RFX2;ZBTB21;ERCC5;HDAC2;DNASE1L1;SMARCA4;SMAD2;C1D;SURF6;LIN9;ELK4;KDM2B;ERCC1;ZMYM3;APP;POU6F1;TAF9;DNMT3A;CHD8;TRIM16;CENPC;NFATC2;DNA2;NUFIP1;PARP4;CLOCK;TDP2;SIRT3;HMBOX1;JRKL;PCBP2;TSHZ1;KHDRBS1;DHX36;BCL6;NKX2-1;ESRRA;FOXS1;CHD4;NFYA;ARID5A;CEBPB;E2F2;PGR;XPC;PSIP1;MEOX2
prerank,C-C chemokine binding (GO:0019957),0.4831724944149901,1.298654313978725,0.14828209764918626,0.5430540093091707,1.0,5/22,15.42%,ACKR2;CCR9;ACKR3;CXCR4;CCRL2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.4427649672573854,1.2980648288822936,0.14123376623376624,0.5395428077924158,1.0,6/35,6.15%,ENPP3;MPPED2;ENPP1;SMPD3;PLCE1;PLCB3
prerank,amino acid binding (GO:0016597),-0.409790079016354,-1.2964232576693298,0.14416475972540047,0.4521377812341745,1.0,8/31,13.19%,GRM7;NOS3;GRIN3A;GLRA3;GRIN2B;GRIN1;NOS1;GCLC
prerank,inward rectifier potassium channel activity (GO:0005242),-0.42637214069353874,-1.2955078842037382,0.14798206278026907,0.4489912245587043,1.0,10/24,26.75%,KCNJ3;ABCC9;KCNJ2;KCNJ6;KCNJ8;KCNJ15;KCNJ10;KCNN3;KCNJ16;KCNK1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5878518533592857,1.2888782292375094,0.19708029197080293,0.5587550116924105,1.0,3/10,4.23%,CASP12;CFLAR;CASP4
prerank,acyl-CoA hydrolase activity (GO:0047617),0.510797624574934,1.2849483278328047,0.16023166023166024,0.5637186243196959,1.0,4/17,10.41%,ACOT11;PLA2G6;ACOT9;ACOT1
prerank,symporter activity (GO:0015293),-0.5313360516576838,-1.2789304224139946,0.1743486973947896,0.48151667617014515,1.0,3/10,12.75%,SLC5A5;SLC5A6;MFSD2A
prerank,protein tyrosine phosphatase activity (GO:0004725),0.37593242372251956,1.2775178043001212,0.1130952380952381,0.5784889766649447,1.0,19/71,12.37%,PTPN13;EYA2;EYA1;TPTE;PTPN14;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN2;PTPN9;PTPN21;PTPN6;CDC14A;EYA4;PTPRU;PTPN1;PTPN18
prerank,translation initiation factor activity (GO:0003743),-0.3787173969112137,-1.2768101377671348,0.15051020408163265,0.48118623359173485,1.0,13/36,27.25%,EIF2B2;EIF3F;EIF5B;EIF1B;EIF4A1;EIF3A;COPS5;EIF1;EIF4A2;EIF3G;EIF3H;EIF3I;EIF4G1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5076212744643818,-1.273161245386423,0.16561844863731656,0.48448074122070484,1.0,3/13,6.64%,SLC9A2;SLC9B2;SLC9A8
prerank,histone acetyltransferase binding (GO:0035035),0.487967956230353,1.2713204536882683,0.17863720073664824,0.5897160017560497,1.0,12/21,24.18%,GLI3;EPAS1;FOXP3;STAT1;MEF2A;TAF7;KANSL1;SIRT2;CITED2;HIF1A;ECD;EGR1
prerank,fatty acid synthase activity (GO:0004312),-0.5368738053520041,-1.2707262641409878,0.18410041841004185,0.48490699921013014,1.0,2/10,3.45%,ELOVL5;ELOVL7
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5395446760634431,1.269350645482961,0.226691042047532,0.5902365967856739,1.0,3/12,12.46%,SULF1;ARSI;ARSB
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5200972162975961,-1.2668084680898735,0.18723404255319148,0.48856989535518414,1.0,4/12,14.26%,SLC9A2;SLC9B2;SLC9A8;SLC9A5
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3717883504720312,-1.2623680908386454,0.13138686131386862,0.49412688221465784,1.0,13/42,11.29%,LRRC4C;BSG;ESAM;CNTN4;CNTN6;ROBO4;NPTN;STXBP6;JAM3;CNTN2;EMB;CDC42EP1;PPP1CA
prerank,insulin-like growth factor binding (GO:0005520),0.5146573311873748,1.2621347540017729,0.17636363636363636,0.6049044082735666,1.0,3/15,4.08%,IGFBP3;IGFBP5;IGFBP6
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4866703761642982,1.2602344579892233,0.20930232558139536,0.604351236904411,1.0,3/21,3.46%,FGF1;FRS2;KL
prerank,mRNA 3'-UTR binding (GO:0003730),0.3643426719979063,1.2599580966956077,0.12280701754385964,0.5997307393108353,1.0,12/79,9.11%,CELF2;RBMS3;RBMS1;IGF2BP1;RC3H1;RBMS2;PABPC5;CPEB1;SECISBP2L;RNF20;HNRNPC;IGF2BP2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5771330522874455,1.25960379534908,0.2222222222222222,0.5956693125359241,1.0,2/10,1.25%,CXCL10;PRKAG2
prerank,methyl-CpG binding (GO:0008327),0.4689403019651433,1.2541186399471995,0.2007168458781362,0.6058337963270589,1.0,10/22,25.52%,ZBTB4;MBD2;ERH;ZBTB21;LRWD1;TET1;PRMT1;MECP2;ZCWPW1;ZBTB33
prerank,kinesin binding (GO:0019894),-0.40819772746968735,-1.2506328733086125,0.16037735849056603,0.5168510494382775,1.0,10/27,16.92%,KIF1B;ACTB;SNCA;AP1AR;MAPK8IP1;NEFH;CLSTN1;MAPK8IP3;TOR1B;PRC1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5012148235657846,-1.2493661237666198,0.20454545454545456,0.5146537642848937,1.0,5/12,12.24%,PIK3R6;PIK3C2B;PIK3R3;ATM;PIK3CD
prerank,cytokine receptor binding (GO:0005126),0.3627374767694077,1.2492270555263687,0.13582089552238805,0.6142258194866393,1.0,20/83,15.42%,TGFBR3;SMAD3;IL6ST;OSM;IL11;IL34;IL23R;VEGFD;IL6;IL18;IL13RA1;ERAP1;TGFBRAP1;JAK1;SH2B3;CSF1;IL22;CCL25;CCRL2;SMAD2
prerank,solute:anion antiporter activity (GO:0140323),0.5256273103279842,1.2491102806296488,0.209009009009009,0.6093062872373337,1.0,2/14,3.56%,SLC7A11;SLC26A9
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5447876178762381,1.2486962570589286,0.21320754716981133,0.6052594048944441,1.0,6/11,20.30%,ANAPC11;AMFR;PRPF19;UBE4B;UBR5;UBE2K
prerank,syntaxin-1 binding (GO:0017075),-0.4298819579686006,-1.2479331102678672,0.16704805491990846,0.5125122267899846,1.0,7/22,9.54%,SYT1;SYNPR;NSF;SNAP25;STXBP1;CPLX1;SNPH
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3929162895156909,-1.2474181621688103,0.15671641791044777,0.5084918515180187,1.0,8/32,13.49%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC1A4;SLC43A2;SLC36A1;SLC3A2
prerank,adenylate cyclase binding (GO:0008179),-0.5266634276700208,-1.246844295691651,0.21285140562248997,0.5047982602067655,1.0,6/10,11.71%,AKAP6;CAP2;CALM1;CALM2;CALM3;ADCY2
prerank,insulin-like growth factor I binding (GO:0031994),0.5326624904460058,1.2464110371021924,0.20527306967984935,0.6062760831233002,1.0,3/13,4.08%,IGFBP3;IGFBP5;IGFBP6
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5291708726211755,1.245481204588714,0.22393822393822393,0.6037172535818879,1.0,1/13,0.31%,SLC7A2
prerank,voltage-gated ion channel activity (GO:0005244),-0.48502286337860456,-1.2453313528823011,0.17745302713987474,0.5030423734418458,1.0,3/14,3.16%,KCND2;CACNA1E;HCN1
prerank,actinin binding (GO:0042805),0.4719103005361879,1.2451407536533259,0.19642857142857142,0.5997186380308749,1.0,7/21,15.06%,CSRP3;DAG1;SYNPO2;CSRP1;CACNA1C;PKD2;RARA
prerank,semaphorin receptor binding (GO:0030215),-0.4299693854706714,-1.243824946503457,0.18561484918793503,0.5013814321117923,1.0,10/23,13.17%,SEMA6D;RIT2;SEMA3C;SEMA4D;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,metalloendopeptidase activity (GO:0004222),0.3585687389045396,1.2435595298725033,0.14350453172205438,0.5991558608016143,1.0,14/76,12.58%,ADAMTSL5;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;MMP14;THSD4;ADAM19;NLN;PMPCB;PAPLN;ADAMTS7
prerank,calcium activated cation channel activity (GO:0005227),-0.4582382311541188,-1.242260338480957,0.18863636363636363,0.5000311236688745,1.0,4/17,7.17%,KCNMB2;KCNMA1;ANO1;TMEM63C
prerank,chemokine receptor binding (GO:0042379),0.4253746340541895,1.2416749644221845,0.19584055459272098,0.5992305359877543,1.0,4/35,7.35%,CXCL10;CXCL16;CKLF;CCL2
prerank,nucleotide diphosphatase activity (GO:0004551),0.5260463596531068,1.241172011367747,0.222011385199241,0.5958442555865993,1.0,6/14,19.19%,ENPP1;FHIT;NUDT13;NUDT6;NUDT4;CILP2
prerank,monocarboxylic acid binding (GO:0033293),0.4952202345359984,1.2407556688462265,0.21834862385321102,0.5921396211740286,1.0,5/18,24.23%,NR2F2;RARA;NAPEPLD;NR1H4;PYGL
prerank,manganese ion binding (GO:0030145),0.40005035734489186,1.2371379205929736,0.16930379746835442,0.5968053609865653,1.0,9/48,7.59%,MPPED2;FAM20C;WRN;LARGE1;GALNT2;GALNT1;GYG1;B4GALT1;NEK4
prerank,Hsp90 protein binding (GO:0051879),-0.3824825701643797,-1.2367863417937723,0.15384615384615385,0.5085513602233098,1.0,10/33,19.37%,SLC12A2;KDR;RPS3;HDAC6;UNC45B;NPAS2;NOD2;MAPT;PACRG;AHSA1
prerank,transcription coactivator binding (GO:0001223),0.46860582164458253,1.233069625491959,0.21607142857142858,0.6033713896165955,1.0,6/20,12.52%,RORA;SMAD3;TERT;TEAD2;SMAD4;VGLL4
prerank,calcium-activated potassium channel activity (GO:0015269),-0.512270198133912,-1.2325873039313,0.2231578947368421,0.5135182509525048,1.0,2/11,1.67%,KCNMB2;KCNMA1
prerank,semaphorin receptor activity (GO:0017154),0.5388540233251353,1.2314925760858495,0.2437137330754352,0.6027754934719769,1.0,2/11,2.87%,PLXNA2;NRP1
prerank,I-SMAD binding (GO:0070411),0.5177598447505937,1.2310326462576349,0.233201581027668,0.5994315400367922,1.0,6/13,15.42%,SMAD3;TGFB1I1;TGFBR1;SMAD6;SMAD4;SMAD2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.5516563809049825,1.2301912037311094,0.24187725631768953,0.5970459797731602,1.0,3/11,4.23%,CASP12;CFLAR;CASP4
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.3978329048535352,-1.2290180149749184,0.1783132530120482,0.5170592251534472,1.0,14/28,31.26%,PRORP;RPP30;DBR1;NUDT16L1;DICER1;EXO1;EDC3;ENDOV;POP7;NUDT16;MRPL44;APEX1;ELAC1;FEN1
prerank,potassium channel regulator activity (GO:0015459),-0.3553706574498595,-1.2240954709434393,0.1671018276762402,0.524107390967705,1.0,11/49,13.12%,DPP10;KCNAB1;KCNMB2;ABCC9;KCNIP4;KCNIP1;DPP6;AKT1;NEDD4L;ADRB2;KCNE4
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3686426775634394,-1.224027617327305,0.14974619289340102,0.5193701274409946,1.0,18/37,26.13%,SLCO1C1;SLCO2A1;COX4I1;UQCRH;SLC22A6;UQCR11;SLC16A7;COX8A;NDUFA4;COX6A1;SLCO4A1;NDUFA4L2;CYB5A;SLCO4C1;UQCR10;SLCO1B1;UQCRQ;COX4I2
prerank,miRNA binding (GO:0035198),0.4294988365533794,1.2210398562403901,0.2144082332761578,0.6169327389213748,1.0,11/30,22.61%,POU5F1;TUT4;RC3H1;ZC3H7B;DDX21;HNRNPA2B1;PUM2;TUT7;ELAVL1;ZC3H12A;PNPT1
prerank,MAP kinase kinase activity (GO:0004708),0.4911737458168231,1.2208559656108773,0.21755027422303475,0.6127243739357056,1.0,8/15,19.11%,MAP2K6;LRRK2;MAPK14;MAP2K5;MAP2K1;MAPKAPK5;MAP2K4;MAPKAPK3
prerank,sodium channel activity (GO:0005272),-0.37195177665398443,-1.220150579335542,0.15841584158415842,0.5233682045831558,1.0,10/37,11.45%,GRIK2;GRIK4;SCN1A;HCN1;GRIK1;SCN2A;CACNA1G;HCN2;SCN8A;SCN9A
prerank,protein tyrosine kinase activity (GO:0004713),0.34113326299565333,1.2180663934908096,0.1484593837535014,0.615462628820212,1.0,23/108,12.25%,TEC;STYK1;EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;FER;ROR1;KIT;EPHA1;PDGFRB;BAZ1B;EPHA4;MST1R;MUSK;HIPK3;PTK2;JAK1;EPHA2
prerank,telomeric DNA binding (GO:0042162),0.41768598285405195,1.2167212609364577,0.2145214521452145,0.6144334862257285,1.0,14/32,20.11%,TERT;WRN;RAD50;SMG5;SMG6;SMG7;HNRNPA2B1;SMG1;UPF3A;TEN1;KDM1A;HMBOX1;CTC1;UPF2
prerank,chemokine receptor activity (GO:0004950),0.43563691208443966,1.213952520343233,0.21572212065813529,0.6170451229291369,1.0,6/24,17.69%,ACKR2;CCR9;ACKR3;CXCR4;CCRL2;GPR75
prerank,voltage-gated sodium channel activity (GO:0005248),-0.4179453636523641,-1.21125231237962,0.20689655172413793,0.5393740081526092,1.0,11/22,23.97%,SCN1A;HCN1;SCN2A;CACNA1G;HCN2;SCN8A;SCN9A;SCN3A;SCN2B;SCN1B;CACNA1I
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4932424775930094,1.2090684480703133,0.2523719165085389,0.6251113720497425,1.0,4/16,13.75%,PIR;HGD;ALOXE3;BCO2
prerank,actin binding (GO:0003779),-0.27639167306955326,-1.208626224705877,0.07569721115537849,0.5407877486219447,1.0,50/170,19.13%,SYNE1;MYRIP;PARVB;SSH2;DMD;NOS3;FMN2;TMSB4X;KCNMA1;KLHL2;CAP2;EPS8;FXYD5;PHACTR4;UTRN;MACF1;SNCA;KLHL1;TMSB10;TLN2;MOBP;SPTB;CCDC88A;MSRB2;MAP1B;CEACAM1;MSRB1;CORO7;ARPC1A;KIF18A;PDLIM3;DBNL;ANLN;MLPH;PHACTR3;ACTN4;TWF1;NOD2;ADD1;MAPT;SSH3;ADCY8;LDB3;GAS2L3;FHL3;PACRG;HPCA;LCP1;MAEA;VASH1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.42909978321375736,1.208334451387777,0.2322695035460993,0.6225300817972923,1.0,8/27,16.48%,POLR2D;POLR1D;POLR1C;POLR3F;POLR2C;MED20;POLR2F;POLR3H
prerank,double-stranded DNA binding (GO:0003690),0.2896108043176732,1.2079549916012104,0.05116796440489433,0.6190241366643323,1.0,95/531,16.25%,TCF4;CREB5;ZBTB20;RBMS1;ELF1;TEAD1;ARNT2;OSR1;GATA6;NFAT5;LBX1;DDX60;MAF;SPIB;POU5F1;NR6A1;GLI3;FOXC2;ZIC4;NFATC4;PRRX2;HIVEP1;ZBP1;NUCKS1;HOXC4;ZIC1;RFX3;CRY1;CREB3L4;ARNT;ZNF276;HLF;TOP1;EN2;TCF12;RAD50;KLF5;SP9;HDGFL3;RARB;FOXP3;TCF7L1;STAT1;ZBTB37;GLIS2;FBH1;POU1F1;HOXA2;NTHL1;ZMYND11;ATF7;ELF4;SP8;TEAD2;CUX1;CREM;RAD51B;HDGFL2;PBX1;EGR3;MSC;TCF7;CUX2;CENPX;POLR3F;ELF2;RBBP8;FOXO3;EGR2;LHX9;NR4A1;KDM5B;HOXA10;NFIC;NR3C1;GMEB1;BHLHE41;PKNOX1;ZBTB12;HIC1;MND1;GTF2H4;RFX2;RARA;SP3;ERCC5;SMAD2;IRF9;ELK4;HOXB4;SOX4;TEF;MBNL2;BCL11B;POU6F1
prerank,amino acid:sodium symporter activity (GO:0005283),0.5445401834072051,1.20713306076776,0.2718978102189781,0.6166592111415928,1.0,3/11,4.08%,SLC1A3;SLC6A13;SLC6A12
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.3942902391665366,-1.204167009211145,0.20495495495495494,0.5470582651406868,1.0,8/27,17.39%,SLC9A2;SLC9B2;SLC8A1;CNNM4;SLC9A8;SLC3A2;SLC9A5;SLC8B1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5254432918199695,-1.1986081470240317,0.24793388429752067,0.5553241112547135,1.0,9/10,32.32%,MGME1;EXD2;DCLRE1C;POLD1;EXO1;APEX1;DCLRE1B;FEN1;TATDN1
prerank,pre-mRNA binding (GO:0036002),0.42722839915055233,1.1966420961665303,0.24187725631768953,0.6397982765325559,1.0,6/28,13.61%,CELF2;RBM41;ZRSR2;SLU7;RNPC3;TARBP2
prerank,O-acyltransferase activity (GO:0008374),0.4112664619984788,1.1945169470115062,0.21391304347826087,0.6410718897386144,1.0,6/30,12.39%,PLA2G4A;MBOAT2;MOGAT3;PLA2G4C;SOAT1;DGAT2
prerank,GTPase activator activity (GO:0005096),0.29804848321334104,1.1936180314445832,0.10778443113772455,0.6391947360384251,1.0,62/313,13.68%,ARHGAP29;RANBP3L;ALDH1A1;RASGRF1;RIN2;RAPGEF4;AKAP13;ARHGAP42;ARHGAP10;DOCK5;DOCK11;ARHGAP20;ARHGAP18;SBF2;DLC1;ASAP1;DENND2A;ARFGAP3;ARHGAP32;DENND4A;ARHGAP28;FGD4;NRP1;RCBTB2;TBC1D16;SEC23A;ERRFI1;MYCBP2;PCP2;RANBP2;ASAP3;PLCE1;RASA1;TAGAP;GRTP1;RALBP1;ARHGEF10L;DENND1A;ARHGEF11;SYDE1;ACAP2;LRRK2;ARHGAP26;EIF2B3;GMIP;HPS1;IQGAP2;NGEF;NUCB2;DNM1L;FNIP1;IQSEC2;ARHGAP9;SIPA1L2;RAB3IP;RAP1GAP;ARRB1;TBC1D7;GNB5;DENND4C;SMAP2;LLGL2
prerank,exonuclease activity (GO:0004527),0.38898485444395176,1.1934756211571644,0.20454545454545456,0.6350989847018045,1.0,8/46,10.98%,ENPP3;ENPP1;REXO5;WRN;RAD50;POLG;EXD1;ENPP2
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4793020458704895,-1.189144826745617,0.24385245901639344,0.5734387221302889,1.0,8/12,42.96%,SLC2A1;SLC2A4;SLC2A2;SLC5A3;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,chemorepellent activity (GO:0045499),0.4245877510161881,1.186380686337229,0.25301204819277107,0.6495753805777312,1.0,3/25,0.83%,SEMA3D;DPP4;EPHA7
prerank,protein heterodimerization activity (GO:0046982),0.312934233963839,1.1847838397668258,0.15364238410596026,0.6496121553387544,1.0,27/178,11.53%,TCF4;BMP6;ATP1A2;ZHX2;MICU1;ARNT2;APOA2;DGKD;CREB3L3;ARNT;BCL2;TPM1;TLR4;EPAS1;MCL1;TOP2B;BDKRB2;VAPA;BAX;MEF2A;PHB2;TAF7;TPM4;IRAK3;PAFAH1B3;BCL2L1;ATP1B2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.27808134237990395,-1.1847549582553645,0.10460251046025104,0.5791511864222951,1.0,36/147,13.52%,RAPGEF5;DOCK9;DOCK4;FGD5;ARHGEF28;CYTH3;PREX2;RASGRF2;ELMO1;ABR;DOCK10;SPATA13;CYTH1;TIAM1;ARHGEF6;DOCK2;ARHGEF15;RAB3GAP1;ARHGEF2;EIF2B2;RAPGEF2;CCDC88A;FGD6;PREX1;HERC2;SMCR8;BCR;SH3BP5L;DOCK8;RAPGEF6;ARHGEF7;ALS2;RGP1;VAV1;DOCK1;RABGEF1
prerank,tubulin binding (GO:0015631),-0.2545087322087285,-1.1832054234490068,0.03468208092485549,0.5776648272691128,1.0,74/295,18.61%,DNM3;MTUS1;SGIP1;UNC5C;AGBL4;SYBU;NAV3;TTLL7;DIP2B;MID1;KIF1B;EML6;REEP1;PAK1;SNCA;KIF21A;RPS3;KIF26B;FMN1;KIF1C;RP1;STARD9;TTLL5;ARHGEF2;CRIPT;GABARAP;STMN2;MID2;CCDC88A;EFHC2;DIXDC1;RCC2;MTCL1;PHF6;MAP1B;TERF1;GABARAPL1;HDAC6;SNPH;ARL8A;KIF26A;KIF18A;NEFH;TRIM36;FGF13;ARHGEF7;PRUNE1;KIF5C;KIF15;NDE1;WASHC1;KIF3B;BRCA2;CLASP2;MAP2;KIF16B;KRIT1;RAB11FIP5;KIF5A;MAPT;CLIP2;RAE1;SKA2;CCT5;CCDC69;GAS2L3;BRCA1;PRC1;STMN4;STMN1;KIF27;PACRG;TPPP;MAST1
prerank,RNA stem-loop binding (GO:0035613),0.5124988194682137,1.18113462375329,0.28598848368522073,0.6549280794857889,1.0,6/12,23.92%,RC3H1;METTL16;CPEB3;EPRS1;ZC3H12A;DHX9
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.45108601910547097,-1.1792487751691425,0.2311212814645309,0.5825088514817567,1.0,7/14,21.92%,NOD1;MAL;ATP2A3;RACK1;PYCARD;BAD;CASP1
prerank,transition metal ion binding (GO:0046914),0.28858730421434897,1.178538083819153,0.11874272409778813,0.6573745689903348,1.0,72/397,14.40%,KMT2A;AGMO;ENPP3;MPPED2;CBLB;SMAD3;MOXD1;ENPP1;FAM20C;PAPPA;KDM7A;SHMT1;AOX1;LITAF;LOXL3;RC3H1;ANPEP;UBA5;WRN;LACC1;LARGE1;SEC23A;MYCBP2;PAM;CSRP1;ZNF3;GALNT2;SEC24D;CUTA;NPEPPS;HDAC4;NSD1;GALNT1;GLO1;GYG1;B4GALT1;ZEB1;NEK4;TRIM24;SKI;ZMYND11;TIMP2;BAZ1B;ZFP37;ACR;SLU7;MNAT1;PDXK;QPCTL;ERAP1;SCD5;CUTC;ENPP2;ESCO1;NQO2;FNTB;EEA1;PTPN1;ENDOU;ZCCHC4;SEC24C;TET2;KDM5B;KDM2A;THAP1;PPM1M;ZNF205;TIMM9;RNPEP;LNPEP;KAT6A;MDM4
prerank,glucuronosyltransferase activity (GO:0015020),-0.4209697721545635,-1.1768850131272857,0.2575107296137339,0.5829238993166742,1.0,3/19,5.53%,CSGALNACT1;B3GAT2;EXT1
prerank,protein serine/threonine kinase activity (GO:0004674),0.29381719866860184,1.1760802223924072,0.1185006045949214,0.659500135128106,1.0,74/334,15.84%,PDPK1;ROCK2;CAMK1D;NRK;STK32B;GRK3;FAM20C;MAPK4;STK39;EIF2AK2;OXSR1;PRKAA2;TSSK3;BMPR1A;CASK;BMP2K;FAM20A;CDK8;DAPK1;TAOK3;IKBKE;NEK8;ARAF;TOP1;LATS2;TGFBR1;AAK1;PRKCZ;MAP3K1;MAPK6;TGFBR2;CLK4;MAP4K1;GSK3B;NEK4;WNK4;RIPK2;SIK3;LRRK2;STK24;STK3;CDK7;TLK2;BRD4;CDK12;AKT3;CDK16;HIPK3;MAPK14;IRAK3;GRK5;MAP2K1;RPS6KA3;DAPK2;MAP3K7;ERN2;MAPK9;MASTL;MAP3K13;SRPK1;ACVR1C;CSNK2A2;WNK1;EIF2AK3;NUAK2;TBK1;MAPKAPK5;MAP3K2;PRKD2;ILK;STK4;CDKL3;ACVR2B;LIMK1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3501507164469772,1.1759079129480985,0.21921921921921922,0.6555128301525396,1.0,13/73,11.33%,LGR4;FPR2;GCGR;GLP2R;GP1BA;MC2R;RXFP2;SORCS2;BDKRB2;OPRD1;NMUR1;NLRP6;MAS1
prerank,nuclease activity (GO:0004518),0.3701007372715538,1.1743773734896323,0.233587786259542,0.6549341418124562,1.0,19/52,23.06%,ENPP1;REXO5;WRN;NTHL1;SND1;ERN2;OGG1;ERCC5;DNASE1L1;DIS3;DNA2;RNASEH1;DFFB;RNASE3;RNASEL;PARN;STK31;ZC3H12A;RNASEH2A
prerank,nucleotidyltransferase activity (GO:0016779),0.4534860157591041,1.1742926705607666,0.2730560578661845,0.6508461657943536,1.0,9/19,22.61%,TUT4;TERT;REV1;TENT2;CRPPA;TUT7;PAPSS1;TENT4B;PNPT1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.4480111575891832,1.1741812826228422,0.28142589118198874,0.6469162719069018,1.0,3/21,1.55%,PDE1A;PDE8B;PDE5A
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3610702719910503,1.1737685945290488,0.2149390243902439,0.6437500770002088,1.0,16/60,10.09%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;ROR1;KIT;EPHA1;PDGFRB;TGFBR2;EPHA4;MST1R;MUSK
prerank,ephrin receptor activity (GO:0005003),0.47938002723805556,1.173355663388197,0.27204502814258913,0.63662617213053,1.0,6/17,12.25%,EPHA7;EPHA3;EPHA8;EPHA1;EPHA4;EPHA2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.47938002723805556,1.173355663388197,0.27204502814258913,0.63662617213053,1.0,6/17,12.25%,EPHA7;EPHA3;EPHA8;EPHA1;EPHA4;EPHA2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.48788136802712945,1.1711566895946914,0.294921875,0.6381850781820068,1.0,4/13,5.76%,PDGFRA;ITGA5;VEGFD;PDGFRB
prerank,histone acetyltransferase activity (GO:0004402),0.4103915411058482,1.1693205245256633,0.2689655172413793,0.6388469353015548,1.0,14/30,20.68%,NCOA3;CREBBP;KAT6B;EPC1;BAZ1A;SRCAP;ARRB1;KAT6A;KAT2B;TAF9;ATF2;CLOCK;EPC2;NAA40
prerank,protein phosphatase regulator activity (GO:0019888),0.3657028449117432,1.1679917486199636,0.23801652892561984,0.6383403201841452,1.0,15/53,17.72%,RCAN2;PTN;PPP2R2B;EIF2AK2;RCAN1;PPP4R2;PPP4R1;PPP1R16A;PPP6R3;PPP1R7;SHOC2;BOD1L1;PPP2R5C;DMPK;PPP2R2A
prerank,glucose transmembrane transporter activity (GO:0005355),-0.42698819491099615,-1.166456404673096,0.2559652928416486,0.6028956319023949,1.0,10/17,42.96%,SLC2A1;SLC2A4;SLC2A2;SLC5A11;SLC2A10;SLC5A3;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,cAMP binding (GO:0030552),-0.4861953350929503,-1.164621182833626,0.30227272727272725,0.6027493373715319,1.0,6/11,8.91%,PDE4D;PDE4B;HCN1;PDE10A;RAPGEF2;PDE2A
prerank,actin monomer binding (GO:0003785),-0.3946108700992298,-1.1638372581769898,0.25476190476190474,0.5996425948294167,1.0,8/22,23.87%,NOS3;TMSB4X;TMSB10;TWF1;PRKCE;PFN2;ABITRAM;PFN1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3698742015813592,1.1592144225823877,0.25938009787928223,0.6572444738480661,1.0,11/48,11.92%,TRPM3;TRPM6;NALCN;P2RX1;SLC4A11;CALHM2;PKD1L3;TMEM165;TRPC1;SLC41A1;GRIN3B
prerank,nuclear receptor binding (GO:0016922),0.32384857099668685,1.1553670539955034,0.22046109510086456,0.6635523046856615,1.0,21/111,13.49%,TCF7L2;SMAD3;NCOA3;TRIP12;TGFB1I1;STAT5B;CRY1;TACC2;NCOA6;TACC1;BAZ2A;NSD1;OASL;STAT1;PHB2;TAF7;PPID;ZNHIT3;NR4A1;MED12;BRD8
prerank,growth factor activity (GO:0008083),0.3497260619976456,1.1543180761757623,0.22205438066465258,0.6621078227244473,1.0,21/74,20.81%,PTN;FGF1;OSM;IL11;VEGFD;TGFA;IL6;IGF2;FGF18;CSF1;ENDOU;BDNF;INHA;FGF20;GDNF;OSGIN1;OSGIN2;IL7;HBEGF;ANGPTL3;AGT
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.43571515445961234,1.1542589517584292,0.29097605893186,0.6581369403714538,1.0,3/23,1.55%,PDE1A;PDE8B;PDE5A
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.38958366556921376,1.1506301443343736,0.2542087542087542,0.6636728094568984,1.0,16/34,27.79%,NSD3;ETFBKMT;METTL21C;SETD4;SETD7;ATPSCKMT;SETDB1;SETD2;KMT5B;SMYD3;EHMT2;SUV39H1;EEF1AKMT4;SETD6;SMYD2;EHMT1
prerank,lipase activity (GO:0016298),0.3754669474230542,1.1498758932477937,0.2681744749596123,0.6615290528154526,1.0,2/43,1.26%,PLA1A;SMPD3
prerank,cytokine receptor activity (GO:0004896),0.3327246264178794,1.1494271476962001,0.23565891472868217,0.6585826260304427,1.0,7/83,2.97%,LEPR;GHR;IL31RA;IL6ST;ACKR2;CCR9;IL23R
prerank,acid-thiol ligase activity (GO:0016878),0.48132975612058215,1.1482107680965752,0.31190926275992437,0.6578323220530174,1.0,4/13,17.64%,ACSL1;SLC27A2;ACSS1;ACSS3
prerank,iron ion binding (GO:0005506),0.3714449827361777,1.1478465278902494,0.2413793103448276,0.654889922424787,1.0,15/48,22.48%,AGMO;KDM7A;AOX1;FECH;FTO;SCD5;TET2;ALKBH1;PHYH;HEPH;JMJD6;EGLN1;TET1;HAAO;NFU1
prerank,kinase binding (GO:0019900),-0.23868604633064372,-1.1452998848271503,0.07194244604316546,0.6431160493359768,1.0,107/434,16.32%,FRMD5;DLG2;SLC12A7;UNC5C;SLC12A2;PTPRJ;PTPRK;PLCG2;PDE8A;BCAR3;TFRC;ACSL3;CSPG4;CIT;ACTB;RPS19;TIAM1;NSF;NBEA;CADPS;CALM1;ACVRL1;UTRN;LRBA;CALM2;RPS6;EMP2;RPS3;ESR1;RPS7;EEF1A1;DAB2IP;CTNNB1;HDAC7;ACTA2;HSP90AB1;CEP68;RCC2;EEF2;WWC1;CALM3;HNRNPA0;CEACAM1;RHOB;PIK3IP1;CNTLN;SIK1;RAD23A;SMCR8;NPM1;RFFL;SYN1;FAS;CCND1;TRIM68;TRIP6;SNAP91;CNKSR2;INKA2;RHOG;TTC28;CAV2;DVL1;SMAD1;POLA1;ANKRA2;BORA;NBEAL2;SPRED2;BARD1;NEFH;TBC1D14;CAV1;ARHGEF7;BCAR1;SRCIN1;CEP43;ATF4;EGFR;WDCP;USF1;CASP9;RHOH;USP37;RGCC;JTB;PPP1CC;PRKRIP1;CYLD;VDAC1;SHC4;PGAM1;RAC1;NR4A3;PARK7;PTPRC;MYOM1;NOD2;PLCG1;CDKN1A;MAPT;LYST;IRGM;SPRED3;VRK1;AP1B1;RHOBTB1
prerank,voltage-gated chloride channel activity (GO:0005247),-0.5046746058161887,-1.1451208636651835,0.3107569721115538,0.6383261739216329,1.0,4/10,17.86%,ANO1;CLCN3;CLCN1;CLCN5
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.48929486349144424,1.143974336344689,0.32967032967032966,0.6614126846911369,1.0,3/12,9.89%,SLC19A1;SLC17A9;SLC25A24
prerank,CXCR chemokine receptor binding (GO:0045236),0.5104578403120436,1.1425897487694665,0.34448818897637795,0.6610107111729233,1.0,1/11,1.09%,CXCL10
prerank,copper ion binding (GO:0005507),0.37448633530538067,1.1422215948382755,0.27257799671592775,0.6580490866071314,1.0,7/42,10.85%,MOXD1;LOXL3;LACC1;PAM;CUTA;ACR;CUTC
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.4869635373810852,-1.1395355208768492,0.3107822410147992,0.6472766892115331,1.0,6/10,24.05%,SLCO1C1;SLCO2A1;SLC22A6;SLCO4A1;SLCO4C1;SLCO1B1
prerank,metallopeptidase activity (GO:0008237),0.31417194839617074,1.1308623236271245,0.23285714285714285,0.6838548148538282,1.0,23/113,14.75%,ADAMTSL5;PAPPA;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;ANPEP;NRDC;BMP1;MMP14;THSD4;ADAM12;ERAP1;ADAM19;MYSM1;NLN;PMPCB;PAPLN;ADAMTS7;RNPEP;LNPEP;ADAMTS15
prerank,GTPase regulator activity (GO:0030695),0.29089781340579607,1.1283741046786486,0.2182741116751269,0.6863766094971296,1.0,44/212,14.53%,ARHGAP29;RANBP3L;ALDH1A1;RIN2;ARHGAP42;ARHGAP10;ARHGAP20;ARHGAP18;DLC1;ASAP1;ARFGAP3;ARHGAP32;ARHGAP28;NRP1;TBC1D16;SEC23A;ERRFI1;RANBP2;ASAP3;RASA1;TAGAP;GRTP1;RALBP1;ARHGEF10L;SYDE1;ACAP2;LRRK2;ARHGAP26;RALGDS;GMIP;IQGAP2;DNM1L;IPO7;ARHGAP9;SIPA1L2;RAP1GAP;ARRB1;TBC1D7;GNB5;SMAP2;LLGL2;WASL;NPRL3;CDC42SE1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4976105538262977,1.1272610715221487,0.33210332103321033,0.6853413748660886,1.0,3/11,9.89%,SLC19A1;SLC17A9;SLC25A24
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4958942500517026,1.1264838816025229,0.3352165725047081,0.6832418438965774,1.0,3/12,11.08%,TRAF5;STAT1;TRAP1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.47238927963337296,1.1262876460261704,0.32437619961612285,0.6800000141540463,1.0,2/14,9.60%,CMPK2;AK5
prerank,CoA hydrolase activity (GO:0016289),0.4509471331253006,1.125186596039551,0.3320964749536178,0.6786414830583947,1.0,3/16,10.41%,ACOT11;ACOT9;ACOT1
prerank,voltage-gated calcium channel activity (GO:0005245),-0.33680165617004937,-1.1246124725610378,0.27249357326478146,0.6813413037050978,1.0,6/37,9.32%,CACNA1E;CACNB2;CACNB4;OPRM1;CACNA1G;CACNA1D
prerank,calcium ion binding (GO:0005509),0.2791003366886032,1.1209971738107223,0.234093637454982,0.686019434157255,1.0,51/323,12.43%,ENPP3;TNNC1;FBN1;MAN1C1;ITPR1;SELP;GJB2;ENPP1;PLA2G4A;MICU1;CLEC3B;CEMIP2;PRF1;S100A6;ANXA2;FBLN1;CDH5;AMY1C;AMY1B;AMY1A;RCN1;ANXA1;S100A10;ADGRV1;ANXA3;PAM;CRP;ANXA11;CPNE1;ANXA4;THBS3;PLA2G4C;DCHS1;GLCE;ANXA5;ANXA7;ESYT1;PCDHB8;PLSCR4;DSC3;DSC2;SLC25A24;TPM4;STIM2;NUCB2;ENPP2;CDH13;PLSCR2;IHH;PPP3CB;SPARC
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.34364384511473817,-1.1200141092945683,0.2707317073170732,0.6885241176695825,1.0,6/34,7.35%,MYO10;ARAP2;CYTH3;ARAP3;HIP1R;AKT1
prerank,aminopeptidase activity (GO:0004177),0.39836563132136044,1.1196672687285056,0.32663316582914576,0.6854049196117166,1.0,9/26,14.49%,ANPEP;MMP14;NPEPPS;CTSH;ERAP1;BLMH;RNPEP;LNPEP;KDM8
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3952114399362579,1.1177036612228455,0.30017152658662094,0.6865795739601629,1.0,6/26,4.74%,SLC6A13;SLC16A11;SLC16A12;SLC16A2;SLC6A12;SLC16A5
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.3261227287666373,-1.1169254780487674,0.27371273712737126,0.6913883616374923,1.0,12/46,15.76%,MGAT5;HEXB;EXT1;POMGNT1;LFNG;MFNG;B3GNT2;PIGQ;GCNT1;MGAT4A;B3GNT9;POMGNT2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.3790586936282109,-1.1121057766008158,0.30131004366812225,0.6992722622275643,1.0,5/21,20.26%,GRM5;GRIA1;CHRNA4;CHRFAM7A;CHRNA7
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4626188034990783,-1.1112413385016437,0.33617021276595743,0.6959775492639559,1.0,5/10,20.18%,PIK3C2B;PIK3R3;ATM;PIK3CD;PIK3C3
prerank,ion channel inhibitor activity (GO:0008200),-0.3333759274778314,-1.1107798638006166,0.29411764705882354,0.6919329778838286,1.0,9/35,10.27%,KCNMB2;FKBP1A;CALM1;MCUB;CALM2;SLC30A1;CAMK2D;NEDD4L;RACK1
prerank,RNA binding (GO:0003723),-0.2113298005666093,-1.1094011103981594,0.0625,0.6905219718060197,1.0,365/1321,22.72%,SORBS2;SYNE1;RIMS1;STRBP;NOL4;RPS24;ACTN1;TMSB4X;RALYL;QKI;HSPA8;TCF20;LRRFIP1;RPL18A;RPS9;RPL19;TFRC;NOVA2;CMSS1;TPT1;FAU;RPS12;ADARB1;RFTN1;RPL26;RPL41;RPS15;MBNL1;RPL24;RPS23;CELF4;RPL5;KHDRBS2;RPS27;RPS19;RPL38;RBFOX3;SCG3;LIN28B;RPS8;PUS7;RPL10A;SETX;RPL27A;RPL13;CSTF2;RBFOX1;LUC7L3;RPS18;MACF1;RPL27;RPS16;ELAVL2;RPS6;RPL35A;RPL21;R3HDM1;RPS3;RPS17;RPL39;RPL37A;RPS7;RPL4;EEF1A1;CPEB2;ADARB2;CEBPZ;RPS15A;PTBP1;ATXN2;RPLP0;RPS25;KIF1C;RPL6;RPS21;ELP1;RPL11;RPL28;RPL8;RPL32;TAF15;RPS28;KHDRBS3;HMGB1;PUF60;PKM;RPL30;RPL13A;SCAF4;STXBP1;HSP90AB1;RPS4X;RPS20;SRP14;ZFR2;MRPL4;DHX15;GTPBP1;YBX1;RPS13;ATP5F1A;TES;CPSF2;RPL18;SRSF2;RCC2;EEF2;ZCRB1;KPNB1;RRP7A;UNK;MTCL1;PHF6;RPS2;HNRNPA0;CNBP;DDX54;SRSF1;NOL11;DDX49;HNRNPK;MYEF2;PCBP1;SSRP1;RPL14;TIAL1;ZC3H11A;RPL22;PPIL4;DDX47;DDX11;APOBEC1;NPM1;HNRNPH2;PUM3;THOC2;YTHDF2;TRA2A;WDR36;FAM32A;SART3;GFM1;DYNC1H1;SREK1;BUD13;KCTD12;YY1;RPS26;GNL3L;TRIP6;DDX17;DNTTIP2;RO60;NKAP;MAP3K20;DHX30;KARS1;CALR;HSPE1;BYSL;RACK1;GDI2;YTHDC2;CCAR2;RPS10;CARS1;RALY;MANF;NVL;NELFCD;NOL12;IGHMBP2;PSMD4;NIP7;EXOSC2;FTSJ3;BARD1;RPL23;RPL17;PTCD2;EIF5B;EIF5A;WBP11;RPL29;EIF1B;FKBP3;EIF4A1;PSMA6;MAK16;H1-0;THUMPD1;PABPC4L;S100A16;ELP5;GSPT2;MRPL1;HSP90AA1;RPP30;PABPC4;MSI2;RPS5;MRPS30;GRN;RPL22L1;EIF3A;MRPS23;FASTKD2;RPS14;PPAN;SLC3A2;TUBB4B;FAM120C;SNRNP35;SART1;LSM14B;DCP1A;ACTN4;PPIA;PPP1CC;VIRMA;NOP56;PRKRIP1;DBR1;SNRPB;HNRNPF;CCDC47;ZGRF1;PARK7;MYO18A;HMGN2;TUBA1B;MRPL28;SRBD1;ADD1;AKAP1;RARS2;FRG1;RBM33;MAPT;PPRC1;CPEB4;MRM1;SRP9;ZCCHC3;ZMAT3;RAE1;XPOT;MTPAP;ANP32A;NUDT16L1;NOL7;UBE2O;RPL12;SMNDC1;ENO1;RPL9;CSTF2T;DDX51;RBM19;XRN2;BRCA1;ZC3H13;IMP3;RPS19BP1;ESF1;LUC7L;RBM3;RPL37;RPS11;LLPH;HSD17B10;PABPC1;MEX3A;DUSP11;PPIB;N4BP1;SNRPF;TRIM28;RNPS1;RIDA;CCDC9;POLDIP3;ERI1;LGALS1;CS;SNU13;YRDC;SRSF9;GNL3;TYW5;FKBP4;EIF1;RPL7A;RPL7;EWSR1;EIF4A2;MRPS5;DICER1;RPL31;MKRN1;C1QBP;PPP1R10;RAVER2;EIF3G;UPF1;RBM15B;RTCA;NOC2L;TRMT9B;UTP6;TRMT6;WRAP53;LSM4;MKI67;NONO;TFB2M;FBRSL1;PURB;RPL3;YARS2;MRPL23;SNRPD1;SNRPD2;NANOS3;MEX3D;ZCCHC8;HNRNPLL;MRPL9;ZC3H8;HEATR1;BMS1;EIF3H;SF3B5;RBM47;CELF6;FAM98A;SAFB2;MRPS31;CHTOP;HDGF;TFB1M;FAM50A;UTP11;BAG4;SRSF6;PPP1R8;HEXIM2;MCAT;WDR46;SRF;MDH2;MRPS12;ALKBH5;NKRF;CDC40;FLYWCH2;SYF2;SAMSN1;TUFM;DHX35;RPL23A;TOE1;PYM1;ALG13;MRPL11
prerank,cytochrome-c oxidase activity (GO:0004129),-0.42254418244925285,-1.1086515256458969,0.34334763948497854,0.6871607299114947,1.0,8/15,29.27%,COX4I1;COX8A;NDUFA4;COX6A1;NDUFA4L2;CYB5A;COX4I2;COX5B
prerank,tau-protein kinase activity (GO:0050321),0.4155364950108647,1.1086409988072108,0.33992805755395683,0.7064614754578863,1.0,3/20,8.60%,ROCK2;GSK3B;SIK3
prerank,PDZ domain binding (GO:0030165),0.34329863643747244,1.1075081652146679,0.31160572337042924,0.7054759836948281,1.0,6/61,3.47%,ARHGAP29;TGFBR3;PLEKHA2;CXADR;SDC2;FZD2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3898926970499445,1.1055815369255029,0.3389830508474576,0.7064720002615232,1.0,15/32,23.70%,KDM7A;P4HTM;FTO;TMLHE;TET2;KDM2A;KDM8;ALKBH1;PHYH;KDM2B;ALKBH4;EGLN1;TET1;HSPBAP1;PHF8
prerank,"DNA binding, bending (GO:0008301)",0.4455942380754032,1.104232306418369,0.36046511627906974,0.7061090165024018,1.0,2/14,1.84%,FOXD1;FOXC1
prerank,E-box binding (GO:0070888),0.37812857836505115,1.103382103725166,0.32130584192439865,0.7043876512654079,1.0,1/34,0.04%,TCF4
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.37426686644177054,1.101250202919953,0.3225806451612903,0.7060053581289781,1.0,3/35,3.11%,TEC;STYK1;FER
prerank,organic anion transmembrane transporter activity (GO:0008514),0.30222099352573034,1.0987260812984196,0.29624478442280944,0.70900128969615,1.0,16/134,7.17%,PDPN;SLC7A2;SLC1A3;SLC6A13;SLC13A3;SLC16A11;GJA1;SLC19A1;SLC6A9;SLC26A9;SLC16A12;SLCO3A1;SLC17A9;SLC35D1;SLC4A11;SLC38A6
prerank,protein kinase binding (GO:0019901),-0.22506315149379838,-1.098248570516975,0.11764705882352941,0.7093277077177745,1.0,116/479,16.32%,FRMD5;SLC12A7;UNC5C;SLC12A2;PTPRJ;PTPRK;PRKCB;PLCG2;GRM5;PDE3B;TFRC;ACSL3;RYR2;CSPG4;BMPR2;CIT;ACTB;RPS19;NSF;NBEA;CADPS;CALM1;ACVRL1;UTRN;LRBA;CALM2;RPS6;EMP2;RPS3;ESR1;RPS7;NELL2;EEF1A1;DAB2IP;PKN1;PRKAR1A;HDAC7;HDAC9;ACTA2;HINT1;CEP68;CCDC88A;RCC2;EEF2;ACE;CALM3;MAP3K11;TCF3;HNRNPA0;CEACAM1;RHOB;PINK1;CNTLN;SIK1;SMCR8;NPM1;RFFL;SYN1;CCND1;TRIM68;DUSP22;SNAP91;CNKSR2;INKA2;DUSP8;RHOG;GCH1;CAV2;RACK1;DVL1;SMAD1;POLA1;ANKRA2;BORA;NBEAL2;SPRED2;NEFH;TBC1D14;PRKAR2B;CAV1;KCNQ1;ARHGEF7;BCAR1;SRCIN1;CEP43;CAVIN2;ATF4;HSP90AA1;TJP2;USF1;ACVR1;MAPK8IP3;CASP9;RHOH;USP37;RGCC;JTB;PPP1CC;PRKRIP1;CYLD;VDAC1;SHC4;PGAM1;RAC1;NR4A3;PTPRC;NOD2;PLCG1;CDKN1A;MAPT;LYST;IRGM;SPRED3;VRK1;AP1B1;RHOBTB1
prerank,sulfotransferase activity (GO:0008146),0.3856974846456113,1.097986866339085,0.3251318101933216,0.7070324562442372,1.0,3/33,4.64%,UST;CHST15;TPST1
prerank,metal ion binding (GO:0046872),0.26571757057161194,1.094892290609406,0.23094425483503983,0.7116616820959198,1.0,79/477,13.70%,EYA2;IGFBP3;ENPP3;TNNC1;FBN1;MAN1C1;ITPR1;SELP;GJB2;ENPP1;PLA2G4A;MICU1;OXSR1;CLEC3B;TSSK3;CEMIP2;PRF1;S100A6;DCTPP1;ANXA2;CLYBL;FBLN1;CDH5;AMY1C;AMY1B;AMY1A;RCN1;ANXA1;S100A10;ADGRV1;ANXA3;WRN;PAM;CRP;ANXA11;PIR;CPNE1;IDH1;ANXA4;TESMIN;THBS3;PLA2G4C;PAPOLG;DCHS1;GLCE;ANXA5;ANXA7;ESYT1;PCDHB8;SIK3;LRRK2;STK3;PDXK;PLSCR4;DSC3;DSC2;SLC25A24;TPM4;STIM2;NUCB2;IRAK3;HACL1;GEM;ENPP2;CDH13;PLSCR2;IHH;ADPRS;PPP3CB;SPARC;TRIM26;IDH2;ERN2;CRNN;OPA1;SRPK1;SMOC2;ACVR1C;BAIAP3
prerank,vinculin binding (GO:0017166),-0.45322054863931,-1.0940067250053829,0.3757700205338809,0.715289218594368,1.0,3/11,3.67%,ACTN1;DMD;UTRN
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.39924078977702404,-1.0939097748492372,0.3317757009345794,0.7102158165136986,1.0,4/18,7.00%,PIK3R1;PIK3R6;PIK3R3;WDR81
prerank,potassium:proton antiporter activity (GO:0015386),-0.4672620953228273,-1.0912392834048006,0.34959349593495936,0.711850539409811,1.0,3/10,14.26%,SLC9A2;SLC9A8;SLC9A5
prerank,acetyltransferase activity (GO:0016407),0.38051848355353673,1.0893466185949967,0.3333333333333333,0.7220660493589076,1.0,10/31,16.90%,CREBBP;KAT6B;NAA16;PAFAH1B3;ACAT1;NAA15;ESCO1;KAT6A;KAT2B;PAFAH2
prerank,epidermal growth factor receptor binding (GO:0005154),0.40005301595251364,1.087289379502394,0.3677536231884058,0.7236993655988849,1.0,4/25,6.06%,EFEMP1;FER;TGFA;ARF4
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4125424885048685,-1.0871136390863607,0.3694690265486726,0.7177662706657577,1.0,2/14,1.61%,SLC26A7;SLC26A2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.4842590159695565,1.0865134094621398,0.3770491803278688,0.7181785193239886,1.0,3/10,10.34%,DUSP10;DUSP16;DUSP5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.4842590159695565,1.0865134094621398,0.3770491803278688,0.7181785193239886,1.0,3/10,10.34%,DUSP10;DUSP16;DUSP5
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.4087879836364329,1.0845363264122931,0.3782771535580524,0.7196371813382179,1.0,7/20,20.84%,AGPAT4;MOGAT3;AGPAT3;DGAT2;LPGAT1;ABHD5;DGAT1
prerank,adrenergic receptor binding (GO:0031690),-0.40890939310922225,-1.0843985530386866,0.3288590604026846,0.7197878264937544,1.0,6/16,20.74%,PDE4D;GNAS;RAPGEF2;AKAP5;C1QBP;ADRB1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.28201039376033893,1.0839518308785303,0.315086782376502,0.7174547432304799,1.0,30/173,14.03%,ZBTB20;ZEB2;MXI1;KCNIP3;POU5F1;ZBTB4;NFATC4;AEBP1;GZF1;OTP;ZNF3;FOXP3;PPARA;ZBTB37;ZEB1;ZNF25;SKI;ZFP37;CREM;E4F1;HEYL;FOXO3;ZNF219;MZF1;THAP1;NR3C1;PRDM5;BHLHE41;ZBTB12;HIC1
prerank,CoA-ligase activity (GO:0016405),0.45445727623846427,1.0828063763367386,0.3830570902394107,0.7168037281903046,1.0,4/14,17.64%,ACSL1;SLC27A2;ACSS1;ACSS3
prerank,cation channel activity (GO:0005261),0.3082406538491492,1.0824056923869647,0.31314623338257014,0.7142333948646795,1.0,18/94,11.92%,TRPM3;MCU;TRPM6;NALCN;ANXA2;KCNQ4;SLC24A3;P2RX1;TMEM38A;SLC4A11;ANO10;CALHM2;OTOP1;PANX1;PKD1L3;TRPC1;ANO6;GRIN3B
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3349351344890322,1.0780222195169873,0.33633633633633636,0.7222508050333851,1.0,13/60,13.45%,LRRK1;CTDSPL;PPM1E;PPM1A;MTMR3;PPEF2;CTDSP2;LRRK2;PPM1B;PPP1CB;CDC14A;PPP3CB;PPM1M
prerank,histone methyltransferase activity (GO:0042054),0.37239017637388167,1.0764411700046697,0.3586206896551724,0.7229815349779385,1.0,14/32,27.79%,SUZ12;KMT2C;NSD3;SETD7;CARM1;SETDB1;SETD2;KMT5B;SMYD3;PRMT1;EHMT2;SUV39H1;SMYD2;EHMT1
prerank,methylated histone binding (GO:0035064),0.3235007614563183,1.0761802627439356,0.34795763993948564,0.7199558767878395,1.0,28/62,26.80%,KDM7A;SUZ12;MORC3;DPF2;TRIM24;ZMYND11;GLYR1;TAF7;RRP8;BPTF;MORC4;KDM8;PYGO1;CHD8;LRWD1;MPHOSPH8;MBTD1;PHF1;PHF13;PHF8;ATRX;ING5;TAF1;ZCWPW1;WDR5;NCAPG2;ING3;ING2
prerank,dynactin binding (GO:0034452),0.4545948636716731,1.0733005165418714,0.3767857142857143,0.7236185385451834,1.0,2/12,7.53%,SNX6;GSK3B
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.4969805724085452,1.0726272773551813,0.39697542533081287,0.7217584785690321,1.0,3/10,10.38%,SLC6A13;SLC6A12;SLC10A1
prerank,MAP kinase phosphatase activity (GO:0033549),0.4534364072932979,1.0712421938245398,0.405189620758483,0.7216923970703127,1.0,3/12,10.34%,DUSP10;DUSP16;DUSP5
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4385871451460803,1.0692568310193131,0.38519924098671726,0.7230472519534812,1.0,2/17,9.60%,CMPK2;AK5
prerank,protein phosphatase binding (GO:0019903),-0.25761232969335907,-1.0691540507683486,0.30033003300330036,0.7562131313946131,1.0,24/117,16.06%,PPP1R16B;GRIN3A;FOXO1;PIK3R1;PHACTR4;MAP3K5;PPP1R3B;MET;DAB2IP;CTNNB1;SNX3;FBXL2;CEACAM1;MFHAS1;PPP1R11;PTPRT;RACK1;KCNQ1;EGFR;SOD1;MYO16;PPP1R3C;MAPT;ADCY8
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.44693655866182713,1.065857982102138,0.38301886792452833,0.7277351457672842,1.0,4/14,8.28%,COL4A3;TIMP3;BST2;TIMP2
prerank,tau protein binding (GO:0048156),-0.3132872280055912,-1.0647330938093682,0.34328358208955223,0.7632998387925647,1.0,11/40,14.54%,ACTB;SNCA;S100B;HSP90AB1;LGMN;HDAC6;TTBK1;HSP90AA1;MARK1;BRSK2;MAP2
prerank,endopeptidase activator activity (GO:0061133),-0.4436082322832454,-1.0634919537282506,0.3838383838383838,0.76104573304299,1.0,4/10,26.43%,PSMD14;PSENEN;PSME1;NLRC4
prerank,microtubule binding (GO:0008017),-0.23643388110591648,-1.0633009616291025,0.25654450261780104,0.7561870501305981,1.0,60/222,21.89%,DNM3;MTUS1;SGIP1;SYBU;NAV3;MID1;KIF1B;EML6;REEP1;MACF1;KIF21A;RPS3;KIF26B;FMN1;KIF1C;RP1;STARD9;ARHGEF2;CRIPT;MID2;CCDC88A;RCC2;MTCL1;MAP1B;TERF1;HDAC6;SNPH;KIF26A;KIF18A;NEFH;FGF13;KIF5C;KIF15;NDE1;KIF3B;CLASP2;MAP2;KIF16B;KRIT1;KIF5A;MAPT;CLIP2;RAE1;SKA2;CEP290;CCDC69;GAS2L3;PRC1;KIF27;TPPP;MAST1;KIF23;KNSTRN;CDK5RAP2;SPAG5;DCTN1;POLB;EML5;NEFM;GAS2L1
prerank,protein phosphatase 2A binding (GO:0051721),-0.35432041050628177,-1.0621202657170692,0.3610503282275711,0.7540932505667921,1.0,6/23,16.06%,GRIN3A;FOXO1;DAB2IP;MFHAS1;MAPT;ADCY8
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4276473674443061,-1.0608562771652574,0.37938144329896906,0.7523899977159701,1.0,2/11,4.80%,LEF1;GATA2
prerank,protein homodimerization activity (GO:0042803),0.25174878993135147,1.0552685107013042,0.31284302963776073,0.750984696567498,1.0,112/589,16.06%,KMT2A;TNNC1;DPP4;SMAD3;NADK2;ZHX2;NR2F2;PDGFRA;FGFR1;ENPP1;MTUS2;MAPK4;GHR;CPQ;GBP2;APOA2;SHMT1;BMPR1A;ZBTB4;S100A6;NR6A1;SNX6;GLIPR2;HSD17B1;DGKD;S100A10;AOX1;TERT;KIT;UBA5;CREB3L3;WRN;ARNT;IL17D;TPST1;CRYL1;BCL2;FECH;EFEMP2;TPM1;RDH5;APPL2;MCL1;ZDHHC3;TPR;IDH1;FOXP3;TRIM5;DPYD;NOS2;GBP5;BST2;STAT1;GYG1;GBP4;SPPL3;GLCE;GOLGA5;SNX9;BAX;RIPK2;EXD1;PHB2;LRRK2;PDXK;TPM4;APPL1;FBXO4;PLEK;IRAK3;DNM1L;PAFAH1B3;BCL2L1;SMAD4;TRIM21;CSF1;NQO2;EEA1;DGAT2;PON3;RAP1GAP;PIP4K2B;MZF1;NOG;THAP1;MAP3K13;ABCD3;PGRMC1;SUPV3L1;NRF1;TARBP2;BHLHE41;CCDC66;SDCBP2;TIMM9;ADRA2C;CIB2;CHMP4A;CHMP4B;NPR3;PKD2;ERCC5;RCHY1;PML;STK4;GDF15;EPHX2;GBP3;ADRA2A;CNOT9;HSPB6;CUBN
prerank,cGMP binding (GO:0030553),-0.42877943693551834,-1.055069466152082,0.4112734864300626,0.7632175515787788,1.0,4/11,8.91%,PDE11A;PDE10A;RAPGEF2;PDE2A
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3154748796702175,1.0535399938262107,0.37106017191977075,0.751836141382171,1.0,14/74,10.68%,NADK2;FAM20C;FAM20A;DGKD;HYKK;PI4KA;PANK2;PIK3C2A;FAM20B;GALK2;GK5;PDXK;TRPT1;XYLB
prerank,solute:sodium symporter activity (GO:0015370),-0.3456332629754192,-1.0532120167568257,0.371007371007371,0.7629279286470404,1.0,21/27,53.58%,SLC4A10;SLC5A6;SLC4A7;SLC20A2;SLC5A11;SLC13A5;SLC5A3;SLC4A5;SLC4A4;SLC34A3;SLC28A2;SLC5A10;SLC5A8;SLC17A7;SLC28A3;SLC28A1;SLC5A1;SLC34A2;SLC5A2;SLC5A9;SLC17A1
prerank,protein kinase inhibitor activity (GO:0004860),-0.311980974640524,-1.0524501485100994,0.38701298701298703,0.7597283000197363,1.0,14/42,18.37%,CIT;SNCA;SMCR8;NPM1;INKA2;RACK1;SH3BP5L;MAPK8IP1;SPRED2;CEP43;PRKRIP1;CDKN1A;IBTK;CDKN1C
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3742880637349236,1.0519940776225616,0.38954468802698144,0.7522437979631674,1.0,4/25,6.54%,PLEKHA2;GAB2;ADAP2;PLEKHA4
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.26539550298564585,1.0518020113758213,0.3522867737948084,0.7491083427187816,1.0,39/254,13.57%,TCF4;SMAD3;RBPJ;ELF1;FOXC1;NFIA;NFAT5;NFYC;SPIB;ZNF395;FOXC2;MYB;LITAF;HOXC4;CREB3L3;PRRX1;HLF;TCF12;KLF5;PPARA;GLIS2;ZSCAN21;CREBRF;MEF2A;ELF4;RLF;E4F1;RFXANK;SMAD4;FOXO3;RFXAP;EGR2;NR4A1;MZF1;HOXA10;NFIC;NR3C1;GMEB1;NRF1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.32831750063359305,1.0497804179847725,0.3772652388797364,0.7507434814907055,1.0,8/49,10.88%,MPPED2;ATP1A2;DUSP10;DUSP28;PTPN22;DUSP16;DUSP5;PPP1CB
prerank,zinc ion binding (GO:0008270),0.26179491540286204,1.0478818958920892,0.3450789793438639,0.7518251937541496,1.0,61/293,16.85%,KMT2A;ENPP3;CBLB;SMAD3;ENPP1;PAPPA;KDM7A;SHMT1;LITAF;RC3H1;ANPEP;UBA5;SEC23A;MYCBP2;PAM;CSRP1;ZNF3;SEC24D;NPEPPS;HDAC4;NSD1;GLO1;ZEB1;TRIM24;SKI;ZMYND11;TIMP2;BAZ1B;ZFP37;ACR;SLU7;MNAT1;PDXK;QPCTL;ERAP1;ENPP2;ESCO1;NQO2;FNTB;EEA1;PTPN1;ZCCHC4;SEC24C;TET2;KDM5B;KDM2A;THAP1;ZNF205;TIMM9;RNPEP;LNPEP;KAT6A;MDM4;IFIH1;RCHY1;KDM2B;SEC24B;RNF2;NAPEPLD;CZIB;P2RX4
prerank,snoRNA binding (GO:0030515),-0.3270185204156262,-1.047263682572077,0.37681159420289856,0.7691273028971126,1.0,16/30,37.95%,BYSL;NOP56;NUDT16L1;IMP3;SNU13;UTP6;HEATR1;BMS1;IMP4;NUDT16;NOP10;PRKDC;NHP2;NUDT1;DHX37;NOP58
prerank,alpha-actinin binding (GO:0051393),0.3829190977308491,1.04610339927789,0.39892665474060823,0.7526336961317815,1.0,7/24,17.13%,DAG1;SYNPO2;CACNA1C;PRICKLE4;PKD2;RARA;PDLIM2
prerank,potassium ion antiporter activity (GO:0022821),-0.39295997916112435,-1.0452895177736592,0.4190687361419069,0.7694538259868479,1.0,3/15,6.64%,SLC9A2;SLC24A2;SLC9A8
prerank,metalloaminopeptidase activity (GO:0070006),0.41615069887441747,1.044938020893631,0.4073394495412844,0.7521353365038709,1.0,6/16,14.33%,ANPEP;MMP14;NPEPPS;ERAP1;RNPEP;LNPEP
prerank,myosin II binding (GO:0045159),-0.44963591502934586,-1.0439651727595536,0.42535787321063395,0.7680015996422438,1.0,3/10,10.39%,SHROOM4;STXBP5L;SHROOM1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3385012063342653,1.0373213662331366,0.37061769616026713,0.7682942572261444,1.0,7/44,11.59%,KMT2A;KMT2C;NSD3;NSD1;SETD4;SETD7;SETD1B
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.44776857108459633,1.034014308111006,0.43702290076335876,0.7729961194863288,1.0,2/12,2.92%,GAB2;FRS2
prerank,NF-kappaB binding (GO:0051059),0.380868100156488,1.0319836431176268,0.4135593220338983,0.7745759030110767,1.0,5/24,7.53%,MTDH;CPNE1;ANXA4;FOXP3;GSK3B
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.4586749176563715,1.0303180828434333,0.4269230769230769,0.7754209062786025,1.0,2/11,8.43%,SASH1;PPEF2
prerank,endoribonuclease activity (GO:0004521),0.3502452164068823,1.030305124977394,0.4065180102915952,0.7719068937248116,1.0,12/32,23.91%,PIWIL4;NYNRIN;SND1;SMG6;ENDOU;ERN2;SLFN14;ZC3H12B;RNASEL;YBEY;ZC3H12A;KHNYN
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4341991333290367,1.0297014269324392,0.436046511627907,0.7699794678353242,1.0,2/14,10.16%,RSAD2;ACO1
prerank,protein kinase C binding (GO:0005080),0.3386366787126719,1.029375992335733,0.3971061093247588,0.7673141152375235,1.0,12/43,16.08%,PRKCSH;NELL1;PARD6G;DACT1;PARD6A;TOP2B;PLEK;GRK5;DACT2;PRKD2;CAVIN3;ADCY6
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.40563769624134566,-1.0292982898114407,0.4426559356136821,0.8039331799400583,1.0,4/13,11.84%,RYR2;PRKAR1A;PRKAR2B;KCNQ1
prerank,beta-tubulin binding (GO:0048487),0.3550890071425213,1.028014353636879,0.40594059405940597,0.7673300936222607,1.0,6/31,10.16%,DLEC1;GJB6;UXT;EML4;PDCD5;APPL1
prerank,phospholipase A2 activity (GO:0004623),0.3702265978162213,1.0277122988906517,0.43478260869565216,0.764418409510237,1.0,5/26,18.00%,PLA2G4A;PLA2G4C;PLA2G6;PLA2G5;ABHD3
prerank,cardiolipin binding (GO:1901612),0.45797143891058184,1.0265781904633708,0.4246031746031746,0.7639161921450927,1.0,4/10,24.56%,GSDME;OPA1;STOML2;GSDMD
prerank,transferrin receptor binding (GO:1990459),0.466738120931006,1.023952076808826,0.44866920152091255,0.7672572086506084,1.0,1/10,1.29%,RGMA
prerank,lysophospholipase activity (GO:0004622),0.3888605083453806,1.0235727318522148,0.4305799648506151,0.7648669678883613,1.0,4/20,10.98%,PLA2G4A;PLA2G4C;PLA2G6;ENPP2
prerank,pyrophosphatase activity (GO:0016462),0.32733487371184783,1.0232794261601927,0.44,0.7622425718090793,1.0,5/50,7.26%,ENPP3;ENPP1;DCTPP1;ENTPD7;DCP2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.411867029809297,-1.0213808523363093,0.4429530201342282,0.8210416580747851,1.0,6/12,21.92%,NOD1;ATP2A3;RACK1;PYCARD;BAD;CASP1
prerank,lipoprotein particle receptor binding (GO:0070325),0.3652566707598085,1.0190937072706092,0.43717728055077454,0.769207281125735,1.0,4/27,4.88%,HSPG2;APOA2;APBB1;CRP
prerank,ribosomal small subunit binding (GO:0043024),-0.37820281596997274,-1.0178251122305315,0.45598194130925507,0.8254030649830413,1.0,9/17,37.00%,CPEB2;NPM1;EIF1B;EIF1;PIM1;ERAL1;DHX29;MTIF2;UNG
prerank,TBP-class protein binding (GO:0017025),-0.3550798319509651,-1.0173874858274983,0.4423963133640553,0.8213323947090035,1.0,10/21,34.69%,ESR1;HHEX;TAF11;PSMC5;GTF2A2;TAF1B;RUVBL2;THRA;PSMC1;GTF2B
prerank,DNA secondary structure binding (GO:0000217),0.3521377260264413,1.0154454933842914,0.4338358458961474,0.7748361396741177,1.0,5/31,11.65%,KMT2A;WRN;RAD51B;FANCM;RBBP8
prerank,SH3 domain binding (GO:0017124),-0.2728783648731229,-1.015368200848807,0.4425770308123249,0.8214387542984481,1.0,15/62,16.22%,AFAP1L1;SGIP1;SHANK3;ENAH;ELMO1;ADAM15;DAB2IP;ARHGAP27;ABI3;VASP;CBL;CASP9;EVL;MAPT;SHANK1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4428519054664837,1.0129729237742768,0.4538606403013183,0.777173849041224,1.0,3/12,3.51%,CDH5;ITGA5;VEGFD
prerank,protein phosphatase activator activity (GO:0072542),0.42875427749902256,1.0125367509612355,0.44854368932038835,0.7747492271917777,1.0,1/13,0.16%,IGFBP3
prerank,cyclic nucleotide binding (GO:0030551),0.3861668503147006,1.012032707557105,0.4514991181657848,0.7727635410722192,1.0,5/21,6.82%,RAPGEF4;PDE5A;SLC19A1;POPDC2;CNBD2
prerank,steroid hydroxylase activity (GO:0008395),0.4089543381844921,1.012003987260226,0.44801512287334594,0.7694697136167854,1.0,2/16,3.20%,CYP7B1;CYP27A1
prerank,phosphatase activator activity (GO:0019211),-0.3921963274161401,-1.010390090520961,0.44742268041237115,0.8296800379175061,1.0,9/14,24.70%,PHACTR4;CALM1;CALM2;CALM3;PPP2R5B;PPP2R5D;PPP1R15A;B3GAT3;PPP2R5A
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3169483461274078,1.00958814365482,0.4327217125382263,0.7718073312664115,1.0,9/49,8.14%,PLA2G4A;ANXA2;ANXA1;ANXA3;CPNE1;ANXA4;PLA2G4C;ANXA5;ESYT1
prerank,retinoic acid receptor binding (GO:0042974),0.40195577648700603,1.0076811452803853,0.4666666666666667,0.7730533068065649,1.0,3/17,6.67%,NCOA6;TACC1;NSD1
prerank,phosphate ion binding (GO:0042301),-0.4301842128936923,-1.0060866873495307,0.4714285714285714,0.8366923256325196,1.0,5/10,30.11%,PDE2A;PNP;ADSS2;ADSS1;RELA
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.35459523802906295,1.0060865505035457,0.43781942078364566,0.7736789202207152,1.0,5/28,11.08%,TRAF5;EDA;STAT1;CASP8AP2;TRAP1
prerank,phosphatase inhibitor activity (GO:0019212),0.38238588824620884,1.0034391198463486,0.47454545454545455,0.7770902667299152,1.0,8/20,24.53%,PTN;ANP32E;BOD1L1;URI1;STYX;PPP1R2;STYXL1;CABIN1
prerank,phosphotyrosine residue binding (GO:0001784),-0.3052753508410688,-1.0034088741046987,0.45588235294117646,0.839324753275312,1.0,8/37,12.58%,PLCG2;BCAR3;SHE;PIK3R1;PIK3R3;LDLRAP1;SYK;VAV1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.34097736904267284,-1.001579603605795,0.463302752293578,0.8391029784876793,1.0,5/23,9.13%,HIP1;HIP1R;SNX3;CLVS1;PLEKHA5
prerank,sodium channel regulator activity (GO:0017080),-0.2978513835876848,-1.001275931330637,0.46464646464646464,0.8346219476208357,1.0,18/37,29.78%,FGF14;FGF12;FXYD5;YWHAH;CAMK2D;NEDD4L;NOS1;FGF13;FXYD1;SCN2B;SCN1B;SGK1;SGK2;SGK3;PKP2;RANGRF;FXYD6;FGF11
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3300666385469272,-1.001204972721864,0.4583333333333333,0.8295701652400627,1.0,5/24,6.84%,RPL26;RPL41;RPL5;RPS7;RPS13
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3593044068431754,1.000966669135349,0.4647887323943662,0.7797128231574927,1.0,5/25,6.74%,MICAL3;CYP27A1;POR;FMO5;NOS2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.40884115293629264,-1.0006571214034496,0.4849137931034483,0.8259212552888886,1.0,6/12,32.15%,B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1;B3GALT1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.40706567635548857,-0.9997362957294336,0.4652173913043478,0.8232990822059288,1.0,1/12,0.57%,PIEZO2
prerank,general transcription initiation factor binding (GO:0140296),-0.3325677706022188,-0.9991097267733817,0.46715328467153283,0.8199944232405099,1.0,11/25,34.69%,ESR1;HHEX;TAF11;PSMC5;GTF2A2;RELA;TAF1B;RUVBL2;THRA;PSMC1;GTF2B
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.29762138513009717,0.998715194909427,0.4376899696048632,0.7819160989076331,1.0,11/75,8.95%,SDR9C7;RDH10;LDHAL6B;PHGDH;PGD;CRYL1;RDH5;ME2;PTGR1;GLYR1;DHDH
prerank,estrogen receptor binding (GO:0030331),-0.3121145795480206,-0.9972184648306759,0.43478260869565216,0.8198245115502997,1.0,5/32,7.57%,LEF1;RERG;ESR1;CTNNB1;DDX54
prerank,carbohydrate kinase activity (GO:0019200),0.4296072719013194,0.9970555243763451,0.45692883895131087,0.7826563144249776,1.0,5/11,18.72%,GALK2;XYLB;KHK;HK1;NAGK
prerank,guanyl ribonucleotide binding (GO:0032561),0.26057668597214284,0.9963350239518599,0.4789272030651341,0.7810563985843862,1.0,48/196,19.31%,MPPED2;GBP6;PDE5A;GBP2;RRAS2;SLC19A1;RAB10;RAB22A;ARL3;RHOBTB2;ARF4;RHOF;GBP5;GTPBP10;GBP4;LRRK2;RRAD;RHOQ;ARF3;RAP2C;GBP7;GEM;RABL6;TUBA1C;TUBE1;RHOC;TUBB6;PIP4K2B;RHOU;ARL4A;MIEF1;ATL1;GBP3;TUBB2B;RIT1;RAB5A;TUBD1;ARF1;TRIM23;RAN;RAP2B;LSG1;RANBP17;RHOT1;GNAI3;RHOT2;ARL6;DIRAS1
prerank,methylation-dependent protein binding (GO:0140034),0.3019130681629666,0.9923487316010795,0.47368421052631576,0.7872226942203485,1.0,25/57,26.80%,KDM7A;SUZ12;MORC3;TRIM24;ZMYND11;GLYR1;RRP8;BPTF;MORC4;KDM8;PYGO1;CHD8;LRWD1;MPHOSPH8;MBTD1;PHF1;PHF13;PHF8;ATRX;ING5;ZCWPW1;WDR5;NCAPG2;ING3;ING2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.42943038218479623,0.9916831374947161,0.48333333333333334,0.7855718855841459,1.0,4/12,16.39%,TENT5A;PAPOLG;TENT2;PAPOLB
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.37876588150749735,-0.9910485137330481,0.47285067873303166,0.8320208197985551,1.0,2/15,1.61%,SLC26A7;SLC26A2
prerank,endopeptidase activity (GO:0004175),0.2505286639274708,0.9908201548996969,0.4873096446700508,0.7844628647789066,1.0,41/257,14.75%,DPP4;USP18;ADAMTSL5;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;CASP4;MMP14;THSD4;CPNE1;CORIN;CTSH;USP9X;USP24;PSMB10;ESPL1;PSMA7;ACR;PLAU;USP47;PSMA3;USP8;CTSW;PSMA5;ADAM19;NLN;PMPCB;PLAT;PAPLN;ADAMTS7;USP40;CELA1;SENP1;USP34;USP36;USP35;KDM8;ADAMTS15
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.21583799617759286,-0.9867091438002097,0.5154639175257731,0.8394447746674375,1.0,69/248,21.26%,DNM3;GNAO1;RAB27A;RIT2;RERG;VWA8;ABCA3;GNAS;EEF1A1;MYL6;NKIRAS1;KIF1C;RAB6B;GTPBP1;EEF2;RAB3C;RAB38;RAB27B;ARL1;RHOB;ARHGDIB;RRAGB;GFM1;RAB35;ATAD1;ARL8A;RHOG;MFN2;GCH1;KIF26A;MFN1;GSPT2;HSP90AA1;KRAS;KIF15;HRAS;RAB5C;ABCD2;RHOH;GNA12;GNA14;RAC1;MYO18A;GPN3;GNAQ;TOR1B;KIF5A;RAP1A;HBS1L;IRGM;RHOBTB1;GNA13;DNAJC27;RABL3;RRAGC;GNAL;GPR88;RAB1B;TPPP;RAC3;SAR1B;IFT22;RND2;RAB18;GNG3;BMS1;ATL2;ARL2;CHD1L
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.25191758291774385,-0.9864313825702378,0.47126436781609193,0.8350671767621508,1.0,23/91,16.24%,PLCB1;HIP1;KCNJ2;SYTL2;HIP1R;SNX3;CLVS1;KCNH1;STXBP6;SYT7;SDCBP;LDLRAP1;RAB35;PLEKHA5;SNAP91;KCNQ1;AMER2;MARK1;KIF16B;KRIT1;TWF1;MAPT;SNX18
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3512759127052849,-0.9827809662921053,0.47285067873303166,0.8403587130082106,1.0,5/19,9.47%,RYR2;GRIN2A;RYR3;GRIN2B;GRIN1
prerank,endonuclease activity (GO:0004519),0.3140395381300545,0.982700509142044,0.47875816993464054,0.8009116592079139,1.0,12/49,15.32%,PIWIL4;NTHL1;NYNRIN;SND1;SMG6;ENDOU;ERN2;SLFN14;OGG1;ZC3H12B;ERCC5;DIS3
prerank,G protein-coupled receptor binding (GO:0001664),0.26751729096898486,0.9813659078953223,0.48523206751054854,0.8008939463590767,1.0,20/132,15.42%,WNT4;WNT6;GRK3;WNT2B;WNT10B;WNT3A;WNT5B;ADM;WNT5A;ARHGEF11;INSL3;ARHGEF12;HOMER3;DVL3;ARRB1;WNT2;RNF43;CCL25;RYK;CCRL2
prerank,U6 snRNA binding (GO:0017070),-0.3865570619148469,-0.9808916713741164,0.5042016806722689,0.8405228646971663,1.0,7/14,31.34%,SART3;EIF5A;LSM4;LSM2;LSM3;LSM8;PRPF8
prerank,mitogen-activated protein kinase binding (GO:0051019),0.35059016265963694,0.9805505412983092,0.5017182130584192,0.7994205333456945,1.0,14/29,23.95%,DUSP10;TPR;DUSP16;ATF7;DUSP5;MAPK14;MAPKAPK5;TNIP1;MAPKAPK3;DIRAS1;MAPK7;CDK5RAP3;PRMT1;DUSP4
prerank,phosphatase binding (GO:0019902),0.27469390759531553,0.9772644574546379,0.48401162790697677,0.8041575359043635,1.0,22/105,15.48%,SMAD3;CDH5;CRY2;CRY1;IKBKE;DZIP3;MTMR3;MVP;DLG1;MAPK14;PTK2;PPP6R3;JAK1;CDC27;SHOC2;CNST;WNK1;EIF2AK3;TBK1;SH3YL1;SMAD2;IQGAP1
prerank,mannosyltransferase activity (GO:0000030),0.3679689807774194,0.9724355930942181,0.5092936802973977,0.8121895460194095,1.0,4/21,7.08%,TMTC4;TMTC1;ALG9;POMT2
prerank,kinase activity (GO:0016301),-0.236998689855776,-0.9704348828538872,0.5,0.8636254815210382,1.0,33/109,21.58%,DGKB;DGKI;DGKH;ITPKB;PGK1;PIK3C2B;DGKZ;PGM2L1;AKT1;RFK;PINK1;CAMK2A;FN3K;IP6K2;LYN;ETNK1;BCKDK;PIK3CD;CERK;SEPHS1;DGKG;PRKD1;PPIP5K1;PPIP5K2;PANK1;CKB;IRAK1;CHKA;NADK;FN3KRP;PIK3C3;CERKL;COQ8A
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.43619510650300364,0.969373170563844,0.5217391304347826,0.8164133790574472,1.0,3/10,10.51%,USP27X;STAMBP;STAMBPL1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.31301082714026857,-0.9692745289479308,0.49640287769784175,0.8618745405697976,1.0,9/30,16.20%,CST3;GAS6;SNCA;SERPINB9;PTTG1;SPOCK1;RPS6KA1;CD27;UBE2O
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4102043779681424,0.9680453499098408,0.5037593984962406,0.8163735564768182,1.0,4/12,9.88%,CDK8;CDK7;BRD4;CDK12
prerank,cysteine-type endopeptidase activity (GO:0004197),0.28922390037495105,0.9679839106804881,0.5222551928783383,0.8132507350373153,1.0,21/78,18.53%,CASP12;USP18;CFLAR;CASP4;CTSH;USP9X;USP24;ESPL1;USP47;USP8;CTSW;CAPN15;USP40;USP34;USP36;USP35;USP12;CTSF;USP15;USP10;CASP3
prerank,clathrin adaptor activity (GO:0035615),-0.3662803992700512,-0.967618358440326,0.4967462039045553,0.8612452508488426,1.0,7/15,26.28%,HIP1;HIP1R;LDLRAP1;AP2B1;AP2A2;AP2A1;AP2M1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.39988537928515,-0.9669424008020113,0.5298969072164949,0.8583279910345559,1.0,4/11,7.06%,TRPC3;TRPC5;TRPC4;TRPC6
prerank,ion gated channel activity (GO:0022839),-0.3248682006652432,-0.9657852695209695,0.5163551401869159,0.8564921449063514,1.0,10/24,18.51%,ANO1;ANO3;KCNT1;TMEM63C;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.36543872002224276,-0.9657296204353587,0.49678800856531047,0.8517078817854022,1.0,3/15,5.99%,PIK3R1;PIK3R6;PIK3R3
prerank,transcription corepressor binding (GO:0001222),0.33645350436397203,0.9641202387334058,0.4948453608247423,0.819606684514515,1.0,2/27,3.83%,RORA;SUZ12
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4434289662695634,0.9613579259441616,0.5154440154440154,0.8224562436505832,1.0,3/10,11.33%,NAA16;NAA30;NAA15
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3564122805278098,-0.9612110107920274,0.5099337748344371,0.858972264529667,1.0,4/16,11.01%,MACROD2;RPS3;CD38;SMUG1
prerank,phosphatidylglycerol binding (GO:1901611),-0.37638693059087774,-0.959933765033148,0.49372384937238495,0.8574786537459805,1.0,2/13,3.64%,PITPNC1;PITPNA
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3685867415940528,-0.9574629648621824,0.5091649694501018,0.8595642313186441,1.0,9/14,41.23%,NCF2;CYBB;KMO;NOX4;CYB5R4;NCF1;NOX3;NCF4;DUOX1
prerank,single-stranded DNA binding (GO:0003697),0.2731385330313518,0.9571040253106907,0.524024024024024,0.8295322877509047,1.0,25/93,20.89%,RBMS1;SSBP2;POLR2D;NUCKS1;CRY2;TOP1;FBH1;FUBP1;NABP1;RAD51B;RPA3;MCM4;RBBP8;RTF1;MCM6;ERCC5;ERCC1;TDP2;PCBP2;DHX36;XPC;CTC1;NABP2;LONP1;SMC6
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.24161132984452122,-0.9567343856813246,0.5479876160990712,0.8564485644646422,1.0,25/85,29.92%,NDST3;MGLL;ABHD2;GDPD1;CA2;LIPE;BCHE;GDE1;ABHD6;AOAH;PLAAT3;PNPLA6;LPL;PNPLA3;PLA2G4F;PAFAH1B2;FAAH;PLA2G7;PTRH2;ABHD15;PLAAT1;LIPC;PLA2G4B;PGLS;PGAP1
prerank,GTPase activity (GO:0003924),-0.21576229088386528,-0.9544122083253099,0.6063348416289592,0.8577851148186955,1.0,55/192,21.21%,DNM3;GNAO1;RAB27A;RIT2;RERG;GNAS;EEF1A1;NKIRAS1;RAB6B;GTPBP1;EEF2;RAB3C;RAB38;RAB27B;ARL1;RHOB;ARHGDIB;RRAGB;GFM1;RAB35;ARL8A;RHOG;MFN2;GCH1;MFN1;GSPT2;KRAS;HRAS;RAB5C;RHOH;GNA12;GNA14;RAC1;GPN3;GNAQ;RAP1A;HBS1L;IRGM;RHOBTB1;GNA13;DNAJC27;RABL3;RRAGC;GNAL;RAB1B;TPPP;RAC3;SAR1B;IFT22;RND2;RAB18;GNG3;BMS1;ATL2;ARL2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3796854827399008,-0.9539530631714697,0.5253456221198156,0.8541596587174318,1.0,3/13,12.24%,PIP5K1B;PIK3C2B;PIK3CD
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.34113181557947914,-0.952456914644599,0.5234899328859061,0.8532900914296699,1.0,5/18,16.03%,GAS6;SNCA;SERPINB9;RPS6KA1;CD27
prerank,neuropeptide hormone activity (GO:0005184),0.3580214002446971,0.9508420095328839,0.5435540069686411,0.8408551106871633,1.0,2/22,5.50%,GHRH;UCN
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.29266943650617133,0.9495709380486003,0.5246422893481717,0.8405183331082217,1.0,11/55,12.58%,MCU;ITPR1;ANXA2;SLC24A3;ATP2B4;PANX1;PKD1L3;TMEM165;TRPC1;GRIN3B;ATP2B1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.33406127355058685,-0.9492241178562545,0.5144628099173554,0.8523555422640949,1.0,8/21,19.03%,CDK14;CDK6;CDK19;CDK15;CDKL2;CDK2;CDK4;CCNK
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.33406127355058685,-0.9492241178562545,0.5144628099173554,0.8523555422640949,1.0,8/21,19.03%,CDK14;CDK6;CDK19;CDK15;CDKL2;CDK2;CDK4;CCNK
prerank,anion:anion antiporter activity (GO:0015301),-0.338298666764135,-0.945553522880216,0.5423340961098398,0.8570619031898834,1.0,2/17,1.61%,SLC26A7;SLC26A2
prerank,galactosyltransferase activity (GO:0008378),0.4123103553010088,0.9450556265991373,0.5403377110694184,0.8479169401641232,1.0,2/11,7.45%,A4GALT;B4GALT1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.3584454291212129,-0.9448206447953567,0.5462555066079295,0.8544200428289955,1.0,3/14,14.97%,CAPN1;CAPN10;CAPNS1
prerank,GTPase binding (GO:0051020),0.24657711306316873,0.9441522161180272,0.610126582278481,0.8467804127589481,1.0,34/194,12.88%,RAPGEF4;AKAP13;RNF152;AFDN;SPTBN1;RADIL;FGD4;AMBRA1;PARD6A;MYCBP2;RANBP2;UNC13B;OPTN;PLCE1;RASA1;EXOC2;RALBP1;NGFR;GOLGA5;CHM;LRRK2;STRN3;MICALL1;DOCK7;CDC42EP4;IQGAP2;TRIOBP;RAB34;DNM1L;ABCA1;RAP1GAP;IFT20;DVL3;TBC1D7
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4075495399513219,-0.9429541155620832,0.5465346534653466,0.8543523612189182,1.0,7/10,41.23%,NCF2;CYBB;NOX4;NCF1;NOX3;NCF4;DUOX1
prerank,receptor tyrosine kinase binding (GO:0030971),0.28850039775127034,0.9426762025288343,0.5415335463258786,0.847042864374313,1.0,12/56,14.20%,CBLB;GAB2;FRS2;ANGPT1;PTPN14;LRP4;PTPN2;SH2B3;PTPN1;MAP3K7;NCK1;SHC2
prerank,peptidoglycan binding (GO:0042834),-0.41346879268309267,-0.941756836013953,0.5148305084745762,0.8528306273247749,1.0,4/10,15.89%,NOD1;PGLYRP1;NOD2;RNASE7
prerank,chloride channel inhibitor activity (GO:0019869),0.4241767457195511,0.9407830331102587,0.5396825396825397,0.8481601829483163,1.0,3/10,14.30%,WNK4;STX8;WNK1
prerank,ephrin receptor binding (GO:0046875),0.3514431738734875,0.9397844271720769,0.5489130434782609,0.8471577763242056,1.0,6/21,18.77%,EFNB2;PTPN1;EFNB1;EFNA1;ANKS1B;SHC1
prerank,magnesium ion binding (GO:0000287),0.25699559401044725,0.9371263781067903,0.5807799442896936,0.8501072034107695,1.0,31/135,18.74%,EYA2;OXSR1;TSSK3;DCTPP1;CLYBL;WRN;IDH1;SIK3;LRRK2;STK3;PDXK;IRAK3;HACL1;GEM;ADPRS;IDH2;ERN2;OPA1;SRPK1;CIB2;NUAK2;STK4;FIGNL1;EPHX2;YDJC;RAN;ABL2;TDP2;PGM1;MVK;DHX36
prerank,calcium channel activity (GO:0005262),-0.23856287302947707,-0.9360444782286369,0.5924855491329479,0.8629605520920236,1.0,13/84,10.97%,CACNA1E;CACNB2;TRPC3;SLC24A2;RYR2;CACNB4;TRPC5;TRPC4;OPRM1;TRPC6;CACNA1D;GRIN1;TMCO1
prerank,NADPH binding (GO:0070402),-0.36885120735263943,-0.9350490465533083,0.5637860082304527,0.8608710659232608,1.0,4/13,25.07%,KCNAB1;MTRR;NDOR1;CRYZ
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3130740203223963,0.9350074297036612,0.5276381909547738,0.8516235732366833,1.0,13/38,19.48%,PLA2G4A;SNX12;PLEKHA4;DENND1A;SNX27;WDR45B;SH3PXD2B;ATG2A;WIPI2;PLEKHF1;SNX21;SESTD1;RUBCNL
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3289290142723897,0.9335756219791098,0.5460992907801419,0.8518211806156123,1.0,9/28,19.11%,PRKAA2;MAP2K6;LRRK2;MAPK14;MAP2K5;MAP2K1;MAPKAPK5;MAP2K4;MAPKAPK3
prerank,gamma-tubulin binding (GO:0043015),-0.32695160942184076,-0.9331819977810746,0.5507900677200903,0.8611899966482772,1.0,8/21,23.42%,PAK1;DIXDC1;ARHGEF7;BRCA2;RAB11FIP5;CDK5RAP2;RACGAP1;TUBGCP3
prerank,gated channel activity (GO:0022836),-0.3603929834684107,-0.9322919886989509,0.5466377440347071,0.8588202257213372,1.0,1/14,0.57%,PIEZO2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.4128935133600733,0.9318710854102286,0.562962962962963,0.8523888346835381,1.0,4/10,15.68%,KDM7A;KDM2A;KDM8;KDM2B
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.2591635356863734,-0.9305242911330561,0.6103542234332425,0.8587370977865627,1.0,13/51,16.55%,SLCO1C1;SLCO2A1;SLC7A5;SLC16A10;CLCN3;SLC5A5;SLC5A6;SLC22A6;SLC25A30;MFSD2A;SLC35E3;SLC20A2;SLCO4A1
prerank,nuclear receptor coactivator activity (GO:0030374),0.29534799466968753,0.9300790674987468,0.5500794912559619,0.853270002967209,1.0,16/52,18.97%,ZMIZ1;NCOA3;NCOA6;TACC1;SFR1;SS18;MED12;BRD8;CARM1;NCOA2;RBM14;CCAR1;CNOT9;TMF1;KDM1A;PPARGC1B
prerank,signal sequence binding (GO:0005048),0.31834070716390417,0.9275224976871697,0.5646481178396072,0.855943599701372,1.0,5/35,7.26%,TNPO1;KDELR3;KPNA7;KPNA6;KPNA4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.290622413699657,-0.9268311702323501,0.5995260663507109,0.8630146999954748,1.0,11/33,18.03%,RNF144B;RNF144A;RPS3;DCUN1D2;UBE3D;DCUN1D5;RNF125;PARK7;DCUN1D1;FOXL2;TOLLIP
prerank,exopeptidase activity (GO:0008238),0.29155376042489417,0.9251983951633752,0.5740458015267176,0.857918093341188,1.0,12/50,14.49%,DPP4;DPEP2;ANPEP;DPP8;NPEPPS;CTSH;ERAP1;BLMH;DPP7;RNPEP;LNPEP;KDM8
prerank,hormone activity (GO:0005179),0.2933279856409946,0.9235429552401494,0.5912762520193862,0.8584249496669174,1.0,9/54,20.81%,GHRH;PTHLH;UCN;NPPC;AGRP;CCL25;INHA;INSL6;AGT
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.23181478263800945,-0.9224699417310556,0.6424050632911392,0.8691236902641147,1.0,12/100,7.35%,MYO10;ARAP2;CYTH3;HIP1;CERT1;ARAP3;HIP1R;DAB2IP;SNX3;CLVS1;KCNH1;AKT1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3537669981922143,0.9215935701184815,0.5732838589981447,0.8595946983851864,1.0,3/20,8.93%,CMPK2;CASK;DLG1
prerank,ankyrin binding (GO:0030506),-0.32451532455837834,-0.9208550643814539,0.5595238095238095,0.8687825409857203,1.0,5/19,9.32%,CDH1;SLC8A1;NRCAM;SPTB;CACNA1D
prerank,phosphatase activity (GO:0016791),0.2740966616729103,0.9192395018803715,0.6052631578947368,0.8618750004013588,1.0,12/73,10.88%,ATP1A2;PLPP3;DUSP10;DUSP28;PTPN22;DUSP16;MDP1;PLPPR3;NT5C;NOCT;DUSP5;PPP1CB
prerank,proton transmembrane transporter activity (GO:0015078),-0.2745357912243402,-0.9181405496507946,0.569620253164557,0.8708821115778727,1.0,15/39,26.13%,CLCN3;ATP6V1B2;COX4I1;UQCRH;UQCR11;COX8A;NDUFA4;COX6A1;CLCN5;NDUFA4L2;ATP6V1F;CYB5A;UQCR10;UQCRQ;COX4I2
prerank,MAP kinase activity (GO:0004707),0.3742568154065093,0.9180300067787109,0.5845864661654135,0.8615207584946569,1.0,4/14,12.92%,MAPK4;MAPK6;MAPK14;MAPK9
prerank,deoxyribonuclease activity (GO:0004536),-0.3621156016166268,-0.9155671749581785,0.5645833333333333,0.872689330517783,1.0,2/14,5.78%,RPS3;MRE11
prerank,transcription coregulator binding (GO:0001221),0.2872996562272111,0.9153314339609901,0.5911251980982567,0.8646951440110723,1.0,4/50,3.92%,RORA;SMAD3;SUZ12;TERT
prerank,anion transmembrane transporter activity (GO:0008509),-0.3731581547381437,-0.9138892674212485,0.5861344537815126,0.8723404966170105,1.0,4/12,16.18%,ABCG2;SLC22A6;SLC39A8;ABCC5
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.35019824463995197,-0.9138051079828855,0.5906040268456376,0.8682016436982863,1.0,5/15,12.24%,PIK3C2B;PIK3R3;PI4K2A;ATM;PIK3CD
prerank,GTP binding (GO:0005525),0.2415516383495525,0.9132767510717635,0.6475195822454308,0.866231260984073,1.0,44/172,19.69%,GBP6;GBP2;RRAS2;RAB10;RAB22A;ARL3;RHOBTB2;ARF4;RHOF;GBP5;GTPBP10;GBP4;LRRK2;RRAD;RHOQ;ARF3;RAP2C;GBP7;GEM;RABL6;TUBA1C;TUBE1;RHOC;TUBB6;PIP4K2B;RHOU;ARL4A;ATL1;GBP3;TUBB2B;RIT1;RAB5A;TUBD1;ARF1;TRIM23;RAN;RAP2B;LSG1;RANBP17;RHOT1;RHOT2;ARL6;DIRAS1;ARFIP2
prerank,carboxy-lyase activity (GO:0016831),0.33443488040304814,0.9099756505635159,0.5665529010238908,0.8706489632022922,1.0,5/23,17.60%,AZIN2;BCKDHA;UMPS;FAHD1;PCK2
prerank,single-stranded DNA helicase activity (GO:0017116),-0.31990792053624234,-0.9080562827442922,0.5849889624724062,0.8774185041293001,1.0,9/19,30.99%,HELQ;RAD51;RFC4;POLQ;WRNIP1;RFC5;RFC2;CHTF18;PIF1
prerank,double-stranded RNA binding (GO:0003725),0.2745730248847746,0.9051239646219226,0.6194144838212635,0.8784140082338591,1.0,13/70,13.61%,SIDT1;EIF2AK2;DDX60;VIM;ZBP1;RC3H1;MTDH;OASL;OAS2;ILF3;ADAR;SUPV3L1;TARBP2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.3922072694324833,-0.9049159771523084,0.5893223819301848,0.8805566562246608,1.0,6/10,28.14%,SLC24A2;SLC8A1;SLC3A2;SLC8B1;SLC24A5;SLC8A3
prerank,RNA polymerase binding (GO:0070063),-0.328579637198235,-0.904747880580638,0.6131868131868132,0.8766081520072564,1.0,6/18,17.81%,STOM;TCERG1L;YTHDC2;ANP32B;BRCA1;PPIB
prerank,fibroblast growth factor binding (GO:0017134),0.3437428849487336,0.9047378018560108,0.5855379188712522,0.8761287973697146,1.0,3/21,5.41%,FGFR1;KL;GLG1
prerank,neuropeptide receptor binding (GO:0071855),0.38151108587240723,0.902818542653515,0.5926605504587156,0.8773439233158096,1.0,1/14,2.10%,GHRH
prerank,WW domain binding (GO:0050699),0.326884033602373,0.9023152107997447,0.5931899641577061,0.875275020310611,1.0,6/26,13.05%,TCEAL7;PMEPA1;LITAF;SCNN1A;TCEAL3;TCEAL6
prerank,3'-5' DNA helicase activity (GO:0043138),0.36222265668293513,0.8997548722375822,0.5916824196597353,0.8780363677641428,1.0,5/16,13.74%,WRN;ASCC3;FBH1;FANCM;MCM6
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.38257115586218826,-0.8983105298147487,0.6051502145922747,0.8877734762046243,1.0,4/10,7.88%,DPP10;DPP6;PRCP;FAP
prerank,hexosyltransferase activity (GO:0016758),-0.22376669656475578,-0.8982212193976565,0.7111801242236024,0.88364546439473,1.0,29/101,24.56%,TMTC2;CSGALNACT1;FUT9;HEXB;EXT1;POMGNT1;DPY19L1;LFNG;MFNG;B3GNT2;B4GALT4;ALG5;PIGM;GCNT1;MGAT4A;TMTC3;B3GNT9;B3GALNT2;POMGNT2;CHSY3;ALG6;POGLUT3;B3GNT3;B4GALT6;PIGB;HAS1;MTAP;B3GAT3;HAS3
prerank,small GTPase binding (GO:0031267),0.23834790994556507,0.8974333944803125,0.6901041666666666,0.880031365366535,1.0,30/169,12.88%,RAPGEF4;AKAP13;RNF152;AFDN;FGD4;PARD6A;MYCBP2;RANBP2;UNC13B;OPTN;PLCE1;EXOC2;RALBP1;NGFR;GOLGA5;CHM;LRRK2;STRN3;MICALL1;DOCK7;CDC42EP4;IQGAP2;TRIOBP;RAB34;DNM1L;ABCA1;RAP1GAP;IFT20;DVL3;TBC1D7
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3608629178105746,0.8957923995127988,0.6127167630057804,0.8803902409578667,1.0,1/15,0.77%,SLC1A3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.3919334509510072,0.8956201566139643,0.5892514395393474,0.877651252064549,1.0,1/12,3.49%,AOX1
prerank,lipoprotein particle binding (GO:0071813),0.34092770805511596,0.8948455223713734,0.6115107913669064,0.8761079562668628,1.0,3/20,4.88%,COLEC12;APOA2;CRP
prerank,triglyceride lipase activity (GO:0004806),-0.3106381300376013,-0.8944330026780595,0.6241457858769932,0.8881577926833212,1.0,5/20,28.13%,LIPE;LPL;PNPLA3;LIPH;LIPC
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3664061558763507,-0.8926818943642157,0.6172566371681416,0.8878064353034375,1.0,6/11,32.09%,SLC2A9;SLC5A11;SLC23A1;SLC23A2;SLC2A10;SLC5A3
prerank,receptor antagonist activity (GO:0048019),0.3582537056971279,0.8894007101940459,0.6037735849056604,0.8848636265366778,1.0,4/17,18.10%,WFIKKN1;DKK3;LRPAP1;IL18BP
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.310792362794197,0.8887931453514915,0.6383701188455009,0.8831424619842337,1.0,3/29,3.56%,SLC13A3;SLC19A1;SLC26A9
prerank,ubiquitin protein ligase binding (GO:0031625),-0.19427654951817636,-0.8885527157115263,0.8388888888888889,0.8928251569701606,1.0,67/254,21.95%,HSPA8;FOXO1;PRR5L;MID1;SMAD7;RPL5;ACTG1;RPL11;PRKAR1A;GABARAP;HSP90AB1;ATP6V0C;HERC2;SLF1;GABARAPL1;PINK1;BAG1;HDAC6;MFHAS1;UBB;TNFRSF1B;RFFL;ELOB;HSPBP1;BAG6;SPOP;CALR;MFN2;USP13;TNK2;ANKRA2;RPL23;PRKAR2B;TPI1;NLK;GPI;CD40;UBOX5;HSP90AA1;FZD4;EGFR;KDM4A;CAMLG;UBA52;WASHC1;TUBA1B;CDKN1A;GPR37;YOD1;HSPA5;TRIM37;BRCA1;UBE2D1;LTBR;CKB;TRIM28;PACRG;PATZ1;WRAP53;FZD5;SMAD5;USP2;ATXN3;TRAF1;SNCAIP;BAG4;UBE2J1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.4005789530153817,0.8882625726684295,0.5988700564971752,0.8813294052357663,1.0,3/11,11.33%,NAA16;NAA30;NAA15
prerank,alpha-tubulin binding (GO:0043014),-0.27778907034120637,-0.8878779105599061,0.6367924528301887,0.8902495983140675,1.0,8/31,13.54%,TTLL7;DIP2B;SNCA;EFHC2;HDAC6;ARL8A;TRIM36;WASHC1
prerank,acetylcholine receptor activity (GO:0015464),-0.302730856680932,-0.8862556305431165,0.6067415730337079,0.8898161220078241,1.0,5/22,20.26%,CHRM3;CHRM2;CHRNA4;CHRFAM7A;CHRNA7
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.23436101040723947,-0.8848917686841947,0.7213114754098361,0.8883209939628185,1.0,17/72,16.24%,PLCB1;HIP1;KCNJ2;SYTL2;HIP1R;STXBP6;SYT7;SDCBP;LDLRAP1;RAB35;SNAP91;KCNQ1;AMER2;MARK1;KRIT1;TWF1;SNX18
prerank,protein tyrosine kinase binding (GO:1990782),-0.2358980933631288,-0.8846180332966922,0.6916666666666667,0.8846563891902599,1.0,14/71,14.82%,DOCK4;NRG3;GRB14;GRM5;BMPR2;GAS6;CEACAM1;DUSP22;RACK1;CBL;HSP90AA1;TJP2;ACVR1;SHC4
prerank,protein kinase activator activity (GO:0030295),-0.24030668361359503,-0.8823958501728965,0.6961325966850829,0.8853300533431481,1.0,13/60,15.71%,GRM5;RPLP1;CALM1;GAS6;CALM2;CALM3;STK11;FGF13;GPRC5A;ALS2;RGCC;CDKN1A;IRGM
prerank,NADP binding (GO:0050661),0.3042121914903516,0.8813230608564152,0.6353982300884956,0.8933550696906832,1.0,6/32,8.09%,HSD17B1;GMDS;PGD;DPYD;NOS2;NNT
prerank,voltage-gated anion channel activity (GO:0008308),-0.34670157097899995,-0.8809719261143365,0.6283367556468172,0.8842034541757299,1.0,8/15,29.31%,ANO1;CLCN3;CLCN1;VDAC1;CLCN5;GPR89B;GPR89A;CLCN6
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.3300851764591574,0.8778230317523155,0.634469696969697,0.8976977775355863,1.0,4/22,10.34%,DUSP10;MTMR3;DUSP16;DUSP5
prerank,histone deacetylase binding (GO:0042826),0.2498664506357289,0.87427030841212,0.6950146627565983,0.9017601649924929,1.0,26/88,20.09%,GLI3;ZMYND15;DACT1;MIER3;BCOR;MIER1;TOP2B;FOXP3;HDAC4;MEF2A;GMNN;CIR1;SMG5;HOXA10;BHLHE41;HIC1;RAD9A;HDAC2;KAT2B;PKN2;NIPBL;YWHAE;DHX36;CHD4;SIRT2;NACC1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3377492093016117,-0.8721844084339648,0.6400862068965517,0.899450052485239,1.0,4/15,15.57%,EPB41;SCARB1;SNAP91;WDFY1
prerank,palmitoyltransferase activity (GO:0016409),-0.27462982044173107,-0.8679926824028029,0.6698564593301436,0.9041492668180486,1.0,13/28,32.40%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;YKT6;ZDHHC5;ZDHHC4;GOLGA7B;ZDHHC13;GOLGA7
prerank,mRNA binding (GO:0003729),0.22018933188325254,0.8675950977631482,0.781908302354399,0.9127471011262559,1.0,56/249,19.86%,CELF2;RBMS3;RBMS1;SAMD4A;SHMT1;PTBP3;RBFOX2;IGF2BP1;PCF11;RC3H1;RBMS2;PABPC5;CPEB1;TPR;SECISBP2L;NANOS2;SRRM2;NOVA1;SNIP1;RNF20;HNRNPC;IGF2BP2;NYNRIN;FUBP1;NOCT;ACO1;TDRD7;SRSF4;EIF4ENIF1;DDX6;SF3B6;PTBP2;RBM5;THOC5;GEMIN5;ZC3H12B;RBM15;RBM14;CSTF3;SRSF5;HNRNPR;HNRNPA2B1;SSB;SHFL;CPEB3;PUM2;SLBP;FXR2;PCBP2;KHDRBS1;DHX36;GRSF1;KHSRP;RBM46;NANOS1;IREB2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3840892521577502,0.8660201816896669,0.638623326959847,0.9130969806297875,1.0,1/11,0.88%,ITPR1
prerank,myosin binding (GO:0017022),0.2712439291297969,0.8639164403105402,0.6842923794712286,0.9144047090977281,1.0,5/55,3.76%,CALD1;KIRREL1;SPATA6;TRAK1;RAB10
prerank,aspartic-type peptidase activity (GO:0070001),-0.3617232110796049,-0.8621631158781357,0.6428571428571429,0.9124275261369817,1.0,1/10,6.96%,CTSD
prerank,androgen receptor binding (GO:0050681),-0.2873355627316563,-0.8617495521539146,0.6897374701670644,0.9092225053348548,1.0,6/25,15.12%,PRKCB;PKN1;TRIM68;CALR;KDM4C;PARK7
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.25601601187288403,-0.8606054782701734,0.714987714987715,0.907457487153794,1.0,8/42,12.58%,PLCG2;BCAR3;SHE;PIK3R1;PIK3R3;LDLRAP1;SYK;VAV1
prerank,adenyl ribonucleotide binding (GO:0032559),0.21681250979361158,0.8586055056342232,0.8206060606060606,0.9215670542187445,1.0,46/291,15.34%,MPPED2;ATP1A2;RAPGEF4;ENPP1;PRKAG2;OXSR1;KSR1;TSSK3;BMPR1A;MYO1B;SLC19A1;DAPK1;RRM1;TOP1;LATS2;TGFBR1;POPDC2;CNBD2;MAP4K1;WNK4;SIK3;STK3;PDXK;TLK2;AKT3;PFKM;IRAK3;HACL1;ABCA1;OAS2;CLPX;DAPK2;ERN2;PIP4K2B;ABCD3;SRPK1;MCM6;TRIB1;WNK1;NUAK2;TRNT1;ERCC6;ABCF1;P2RY1;MIEF1;STK4
prerank,neuropeptide receptor activity (GO:0008188),-0.2744759300231381,-0.8580547491275066,0.6770025839793282,0.9086967246601261,1.0,8/29,25.66%,SORCS1;SORCS3;OPRM1;TACR3;GPR37;NMUR2;GRPR;KISS1R
prerank,peptidase activator activity (GO:0016504),-0.29120530977677717,-0.8577795918959216,0.6745283018867925,0.9052083301995715,1.0,6/22,17.09%,MAL;PINK1;PSMD14;CAV1;PSENEN;PSME1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.2795644123541543,-0.8565154980164693,0.6754807692307693,0.9037362022021536,1.0,4/27,6.54%,SLC12A2;SLC9B2;CNNM4;ATP2A3
prerank,damaged DNA binding (GO:0003684),0.27572704013735533,0.854653131221629,0.685374149659864,0.9262980781147323,1.0,10/44,15.93%,CRY2;CREBBP;NTHL1;XRCC1;RPA3;DCLRE1A;RBBP8;OGG1;ERCC5;ERCC1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.20872685821178377,0.8540443840330306,0.8497706422018348,0.924437706372067,1.0,85/431,18.14%,ATP1A2;GBP6;ENPP1;PRKAG2;OXSR1;KSR1;GBP2;TSSK3;RRAS2;BMPR1A;MYO1B;RAB10;DAPK1;RAB22A;ARL3;RRM1;TOP1;LATS2;TGFBR1;RHOBTB2;ARF4;RHOF;GBP5;GTPBP10;GBP4;MAP4K1;WNK4;SIK3;LRRK2;STK3;RRAD;RHOQ;PDXK;ARF3;TLK2;RAP2C;AKT3;GBP7;PFKM;IRAK3;HACL1;GEM;RABL6;ABCA1;OAS2;TUBA1C;TUBE1;RHOC;CLPX;DAPK2;TUBB6;ERN2;PIP4K2B;ABCD3;SRPK1;MCM6;TRIB1;RHOU;WNK1;NUAK2;TRNT1;ARL4A;ERCC6;ABCF1;P2RY1;STK4;ATL1;GBP3;TUBB2B;RIT1;RAB5A;TUBD1;ARF1;HSPA9;CHD8;P2RX4;TRIM23;RAN;RAP2B;MKNK2;DMPK;LSG1;RANBP17;RHOT1;TAP2
prerank,cysteine-type peptidase activity (GO:0008234),0.25243454272377813,0.8539978637657882,0.7289855072463768,0.9214083287515188,1.0,21/73,20.30%,USP18;CASP4;CTSH;USP9X;USP24;ESPL1;USP47;USP8;CTSW;BLMH;USP40;USP34;USP36;USP35;USP12;CTSF;USP15;USP10;CASP3;USP7;PDIA3
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.22627402182008471,-0.8538821004223693,0.7657142857142857,0.9053433891713555,1.0,13/70,16.77%,CSGALNACT1;HEXB;EXT1;POMGNT1;LFNG;MFNG;B3GNT2;GCNT1;MGAT4A;B3GNT9;B3GALNT2;POMGNT2;CHSY3
prerank,single-stranded RNA binding (GO:0003727),-0.2469990944758889,-0.8514911201007638,0.7352185089974294,0.9059594505689591,1.0,6/43,8.27%,STRBP;ADARB2;PTBP1;ZFR2;CNBP;DDX11
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2810280336104051,-0.851446444666245,0.7031630170316302,0.9020275063614117,1.0,5/26,10.71%,AGBL4;CPE;CPD;ACE2;CPA6
prerank,low-density lipoprotein particle binding (GO:0030169),-0.31372507116253867,-0.8508468527646706,0.6659192825112108,0.8992957017794703,1.0,4/16,6.80%,THBS1;SORL1;STAB1;SCARB1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.31581917363882134,0.8505201557261394,0.6890034364261168,0.925725142201372,1.0,3/22,4.88%,HSPG2;APBB1;CRP
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.33925830865995543,0.8470086921489146,0.646484375,0.9297071043596806,1.0,1/16,0.98%,SLC13A3
prerank,CCR chemokine receptor binding (GO:0048020),0.29916460300711867,0.8461208272404038,0.6735395189003437,0.928317503679546,1.0,5/28,15.42%,MSMP;CCL2;NES;CCL25;CCRL2
prerank,calcium-release channel activity (GO:0015278),0.33938290310346225,0.8459436423826296,0.6544117647058824,0.9255566756910506,1.0,7/17,23.17%,ITPR1;TPCN1;PKD2;TRPA1;ITPR2;ITPR3;TPCN2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3061064575657978,0.8446323112040452,0.6736474694589878,0.9250755478391499,1.0,1/26,0.47%,PTN
prerank,phosphatidic acid binding (GO:0070300),0.3275422848770665,0.8444151910390814,0.6692307692307692,0.9224848102185054,1.0,7/19,20.13%,SMPD3;PACSIN2;MICALL1;OPA1;MAPKAP1;SESTD1;PITPNM1
prerank,mannose binding (GO:0005537),0.36305673762097834,0.8443986818273116,0.6514285714285715,0.9194599253644296,1.0,3/12,14.13%,CLN5;ACR;LMAN1L
prerank,phosphatidylinositol binding (GO:0035091),-0.2122715385003911,-0.8424943030491461,0.8212121212121212,0.9120187587829437,1.0,18/91,15.58%,EPB41;MCF2L;HIP1;PITPNC1;PITPNA;HIP1R;CCDC88A;MPPE1;SCARB1;SNAP91;PIGU;PIGK;FES;GAP43;PASK;SNX8;WDFY1;MAPT
prerank,DNA polymerase activity (GO:0034061),0.3173530495999683,0.8416342318483145,0.658703071672355,0.9221617221585673,1.0,4/22,8.89%,POLH;TERT;POLG;REV1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3494841475664966,0.8405682852431042,0.6618705035971223,0.9212400009566745,1.0,3/14,9.95%,MTHFD1;ALDH4A1;PYCR3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3323487808449562,-0.8393612866737553,0.6777777777777778,0.9141319340945103,1.0,6/12,17.26%,JMJD1C;KDM4D;KDM4C;KDM4A;HR;PHF2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.337439953514435,-0.837814996416769,0.6808510638297872,0.9130816350631313,1.0,2/12,10.68%,ENTPD1;SLC25A42
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.28581628397327574,-0.8376041006008541,0.7220902612826603,0.9096181911933212,1.0,9/21,25.27%,REV3L;POLA1;POLE;POLD1;POLB;POLQ;POLK;CHRAC1;POLE3
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.269962513213416,-0.8323450311084948,0.7084282460136674,0.9153714681546511,1.0,10/29,21.85%,CIT;PRKAR1A;INKA2;SPRED2;PRKAR2B;PKIG;CDKN1A;PKIB;SPRED1;HEXIM2
prerank,myosin V binding (GO:0031489),-0.3122170527473258,-0.8311420523801127,0.7274590163934426,0.9137661712013468,1.0,3/15,7.31%,RAB6B;RAB3C;RAB27B
prerank,phospholipase activity (GO:0004620),0.25045012880431866,0.8279215711079789,0.7545454545454545,0.9426201648057831,1.0,7/67,10.98%,SMPD3;PLA2G4A;PLCE1;PLCB3;PLA2G4C;PLA2G6;ENPP2
prerank,Wnt-activated receptor activity (GO:0042813),0.3410947905661562,0.8258928111748374,0.6901960784313725,0.9435064191579332,1.0,2/15,3.53%,FZD2;ROR1
prerank,metalloexopeptidase activity (GO:0008235),0.2684005376688633,0.8251684050620609,0.7413249211356467,0.9417941546812723,1.0,12/51,14.43%,CPQ;ANPEP;AEBP1;MMP14;PEPD;NPEPPS;CPB2;ERAP1;CPXM2;RNPEP;LNPEP;AGBL2
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.28663408144661173,-0.8242467533571416,0.7119047619047619,0.9231736664542897,1.0,5/21,18.48%,AKAP6;RYR2;KCNQ1;AKAP1;AKAP5
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.2706899459952092,-0.8230594831958791,0.716589861751152,0.9213669352610939,1.0,10/24,28.58%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;YKT6;ZDHHC4;GOLGA7B
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.29880643487480996,0.8204556608164884,0.6917808219178082,0.9477723445287752,1.0,2/24,3.93%,CAMK1D;DAPK1
prerank,P-type ion transporter activity (GO:0015662),-0.3268854476792701,-0.8203515049725966,0.6995884773662552,0.9223299493938467,1.0,6/12,27.32%,ATP2C1;ATP2A3;ATP2A2;ATP2B3;ATP2B2;ATP2C2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3366061248519884,0.8201446079240927,0.6920222634508348,0.9452519549791292,1.0,5/15,19.48%,PLA2G4A;SH3PXD2B;PLEKHF1;SESTD1;RUBCNL
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3085723092060878,0.8161475252635624,0.7125220458553791,0.9495144090904649,1.0,9/22,23.44%,RBMS3;CPEB1;ILF3;CPEB3;DHX36;KHSRP;ELAVL1;ZC3H12A;ZFP36L2
prerank,solute:proton symporter activity (GO:0015295),-0.3059290186508348,-0.8161069248497647,0.7238493723849372,0.9261948949291071,1.0,4/16,13.72%,SLC15A2;SLC2A9;SLC36A1;SLC39A8
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.31918522082116607,0.8149679739252325,0.7123809523809523,0.9486336686308944,1.0,2/18,5.12%,HSD17B1;RDH5
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2799227651132289,0.8145631125942963,0.7165492957746479,0.9463689270180757,1.0,7/31,14.77%,UBE2U;UBE2Z;UBE2C;UBE2Q2;UBE2E3;UBE2R2;BIRC6
prerank,hexosaminidase activity (GO:0015929),0.3494454096302482,0.811542098790061,0.7226415094339622,0.9489904873291997,1.0,1/12,2.21%,CEMIP2
prerank,kinase activator activity (GO:0019209),-0.25482727035856806,-0.808874165154381,0.7688442211055276,0.9353698017113078,1.0,6/30,14.05%,RPLP1;STK11;MALT1;FGF13;GPRC5A;RGCC
prerank,MHC protein binding (GO:0042287),-0.2796105621202327,-0.8081939890082129,0.7465753424657534,0.9326782025297283,1.0,4/20,13.87%,ATP5F1A;CD74;ATP5F1B;TUBB4B
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.24427818571285578,-0.8078697029989392,0.8111380145278451,0.9292970935883026,1.0,10/38,18.40%,SHANK3;PIK3R1;GRIP1;SHANK2;LDLRAP1;MAPK8IP3;SHANK1;MMS19;DEDD2;CARD10
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2516720800840991,0.8074062441550569,0.7654516640253566,0.9534574462333979,1.0,18/54,20.31%,MIER3;MIER1;NTAN1;HDAC4;ACY3;ASPA;HINT3;NAAA;ACR;SIRT4;AMDHD2;HDAC2;PDF;AGA;NIT1;PIGL;SIRT2;NADSYN1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.27645661376849784,0.8065504247396096,0.7487765089722676,0.9519671107622606,1.0,9/34,16.31%,FAM20A;STK3;IGF2;MAP2K1;PARP16;MTCP1;STK4;IQGAP1;RICTOR
prerank,thiol-dependent deubiquitinase (GO:0004843),0.23360590488146274,0.8035042986716692,0.817629179331307,0.9544336834983731,1.0,28/83,23.01%,USP18;USP9X;USP24;USP27X;STAMBP;USP47;USP8;STAMBPL1;MYSM1;USP40;USP34;USP36;USP35;USP12;USP45;USP15;JOSD1;USP32;USP10;USP39;USP4;BRCC3;USP7;PAN2;ZC3H12A;USP26;OTUD5;USP19
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2913310422426576,0.8033901590191654,0.7274305555555556,0.9516099129358575,1.0,8/24,19.69%,PLA2G4A;OSBPL8;OSBPL5;PLEKHA8;PLEKHF1;SESTD1;RUBCNL;ARFIP2
prerank,death domain binding (GO:0070513),0.35291969823282376,0.8022850343376985,0.7251908396946565,0.9505027755169604,1.0,4/11,11.25%,BCL2;MCL1;BAX;BCL2L1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.34002916775621495,-0.8012646467754456,0.6931106471816284,0.9365295148618591,1.0,2/10,8.28%,ADARB2;APOBEC1
prerank,ADP binding (GO:0043531),-0.2634850834190211,-0.8000237458911691,0.7832957110609481,0.93465679603989,1.0,6/25,15.34%,ME1;PGK1;ATP5F1A;GCLC;MYO18A;ATP5F1D
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.20169619438151504,0.7989469768412891,0.9185905224787363,0.953241842757746,1.0,37/269,12.21%,SMAD3;STAT2;POU5F1;AMBRA1;TRAF5;PARP9;IKBKE;APBB1;BCL2;VCL;PTPN22;CUL4A;DTX1;DTX3L;CCDC50;FHIT;STAT1;GSK3B;RNF20;NGFR;SNX9;TNFRSF14;SKI;UBE2C;SLC22A18;SLF2;PSMA3;SUMO1;SMAD6;DIO2;TRIOBP;DNM1L;SPOPL;SMG5;JAK1;CUL3;EGR2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.34238810735671504,-0.7987207041712802,0.7066115702479339,0.9327618824433608,1.0,5/10,30.07%,ANKRD13A;ANKRD13B;FAN1;LAPTM5;FAAP20
prerank,SUMO binding (GO:0032183),0.3370215999139671,0.7983262026371549,0.7223264540337712,0.9512784580011422,1.0,4/13,15.23%,RNF111;CASP8AP2;CBX4;PML
prerank,syntaxin binding (GO:0019905),-0.21697283701831666,-0.7973819362412994,0.8857142857142857,0.9311160024717229,1.0,22/61,26.66%,SYT1;SYNPR;NSF;SNAP25;STXBP5L;STXBP1;STX16;CPLX1;SNPH;NAPA;SYT9;SYT2;CACNA1A;SYPL1;SYT6;VPS18;SYT5;VAMP1;SYT10;STX7;SNAP29;SYT17
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2879869471475033,0.7948733168653341,0.7429078014184397,0.9542411838099679,1.0,4/27,6.49%,RNF217;RNF19A;SIAH2;PPARA
prerank,histone demethylase activity (GO:0032452),0.28472792280292347,0.7944315287037078,0.7762938230383973,0.9520138601066059,1.0,8/27,18.31%,KDM7A;KDM3B;JARID2;KDM5B;KDM2A;KDM8;KDM2B;KDM1A
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3221705775552483,0.791678254628779,0.7289048473967684,0.9535371282716603,1.0,6/16,21.82%,SLC5A7;SLC22A2;SLC22A4;SLC44A2;SLC7A8;SLC22A3
prerank,SH2 domain binding (GO:0042169),0.27844208689442324,0.7899764805708314,0.7717569786535303,0.9534627207326919,1.0,3/31,3.80%,DLC1;DAG1;AFAP1
prerank,nucleosomal DNA binding (GO:0031492),0.3042426262428013,0.7877918041457254,0.7419354838709677,0.954093866956016,1.0,7/21,15.51%,MBD2;HNRNPC;GATAD2B;ACTL6A;HDAC2;SMARCA4;SMARCC1
prerank,Notch binding (GO:0005112),0.29384402233541806,0.7859545724083465,0.7728085867620751,0.9541878873613078,1.0,3/22,6.08%,SNED1;AAK1;DTX1
prerank,cation transmembrane transporter activity (GO:0008324),0.24742862967044604,0.7853359233971008,0.7996845425867508,0.9522242509784438,1.0,7/48,12.53%,SLC7A2;SLC6A9;SLC38A6;PKD1L3;SLC41A1;SLC38A1;SLC38A9
prerank,heme binding (GO:0020037),-0.20938728653812452,-0.7841724165727878,0.8931506849315068,0.947999057750394,1.0,21/65,29.21%,NOS3;SDHC;GUCY1B1;NOS1;HMOX2;CYP2A6;PTGIS;CYBB;EIF2AK1;HEBP1;CYP2S1;SDHD;CYB5A;CYP46A1;NOX4;HMOX1;CYP2R1;ABCB6;CYP26B1;CYB5R4;FLVCR1
prerank,neuropeptide binding (GO:0042923),-0.2819808650827102,-0.7828336504739807,0.7611607142857143,0.9462630759786884,1.0,2/18,4.60%,OPRM1;SORL1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3370642449094797,0.7748250578014044,0.7089108910891089,0.9659413819659939,1.0,2/11,13.92%,FBXO11;CARM1
prerank,5'-3' exonuclease activity (GO:0008409),-0.28952339623650514,-0.773556961505868,0.791578947368421,0.9567707571436248,1.0,9/14,31.77%,MRE11;XRN2;DCLRE1C;CPSF3;FAN1;EXO1;DCLRE1B;FEN1;TRIR
prerank,muscle alpha-actinin binding (GO:0051371),0.3128282563083191,0.7710534231929225,0.7610294117647058,0.9686107109822994,1.0,4/15,17.13%,SYNPO2;PRICKLE4;PKD2;PDLIM2
prerank,N-methyltransferase activity (GO:0008170),0.2936094646202504,0.7704810590396964,0.7688266199649737,0.9666123185142718,1.0,7/20,23.50%,HNMT;ZCCHC4;FDXACB1;METTL15;PEMT;METTL5;PRMT1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.32925298179535456,0.7699133001260832,0.7603143418467584,0.964670728858051,1.0,12/12,67.10%,SPPL3;PSEN1;SPPL2A;BACE2;DDI2;BACE1;PGC;ASPRV1;SPPL2B;CTSE;NAPSA;HM13
prerank,four-way junction DNA binding (GO:0000400),0.3099997896211,0.7691102464849304,0.7842778793418648,0.9630085796547289,1.0,3/17,10.59%,WRN;RAD51B;FANCM
prerank,GDP binding (GO:0019003),0.23179657746823135,0.7663431036114824,0.8635658914728682,0.9641922779807903,1.0,18/63,22.75%,RRAS2;RAB10;RAB22A;ARL3;RAP2C;GEM;MIEF1;RIT1;RAB5A;TRIM23;RAN;RAP2B;GNAI3;DIRAS1;NRAS;RAP2A;RAB14;RRAGD
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.32810244178017695,0.7638666217797617,0.7412451361867705,0.964869081488853,1.0,11/11,67.21%,DDAH2;PADI2;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;ARG2;DDAH1
prerank,hyaluronic acid binding (GO:0005540),-0.3247947096030798,-0.7634803742122528,0.7945205479452054,0.9677839031145125,1.0,6/10,31.85%,LAYN;CEMIP;C1QBP;STAB2;CHODL;HYAL2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.23425223342835866,-0.7621716484625938,0.8465227817745803,0.9657440743510103,1.0,9/34,19.06%,DIS3L2;EXOSC2;ANGEL2;EXD2;XRN2;CNOT2;ERI1;EXOSC4;CNOT8
prerank,pseudouridine synthase activity (GO:0009982),-0.29506072412938156,-0.7601425830337107,0.7888198757763976,0.9648515567147121,1.0,7/13,29.86%,PUS7;PUS3;TRUB1;PUSL1;RPUSD2;RPUSD1;RPUSD3
prerank,kinase inhibitor activity (GO:0019210),-0.2382780091916752,-0.7595798073031554,0.875609756097561,0.9617538908169411,1.0,10/33,18.37%,SNCA;SMCR8;NPM1;LRP6;SH3BP5L;MAPK8IP1;RHOH;PRKRIP1;CDKN1A;CDKN1C
prerank,disordered domain specific binding (GO:0097718),0.2845042291230368,0.7548364046413569,0.799645390070922,0.9753376359274987,1.0,3/23,8.76%,FN1;NCOA3;TEAD2
prerank,ATP binding (GO:0005524),0.19102173602352276,0.752752163983317,0.9716399506781751,0.9753040883178299,1.0,40/266,15.34%,ATP1A2;ENPP1;PRKAG2;OXSR1;KSR1;TSSK3;BMPR1A;MYO1B;DAPK1;RRM1;TOP1;LATS2;TGFBR1;MAP4K1;WNK4;SIK3;STK3;PDXK;TLK2;AKT3;PFKM;IRAK3;HACL1;ABCA1;OAS2;CLPX;DAPK2;ERN2;PIP4K2B;ABCD3;SRPK1;MCM6;TRIB1;WNK1;NUAK2;TRNT1;ERCC6;ABCF1;P2RY1;STK4
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.28189110099244075,-0.7522494762735388,0.8365591397849462,0.9681082270079383,1.0,8/16,28.93%,MTMR6;MTMR12;MTMR7;MTMR2;SYNJ1;MTMR1;MTMR9;MTMR10
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2655651834193309,0.7494049209110865,0.8143100511073254,0.9771057401246795,1.0,11/29,19.61%,ABHD10;LCT;MGAM;ADPRS;CTBS;GANAB;NEU3;GANC;GBA2;PGGHG;IDUA
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.29194268954478697,-0.7486529126660268,0.8131868131868132,0.9689815807065937,1.0,8/14,28.93%,MTMR6;MTMR12;MTMR7;MTMR2;SYNJ1;MTMR1;MTMR9;MTMR10
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.2937707846753142,-0.7460162248994607,0.8029045643153527,0.9687029536105203,1.0,6/14,20.89%,USP13;MINDY3;MINDY2;YOD1;MINDY1;ATXN3
prerank,chemoattractant activity (GO:0042056),0.26820389603059425,0.7460029139560654,0.8096947935368043,0.9787915467981521,1.0,2/26,3.51%,CXCL10;VEGFD
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3107008078454865,0.7458622022241517,0.7833655705996132,0.9761138188472325,1.0,2/13,11.36%,AGPAT4;AGPAT3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24746339363606673,0.7451690507468949,0.8135593220338984,0.9742391926958704,1.0,7/34,14.77%,UBE2U;UBE2Z;UBE2C;UBE2Q2;UBE2E3;UBE2R2;BIRC6
prerank,MHC class I protein binding (GO:0042288),-0.29255379965806405,-0.7448994074735754,0.7952069716775599,0.9664644233336448,1.0,3/13,13.87%,ATP5F1A;ATP5F1B;TUBB4B
prerank,ferrous iron binding (GO:0008198),-0.26423347371210176,-0.7440016474548774,0.819634703196347,0.9637747113228522,1.0,3/21,4.96%,FTH1;SNCA;FTL
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3179633809548118,-0.7438755098531319,0.812,0.9601682401950717,1.0,7/10,45.01%,NAA50;BRCA2;USP22;MSL3;KAT8;HAT1;NAA60
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3189482709106295,0.7371889314806264,0.7853107344632768,0.9819386154450274,1.0,4/11,20.44%,RAD50;HNRNPA2B1;CTC1;NABP2
prerank,thioesterase binding (GO:0031996),0.31846949768527777,0.7309834886891753,0.7675276752767528,0.9871378498601309,1.0,1/11,3.15%,TRAF5
prerank,ATPase activator activity (GO:0001671),0.2840567474424235,0.7306858028544306,0.7869158878504673,0.9845793229413613,1.0,6/20,18.09%,DNAJA2;DNAJC1;TOR1AIP1;ATP1B2;DNAJB2;DNAJB6
prerank,G protein-coupled receptor activity (GO:0004930),0.1861549513883292,0.729677151694962,0.9809402795425667,0.9829201533890405,1.0,17/239,7.85%,LPAR1;ADGRD1;LGR4;FPR2;ADORA2A;GCGR;ADGRV1;GLP2R;F2RL3;MC2R;C5AR2;RXFP2;PDGFRB;QRFPR;BDKRB2;ADGRL1;OPRD1
prerank,ATPase regulator activity (GO:0060590),0.24579935733438915,0.7287342085836273,0.8470790378006873,0.9812906191597749,1.0,11/38,18.09%,SIL1;DNAJA2;DNAJC1;TOR1AIP1;FNIP1;ATP1B2;GRPEL1;HSPH1;ATP5IF1;DNAJB2;DNAJB6
prerank,deubiquitinase activity (GO:0101005),0.2074696525870509,0.7274134517689758,0.9317507418397626,0.9802358231142692,1.0,28/88,23.01%,USP18;USP9X;USP24;USP27X;STAMBP;USP47;USP8;STAMBPL1;MYSM1;USP40;USP34;USP36;USP35;USP12;USP45;USP15;JOSD1;USP32;USP10;USP39;USP4;BRCC3;USP7;PAN2;ZC3H12A;USP26;OTUD5;USP19
prerank,phosphatidate phosphatase activity (GO:0008195),-0.2843402221837003,-0.7230990143483267,0.8532494758909853,0.9820555413105033,1.0,7/13,23.65%,PLPPR1;PLPP5;PLPP1;PLPPR2;LPIN3;PLPPR5;PLPPR4
prerank,adenylyltransferase activity (GO:0070566),0.28049056830685776,0.7220558209315723,0.8116197183098591,0.9840869108224193,1.0,9/21,24.73%,OASL;PAPOLG;OAS2;TENT2;PAPOLB;FLAD1;TENT4B;SELENOO;PAPOLA
prerank,carboxypeptidase activity (GO:0004180),-0.2216965340307172,-0.7215174129876409,0.9081364829396326,0.980094425668524,1.0,10/35,22.20%,AGBL4;CPE;CPD;ACE2;CPA6;MINDY2;MINDY1;VASH1;CPXM1;CPZ
prerank,omega peptidase activity (GO:0008242),0.20468398806875027,0.7195780110111755,0.95,0.9843019835203648,1.0,29/89,23.01%,USP18;USP9X;USP24;USP27X;STAMBP;USP47;USP8;STAMBPL1;MYSM1;USP40;USP34;USP36;USP35;USP12;USP45;USP15;JOSD1;USP32;USP10;USP39;USP4;BRCC3;USP7;PAN2;APEH;ZC3H12A;USP26;OTUD5;USP19
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.2868833697014006,0.718875255894566,0.817658349328215,0.9823927202909222,1.0,2/15,11.36%,AGPAT4;AGPAT3
prerank,DNA replication origin binding (GO:0003688),0.2638806433920781,0.7153109035937928,0.8299065420560747,0.9838618699688598,1.0,5/23,15.69%,ORC5;MCM4;MCM6;ORC3;ORC4
prerank,serine-type peptidase activity (GO:0008236),0.20586252433166294,0.7149053980253071,0.9417910447761194,0.9815903467088319,1.0,17/96,21.80%,DPP4;PRSS57;CORIN;CTSH;ACR;PLAU;PLAT;ENDOU;CELA1;KLK1;KLK6;PRSS48;HP;HPR;APEH;NAALAD2;GZMM
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.27765127468039047,0.7142416803903461,0.8248175182481752,0.9796769236893347,1.0,4/17,13.37%,DPYD;PTGR1;LBR;PECR
prerank,ribonuclease P activity (GO:0004526),-0.2996336520727074,-0.713166214150419,0.8153526970954357,0.9858257737984416,1.0,2/11,12.78%,PRORP;RPP30
prerank,lipid phosphatase activity (GO:0042577),-0.2753694195005363,-0.7110714944171804,0.8492239467849224,0.9842314640792775,1.0,7/14,23.65%,PLPPR1;INPP5K;PLPP1;PLPPR2;SGPP1;PLPPR5;PLPPR4
prerank,ribosome binding (GO:0043022),0.22860861252322578,0.708921104726053,0.8842975206611571,0.9831004705842544,1.0,12/46,17.08%,SRP68;CPEB1;SBDS;NAA16;NAA15;SLFN14;EFL1;GEMIN5;MRPS27;SRP19;SHFL;CPEB3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.2919361728316199,-0.7062581712342836,0.8295218295218295,0.9817327486174636,1.0,5/11,23.87%,BAG1;HSPBP1;GRPEL2;BAG4;PFN1
prerank,adenyl nucleotide binding (GO:0030554),-0.2919361728316199,-0.7062581712342836,0.8295218295218295,0.9817327486174636,1.0,5/11,23.87%,BAG1;HSPBP1;GRPEL2;BAG4;PFN1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.31116310929547497,0.7053857928456327,0.8211382113821138,0.9842105782786613,1.0,2/10,7.62%,DSE;GLCE
prerank,Hsp70 protein binding (GO:0030544),-0.22091338078519435,-0.7028889649106747,0.9123222748815166,0.9814085291180418,1.0,17/31,43.61%,SNCA;RPS3;NOD2;GPR37;SACS;PACRG;DNAJA1;MVD;METTL21A;CYP2E1;IQCG;TSC1;DNAJC8;FICD;HDAC8;ERN1;CYP1A1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.30294669480686964,-0.7016048782308624,0.8546511627906976,0.9791030670532826,1.0,5/10,30.07%,ANKRD13A;ANKRD13B;FAN1;LAPTM5;FAAP20
prerank,FMN binding (GO:0010181),0.30718712874794485,0.7015278266526759,0.8190854870775348,0.9857263480628754,1.0,3/11,14.03%,POR;NOS2;HAO1
prerank,BMP binding (GO:0036122),0.3102870086090014,0.7013758480787502,0.8194945848375451,0.9831261774180421,1.0,1/11,2.63%,NBL1
prerank,death receptor binding (GO:0005123),-0.2584545767327554,-0.6992827259182086,0.8792372881355932,0.977720928317203,1.0,7/15,29.81%,DAB2IP;NGF;TMBIM1;NTF3;MYD88;FADD;PIDD1
prerank,serine-type endopeptidase activity (GO:0004252),0.2062519602981164,0.6980710612962024,0.936267071320182,0.9839390854287489,1.0,14/80,21.80%,DPP4;CORIN;CTSH;ACR;PLAU;PLAT;CELA1;KLK1;KLK6;PRSS48;HP;HPR;APEH;GZMM
prerank,microtubule plus-end binding (GO:0051010),0.26480557707814434,0.6947252548848872,0.85,0.984670189131068,1.0,7/20,22.61%,CLASP1;CLIP4;FBXW11;TTBK2;MAPRE3;CLIP3;MAPRE2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.25965751300107814,0.6946667633222505,0.8788426763110307,0.9820010463771872,1.0,1/24,0.87%,CMPK2
prerank,ribonuclease activity (GO:0004540),0.21525424925915346,0.6920891559911698,0.9201277955271565,0.9819567599826438,1.0,16/56,23.91%,PIWIL4;NYNRIN;SND1;SMG6;ENDOU;ERN2;SLFN14;ZC3H12B;EXOSC10;RNASEH1;RNASE3;RNASEL;YBEY;ZC3H12A;RNASEH2A;KHNYN
prerank,enoyl-CoA hydratase activity (GO:0004300),0.30678445507924257,0.6915373178690006,0.8265107212475633,0.9797915663025369,1.0,4/10,28.10%,ECHDC3;HADHA;ECHS1;ECHDC2
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.21954876922682987,0.6907544863556693,0.9254457050243112,0.9779030568139879,1.0,5/49,7.13%,ZFAND6;IKBKE;OPTN;DZIP3;PARP10
prerank,chloride channel regulator activity (GO:0017081),0.2849426802698737,0.6878998866181387,0.8552380952380952,0.9779030568139879,1.0,3/14,14.30%,WNK4;STX8;WNK1
prerank,histone deacetylase activity (GO:0004407),0.26565313835069815,0.6878143545713843,0.8607594936708861,0.975280874324134,1.0,3/19,6.62%,MIER3;MIER1;HDAC4
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.28520444183074206,-0.6862637347008097,0.8763557483731019,0.9867376575343029,1.0,5/11,26.62%,MAP3K5;MAP3K20;EGFR;TAOK2;MAP3K4
prerank,DNA polymerase binding (GO:0070182),-0.24770644064044778,-0.6858658962359376,0.895397489539749,0.9834024247109581,1.0,4/18,16.40%,HMGB1;HSP90AB1;HSP90AA1;RAD51
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.273147560833327,-0.6843147052741634,0.8719512195121951,0.9810596781650665,1.0,6/13,51.06%,MIF;ECI1;IDI1;DCT;HSD3B2;IDI2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.29339723416313246,0.6841173086083163,0.8429602888086642,0.9762625796479072,1.0,4/12,26.46%,GEMIN5;CYFIP2;CYFIP1;LARP1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2530106546991343,0.6775747574015737,0.8852173913043478,0.9799710131110252,1.0,3/22,7.13%,IKBKE;OPTN;PARP10
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.21242945318359963,-0.675599907585218,0.9482352941176471,0.9854070336220048,1.0,7/35,15.90%,H3-3A;NPM1;SMARCB1;RRN3;HDAC1;PARK7;KLF10
prerank,protein kinase regulator activity (GO:0019887),0.1928688571071631,0.6701059247940112,0.9693430656934306,0.9841116061317852,1.0,5/95,5.14%,CXCL10;PRKAG2;PARVA;TAOK3;CCND3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.2758717829066858,-0.6672389750616186,0.8862275449101796,0.9887767640516709,1.0,5/11,39.59%,RDH11;DHRS13;RDH12;ALDH3A1;RDH13
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.28912365558885345,0.6669354971024766,0.8413001912045889,0.984223663167423,1.0,4/12,21.33%,NOCT;PAN3;PARN;PAN2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.2542387134978276,0.6648671260604023,0.895117540687161,0.9833791425534237,1.0,8/20,24.36%,USP9X;USP47;SENP3;SENP1;USP7;OTUD5;USP25;SENP2
prerank,ubiquitin-specific protease binding (GO:1990381),-0.23493596571913616,-0.6609357894144521,0.919047619047619,0.9901405744796555,1.0,4/19,15.12%,RAD23A;SART3;BAG6;PARK7
prerank,Toll-like receptor binding (GO:0035325),-0.27877536994799357,-0.6605528285601913,0.9039665970772442,0.9868243476366385,1.0,7/11,36.59%,DAB2IP;TOLLIP;MYD88;TLR6;TLR1;S100A9;TIRAP
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.21651759983761001,-0.6600856875221445,0.9545454545454546,0.9836177558217805,1.0,6/26,20.37%,CSGALNACT1;B3GNT2;B3GNT9;B3GALNT2;CHSY3;B3GNT3
prerank,ATP hydrolysis activity (GO:0140603),0.21754540824298485,0.6575102877910918,0.9418803418803419,0.9868040825156595,1.0,2/41,2.04%,RNF213;ABCA4
prerank,O-methyltransferase activity (GO:0008171),-0.2840390611134289,-0.6573390510582255,0.8865546218487395,0.9822053883222401,1.0,3/10,22.38%,ASMT;FTSJ3;COQ3
prerank,tRNA binding (GO:0000049),0.21454614250307555,0.6545128811215162,0.9249592169657422,0.9865777369461445,1.0,10/43,16.53%,TERT;PUS1;SEPSECS;TRNAU1AP;CTU1;TRMT10B;ALKBH1;TRNT1;MRPS27;SSB
prerank,hydro-lyase activity (GO:0016836),-0.19202605201953787,-0.6543992833823923,0.9704433497536946,0.9808438106889438,1.0,8/41,16.38%,CA4;CA2;PARK7;HACD3;APIP;CYP2S1;FAHD2A;ENO1
prerank,RNA methyltransferase activity (GO:0008173),-0.2333327099800987,-0.6512747703684848,0.9456521739130435,0.9796095433359209,1.0,9/19,40.45%,TRMT13;FTSJ3;TRMT9B;METTL8;BCDIN3D;FBL;TRDMT1;FBLL1;METTL4
prerank,sequence-specific mRNA binding (GO:1990825),0.2932909981267454,0.6471923271373603,0.908745247148289,0.9896808929570738,1.0,5/10,29.70%,SSB;SHFL;DHX9;ETF1;FMR1
prerank,transaminase activity (GO:0008483),0.28380155929588713,0.6395428148203297,0.8707070707070707,0.9927118223368822,1.0,3/11,21.95%,ABAT;AGXT;PSAT1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2612791895549569,-0.6395344138869853,0.9069767441860465,0.9842205497333923,1.0,6/13,25.05%,ZGRF1;GEN1;DICER1;FAN1;EXO1;ENDOV
prerank,RNA cap binding (GO:0000339),0.2583539282901482,0.6384584942376098,0.9036144578313253,0.9909496905040858,1.0,4/16,22.31%,LSM1;GEMIN5;CYFIP2;CYFIP1
prerank,3'-5' exonuclease activity (GO:0008408),0.2056228387922726,0.6323450968622985,0.965964343598055,0.9927305495943138,1.0,11/45,16.77%,WRN;RAD50;POLG;EXD1;NOCT;DIS3L;USB1;RAD9A;DIS3;ERI3;EXOSC10
prerank,CARD domain binding (GO:0050700),-0.24751029329663252,-0.6297127552608699,0.9166666666666666,0.9869328017200134,1.0,5/14,21.92%,NOD1;NOD2;IRGM;CARD10;CASP1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.21620756791619464,0.625554384288292,0.9485049833887044,0.9948278421154321,1.0,13/33,25.18%,DCP2;NOCT;XRN1;DIS3L;USB1;DIS3;ERI3;EXOSC10;PARN;PAN2;PNPT1;EXOSC5;ANGEL1
prerank,death receptor activity (GO:0005035),0.271567891697496,0.6235067951879448,0.9007782101167315,0.993608805934645,1.0,2/11,8.14%,NGFR;TNFRSF14
prerank,ATPase binding (GO:0051117),0.184816584269729,0.6228909858619558,0.9808,0.9913871199969669,1.0,15/71,17.66%,TMTC4;SLC26A9;PTPN3;SNTA1;TOR1AIP1;TRPC1;ABCA1;ATP1B2;TCIRG1;CHMP4A;PKD2;ATP6V1E1;TAF9;ATP5IF1;NUFIP1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.24417182583290686,-0.6197795531027716,0.9175946547884187,0.9894658622484073,1.0,9/14,50.42%,PRORP;RPP30;POP7;TSEN34;ELAC2;RPP21;RPP40;POP1;POP5
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.24568556593724178,-0.6109048396798654,0.9234042553191489,0.9910474660521653,1.0,10/12,53.56%,GPR88;RRH;OPN1MW3;OPN1MW;ELOVL4;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.24527806798340382,-0.6025114757528922,0.9116465863453815,0.9918067298744476,1.0,2/12,9.94%,H3-3A;HDAC1
prerank,snRNA binding (GO:0017069),0.19471186768763682,0.5938424631092916,0.9741518578352181,1.0,1.0,6/42,16.47%,RBM41;SNRPA1;SF3B3;RNPC3;GEMIN5;DDX21
prerank,GABA receptor binding (GO:0050811),0.25660914946171615,0.593281801490263,0.9200743494423792,1.0,1.0,3/11,18.08%,TRAK1;JAKMIP1;ARFGEF2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.20226144070878252,-0.5869081829465558,0.9635535307517085,0.9953264722343829,1.0,1/21,1.20%,GRIK2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2575021649718617,0.578786315529299,0.9498069498069498,1.0,1.0,3/10,22.73%,CDKN2B;KAT2B;HEXIM1
prerank,mRNA methyltransferase activity (GO:0008174),0.24908976773383568,0.5762474288901734,0.9458955223880597,1.0,1.0,12/12,75.11%,METTL16;PCIF1;CMTR1;METTL3;CMTR2;TRMT61B;NSUN2;RNMT;TRMT61A;METTL14;TRMT10C;METTL8
prerank,vitamin D receptor binding (GO:0042809),-0.2184810494467146,-0.5740523456969818,0.9372384937238494,0.9970996786628067,1.0,3/14,17.00%,MED30;TAF11;RXRA
prerank,nucleotidase activity (GO:0008252),-0.21570820448821962,-0.5697358537452518,0.9625550660792952,0.9951830945713126,1.0,4/15,19.41%,BPNT2;NT5C2;NT5C3A;ACP3
prerank,5'-nucleotidase activity (GO:0008253),0.24124934502105275,0.5668371204910799,0.9398496240601504,1.0,1.0,2/13,10.24%,NT5C;NT5DC1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.2352564174032317,0.5588482041653289,0.9532374100719424,1.0,1.0,5/13,24.92%,TRMT10B;THUMPD3;METTL1;FTSJ1;TARBP1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.22922377535978322,-0.5554318872288782,0.9661016949152542,0.9967204446951533,1.0,6/11,34.40%,NUDT16L1;NUDT3;NUDT16;DCPS;NUDT11;NUDT1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.16226271827390806,-0.5553399746123723,0.992,0.9932602007205442,1.0,20/42,40.02%,CCND1;CNPPD1;CDKN1A;CCNF;CCNG1;CCNK;CCNC;HEXIM2;CDK5R2;CCNE2;CCNE1;CCNQ;INCA1;CCNA2;CDKN2D;CCNB1;CCNB2;CKS1B;CCNT1;CDK5R1
prerank,nuclear export signal receptor activity (GO:0005049),-0.22850793253871546,-0.5513428697547469,0.9560878243512974,0.9910382012421171,1.0,4/11,27.60%,XPO7;XPO1;NUP42;XPO6
prerank,microtubule minus-end binding (GO:0051011),0.23431711087687576,0.5509866286230309,0.9495495495495495,1.0,1.0,3/13,15.63%,TUBGCP4;TUBGCP2;TUBGCP5
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2259788094139249,-0.5441191499792774,0.9523809523809523,0.9896265187036527,1.0,7/11,41.81%,RPS3;HMCES;NEIL2;APEX1;APLF;NEIL1;NEIL3
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.17930130691951546,0.5387602189396995,0.9904761904761905,1.0,1.0,15/40,27.32%,HNMT;RRP8;COMT;THUMPD3;AS3MT;DNMT3A;PEMT;CARNMT1;LRTOMT;ICMT;METTL2B;METTL2A;TARBP1;SUV39H1;DPH5
prerank,endodeoxyribonuclease activity (GO:0004520),0.20509419398563067,0.5370739554420336,0.9833333333333333,1.0,1.0,5/20,17.42%,RAD50;RBBP8;ERCC5;ERCC1;DNA2
prerank,exoribonuclease activity (GO:0004532),-0.21567956174871206,-0.5310142081786909,0.9672489082969432,0.9895810507251844,1.0,7/12,45.33%,EXOSC2;EXOSC4;EXOSC1;EXOSC3;EXOSC8;EXOSC9;CNOT7
prerank,UDP-galactosyltransferase activity (GO:0035250),0.2393660191129742,0.5279574903932663,0.9573643410852714,1.0,1.0,1/10,7.45%,B4GALT1
prerank,antiporter activity (GO:0015297),0.2028555818026426,0.5244017397839223,0.968476357267951,1.0,1.0,4/20,14.99%,SLC35D1;SLC35D2;SLC35C1;SLC25A10
prerank,N-acyltransferase activity (GO:0016410),0.18406953686406685,0.5237248834631695,0.9932203389830508,1.0,1.0,2/32,4.41%,CERS5;CERS6
prerank,ubiquitin binding (GO:0043130),0.15263332434653545,0.5160077455746045,1.0,1.0,1.0,2/73,3.39%,SMAD3;NEDD4
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.22634126628657453,0.508862476201149,0.9694072657743786,1.0,1.0,4/11,26.13%,SLC22A4;SLC22A3;SLC25A20;SLC25A29
prerank,purinergic nucleotide receptor activity (GO:0001614),0.20277294359036063,0.5031080901378259,0.9797421731123389,1.0,1.0,3/15,16.85%,P2RX1;P2RY1;P2RX4
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.19906782753514757,-0.49300138404310734,0.98635477582846,0.9942932804358997,1.0,6/12,40.58%,NDUFS7;CRYZ;AIFM2;NQO1;CBR4;CBR1
prerank,methyltransferase activity (GO:0008168),0.15038375633570633,0.4684252631637757,0.9968102073365231,1.0,1.0,9/46,21.53%,METTL27;AMT;RRP8;COMT;AS3MT;MGMT;CARNMT1;LRTOMT;FTSJ1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.15163609500753614,0.455634759796606,0.9966499162479062,1.0,1.0,11/35,27.98%,FTO;TRPT1;DTWD1;ALKBH1;TYW3;PUS10;FTSJ1;DUS3L;QRSL1;GATB;QTRT1
prerank,glutathione transferase activity (GO:0004364),0.16653062910421781,0.45192163750528813,0.992818671454219,1.0,1.0,2/23,12.34%,GSTK1;GSTA3
prerank,tRNA methyltransferase activity (GO:0008175),0.1668039608647444,0.4112501765210314,0.998109640831758,1.0,1.0,6/16,24.92%,THUMPD3;TYW3;FTSJ1;METTL2B;METTL2A;TARBP1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.17437700081601903,0.40814652863396306,1.0,1.0,1.0,11/11,82.57%,CHRNA5;CHRNB1;CHRNB2;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA9;CHRNA7;CHRNA4
prerank,ribonuclease P RNA binding (GO:0033204),-0.17117471281384916,-0.39963124240017045,1.0,0.9990148949279272,1.0,6/10,50.42%,RPP30;POP7;RPP21;RPP40;POP1;POP5
prerank,N-acetyltransferase activity (GO:0008080),0.1541838387773884,0.3955006496366994,0.9981447124304267,0.9986228112979013,1.0,3/19,15.86%,ESCO1;NAT2;KAT2B
